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SUMMARY
Herpes simplex virus (HSV) has been implicated in the 
aetiology of human cervical cancer, but despite intensive 
investigation the oncogenic properties of HSV are still not 
well understood. Studies reported here, explore one possible 
molecular mechanism by which this virus may cause oncogenic 
transformation; namely, the induction of cellular 
polypeptides which play a role in oncogenesis.
A group of cellular polypeptides specific to cells 
showing the immortalized phenotype were previously detected in 
a range of cell lines, including the Bn5T cell line which is 
derived from rat embryo fibroblasts transformed by a fragment 
of the HSV type 2 (HSV-2) genome. These polypeptides which 
will be referred to as Bn5T:TBS polypeptides, are not 
detectable in control rat embryo fibroblasts. Bn5T:TBS 
polypeptides are immunoprecipitated by tumour bearing serum 
(TBS) and studies presented in this thesis confirm that they 
are also immunoprecipitated by the monoclonal antibody TG7A. 
The TG7A monoclonal was raised against affinity purified DNA 
binding proteins from HSV-2 infected cells and recognizes 
cellular polypeptides induced on infection by the virus. This 
suggests that Bn5T:TBS polypeptides are related to 
polypeptides induced in HSV-2 infection.
Another feature of Bn5T:TBS polypeptides is that they all 
show oncofoetal expression, suggesting that they have a 
physiological role in cell proliferation and differentiation. 
Members of the Bn5T:TBS set have always been found to be 
either co-expressed or not expressed at all, in a range of 
different cell types and culture conditions. This suggests 
that these polypeptides may have a common precursor or be 
induced by the same factor(s) and it also suggests that they
may have a common function. Three of the six members of the 
Bn5T:TBS set give similar peptide maps, suggesting that they 
possess similar or shared domains. In addition, pulse 
labelling and pulse-chase labelling experiments suggest that 
at least two members of the set result from post-translational 
processing events.
Immunological and peptide mapping studies indicate that a 
Bn5T:TBS polypeptide of 97kDa molecular weight, is related to 
the 90kDa heat shock protein (HSP90) and that it may share a 
domain with an HSV-2-induced form of HSP90. The TG7A 
monoclonal recognizes a highly conserved epitope present on a 
bacterial heat-shock protein, an HSV-2-induced 90kDa 
polypeptide (also recognized by a monoclonal against HSP90) 
and a 97kDa transformed cell polypeptide belonging to the 
Bn5T:TBS set. These findings suggest that an HSV-2-induced 
form of the HSP90 may play a role in oncogenic transformation 
by the virus.
The synthesis of Bn5T:TBS polypeptides has not been 
detected in the rabbit reticulocyte lysate in vitro 
translation system and possible reasons for this have been 
investigated. Further, data from an amino acid sequencing 
study suggests that the 97kDa polypeptide in the Bn5T:TBS set 
has a domain with homology to one form of bovine casein; 
likely explanations are discussed in detail.
ABBREVIATIONS
The following abbreviations are used in this thesis:
AFP alpha-foetoprotein
ATP adenosine triphosphate
BHK baby hamster kidney
b.p. base pairs
CEA carcinoembryonic antigen
CEF chick embryo fibroblasts
CIN cervical intra-epithelial neoplasia
CMV cytomegalovirus
c-onc cellular oncogene
c.p.e. cytopathic effect
c.p.m. counts per minute
dATP deoxyadenosine triphophate
DNA deoxyribonucleic acid
DNase deoxyribonuclease
d.s. double stranded
DW distilled water
E early gene
EBV' Epstein-Barr virus
EBNA Epstein-Barr virus nuclear antigen
EC embryonal carcinoma
EDTA ethylenediamide tetra-acetic acid
GRP glucose regulated protein
h hour
HGPRT hypoxanthine-guanine phosphoribosyl
transferase
HPLC high performance liquid chromatography
HPV human papillomavirus
HSP heat-shock protein
HSV herpes simplex virus
HSV-1 herpes simplex virus type 1
HSV-2 herpes simplex virus type 2
IE immediate-early HSV gene
i.p. immunoprecipitation/
immunoprecipitate(d)
IVT in vitro translation
k.b. kilobases
L late gene
LTR long terminal repeat
MEF mouse embryo fibroblast
MHC major histocompatibility complex
min. minutes
m.o.i. multiplicity of infection
MTR morphological transformation region
m.u. map unit
MuLV murine leukaemia virus
MW molecular weight
NK natural killer cell
NPT nonpermissive temperature
OFA oncofoetal antigen
ori origin of DNA replication
p.f.u. plaque forming units
p.i. post infection
pi isoelectric point
PT permissive temperature
RE rat embryo
RNA ribonucleic acid
RNase ribonuclease
r.p.m. revolutions per minute
RR ribonucleotide reductase
RSV Rous sarcoma virus
S Svedberg unit of sedimentation
SD standard deviation
SDEA stage-dependent embryonic antigen
SDS-PAGE sodium dodecyl sulphate polyacrylamide
gel electrophoresis
SV40 simian virus 40
syn syncytial
syn+ non-syncytial
TBS tumour bearing serum
TCA trichloroacetic acid
TK thymidine kinase
ts temperature sensitive mutant
TSTA tumour-specific transplantation
antigen
u units
UV ultraviolet
Vmw(X) virus-specific polypeptide of apparent
molecular weight(X)
v-onc viral oncogene
wt wild type
ug microgram
1 INTRODUCTION
The aim of this project was to explore one possible 
mechanism by which herpes simplex virus may induce oncogenic 
transformation. Studies described in this thesis have further 
characterized certain HSV-induced cellular polypeptides, which 
may have an important role in viral oncogenesis. As an 
introduction to this subject, an overview of the molecular 
biology of herpes simplex virus is presented in section 1.1; 
emphasis being given to genome organization, transcriptional 
regulation and virus-host interactions. Potential mechanisms 
of oncogenic transformation by HSV are then reviewed in 
relation to other DNA tumour viruses in section 1.2 and 
evidence for the transcriptional activation of certain 
cellular genes is described. Results presented in this thesis 
suggest that HSV-induced polypeptides are related both to a 
stress protein and to certain cellular tumour antigens. The 
properties of stress proteins are therefore outlined in 
section 1.3, while the characteristics of tumour antigens are 
reviewed in section 1.4.
1.1 Herpes simplex virus; general molecular biology
1.1.1 Classification
Herpes simplex virus (HSV) is a member of the herpesvirus 
genus or family. This family of viruses is subdivided into 
three sub-families on the basis of biological properties: The
alpha-, beta- and gammaherpesviruses (Roizman et a l ., 1978; 
Matthews, 1982; Roizman, 1982). Alphaherpesviruses show a 
relatively short replicative cycle, a variable host range and 
frequently establish latent infections in ganglia. HSV type 1
1 .
(HSV-1), HSV type 2 (HSV-2), varicella-zoster virus and 
pseudorabies virus are members of this group.
Betaherpesviruses have a relatively long replicative cycle, a 
narrow host range and may establish a latent state in 
secretory glands and lymphoreticular cells, and included in 
this group are human and mouse cytomegaloviruses. 
Gammaherpesviruses have a variable replicative cycle, are 
restricted to either T or B lymphocytes in vitro and 
frequently give rise to a latent infection in lymphoid tissue. 
Examples from this group are Epstein-Barr virus, Marek’s 
disease virus and herpesvirus saimiri.
1.1.2 Structure of the virion
Members of the herpesvirus genus have been recognized 
primarily by the architecture of the virion (Fenner et al ., 
1974). They are large DNA viruses of 150-170nm in diameter 
and are composed of the following structures (see figure 1.1):
(a) Core: This is a proteinaceous structure, around which
the double-stranded (d.s.) DNA genome is arranged (Epstein, 
1962; Ben-Porat and Kaplan, 1962; Furlong et al ., 1972).
(b) Capsid: An icosahedral structure (20 equilateral
triangular faces), composed of 162 protein capsomeres which 
surrounds the core (Wildy et a l ., 1960). It is approximately 
100nm diameter.
(c) Tegument: An amorphous layer, between the capsid and the
envelope (Roizman and Furlong, 1974).
(d) Envelope: A lipid membrane which forms the outer margin
2 .
Figure 1.1; Diagramatic representation of a section through 
herpesvirus particle.
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of the virus particle (Wildy et a l ., 1960) and is derived from 
the inner nuclear membrane of the cell (Darlington and Moss, 
1968).
1.1.3 Lytic cycle of HSV
(a) Adsorption and penetration: Adsorption of HSV to the v
cell surface occurs maximally within 30 min. of addition of
virus to cells (Hochberg and Becker, 1968) by a process which 
is thought to involve cell receptors for the virus. HSV-1 and
HSV-2 do not appear to have the same receptors as they
interfere with the adsorption of strains of the homologous, 
but not heterologous, serotype (Vahlne et a l ., 1979; Addison 
et a l ., 1984). Electron microscopy studies suggest that 
penetration occus mainly by fusion of the viral envelope with 
the cell membrane (Abodeely et a l ., 1970) but there is 
evidence that virions are internalized by endocytosis as well 
(Hummeler et a l ., 1969).
(b) Uncoating of viral genome: Uncoating of the HSV genome 
is a poorly understood process. De novo RNA and protein 
synthesis do not appear to be required for virus uncoating, 
which suggests that either cellular enzyme(s) or viral capsid 
component(s) are responsible (Hochberg and Becker, 1968). 
Nuclease-sensitive input virus DNA can be detected in the cell 
nucleus 15-60 min. post infection (p.i.) (Hummeler et a l ., 
1969).'
(c) Transcription, Translation and Replication:
Transcription of viral DNA and viral DNA replication occur in 
the cell nucleus. Translation of viral polypeptides occurs in
3.
the cell cytoplasm. These processes are described in detail 
below, as are the concurrent alterations in cellular 
metabolism.
(d) Assembly and release: Herpesvirus capsids are assembled
in the cell nucleus (Morgan et a l ., 1954). As viral protein 
synthesis occurs in the cytoplasm, viral structural proteins 
must be transported into the nucleus for encapsidation to 
occur. The process of cleavage of concatameric viral DNA into 
unit length genomes is closely linked with the packaging of 
DNA into capsids (Vlazny et a l ., 1982). Nucleocapsids are 
enveloped at the inner lamella of the nuclear membrane and 
appear to become enveloped by budding outward into the 
perinuclear space from areas of the inner lamella that are 
enriched with viral antigens (Ben-Porat and Kaplan, 1971;
Spear and Roizman, 1972). Egress of virus from the cell is 
first seen at approximately 8h p.i. at 37°C and seems to occur 
by exocytosis (Nii et a l ., 1968; Katsumoto et al., 1981).
1.1.4 HSV-encoded proteins
HSV-encoded proteins will 
context of their functions in 
However, a brief summary is gi
(a) Structural proteins: HSV
implicated in virus adsorption 
spread of infectious virus and 
Marsden, 1987). They are pres 
and on the plasma membrane of 
virus-specific proteins recogn 
following infection. Proteins
be largely discussed in the 
the viral multiplication cycle, 
ven here.
encoded glycoproteins have been 
and penetration, cell to cell 
cell fusion (reviewed by 
ent both on the virion envelope 
infected cells and are the major 
ized by the host immune system 
present in the capsid and
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tegument of the virion have been reviewed by Dargan (1986).
(b) Enzymes: Virus encoded enzymes involved in synthesis of
viral DNA include thymidine kinase, ribonucleotide reductase, 
deoxyuridine triphosphatase, DMA polymerase, exonuclease and 
topoisomerase (reviewed by McGeoch, 1987). An HSV-1 encoded 
protein kinase has recently been identified, which is the 
product of the viral gene US3 (Purves et a l ., 1987; Frame et_ 
al., 1987). This is of particular interest in relation to 
viral oncogenesis and is discussed in section 1.2.6.
(c) Other proteins: Proteins that interact with viral DNA
include the major DNA binding protein and the "orig” binding 
protein (reviewed by McGeoch, 1987). Proteins that regulate 
viral transcription are described in section 1.1.9.
1.1.5 Genome structure
Most studies on HSV genome arrangement have focussed on 
HSV-1. However, intertypic recombination and complementation 
data (Timbury and Subak-Sharpe, 1973; Esparza et al ., 1976; 
Marsden et a l ., 1978; Schaffer et a l ., 1978) and DNA/DNA 
hybridization studies (Davison and Wilkie, 1983a) indicate 
that HSV-1 and HSV-2 genomes are essentially colinear with 
viral genes mapping at equivalent positions on both genomes.
The entire nucleotide sequence of HSV-1 has now been 
determined (Dr D. McGeoch, 12th International Herpesvirus 
Workshop) .
(a) Chemical composition: The HSV-1 genome is a linear
double stranded DNA molecule of MW 95-100 X 10^ daltons 
(Becker e t a l . , 1968) and 152,260 residues in length with a
5.
base composition of 68.3% G+C (McGeoch et al . , 1988a).
(b) Long and short segments: Electron microscopy studies of 
structures produced by intramolecular hybridization of 
single-stranded DNA have shown that the HSV genome can be 
divided into long (L) and short (S) segments (see figure 1.2), 
each containing a unique sequence flanked by a pair of repeat 
sequences in opposing orientation (Sheldrick and Berthelot, 
1974). The long unique sequence (U^) of 110 k.b. is flanked 
by internal and terminal long repeats (IRl an<3 TRL ) both of
9.2 k.b. and the short unique sequence (Ug) of 13 k.b. by the 
internal and terminal short repeats (IRg and TRg) both of 6.6 
k.b.. Sequences of R^ and Rg are distinct (Me Geoch, 1987). 
HSV virion DNA contains equivalent amounts of 4 genome isomers 
in which and Ug are in different orientations (Delius and 
Clements, 1976). These isomers are apparently functionally 
equivalent, each producing viable progeny (Davison and Wilkie, 
1983b, 1983c). The biological significance of these different 
genome isomers is not yet known.
(c) "a" sequence: The "a” sequence is an element present at
both genomic termini in the direct orientation and at the 
junction of IR^ and IRg in the inverse orientation (Grafstrom 
et al ., 1974, 1975; Wagner and Summers, 1978). The HSV-1 "a" 
sequence varies from 250 base pairs (b.p.) to 500 b.p. due to 
a variable number of tandemly reiterated sequences, while the 
HSV-2 sequence which does not contain a reiteration has a 
constant size of 251 b.p. (Davison and Wilkie, 1981; Mocarski 
and Roizman, 1981; Varmuza and Smiley, 1985). The "a" 
sequence is thought to play a role in circularization of the 
genome following infection, in DNA maturation and
6.
Figure 1.2; Schematic representation of an HSV genome. The
genome consists of long (L) and short (S) regions. Each of 
these regions consist of a unique segment (U^ and Ug) flanked 
on either side by segments that are inverted repeats of 
eachother (Rg and R^ regions). Inverted repeats may be either 
terminal (TR^ and TRg) or internal (IR^ and IRg). The "a" 
sequence is present as a direct repeat at the genomic termini 
and in an inverted orientation at the L-S junction. Inversion 
of L and S regions occurs between inverted copies of the "a" 
sequence and this yields four possible isomers of HSV, each 
differing in the relative orientation of UL and US. (McGeoch 
et al., 1988)
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encapsidation (see below) and in the inversion of L and S 
segments. Inversion will occur if DNA fragments are flanked 
by "a" sequences in the inverted orientation but not if they 
are in the same orientation (Mocarski et a l ., 1980; Mocarski 
and Roizman, 1981; Smiley et a l ., 1981). Inversion could 
occur either by recombination or circularization of the genome 
followed by cleavage.
(d) Short tandem reiterations: Tandem sequence reiterations
have been observed in Ug, Rg and R^, with unit lengths of 5 to 
54 b.p. (Rixon et al ., 1984; McGeoch et a l ., 1985; Perry, 
1986). Reiterations may serve to increase the level of 
genetic exchange between the repeat regions (Rixon et a l .,
1984). In support of this suggestion one set of reiterations 
in the Rg segments has homology with sequences at 
immunoglobulin class-switch recombination sites (Gomez-Marquez 
e t a l . , 1985) .
(e) Organization of genes: Figure 1.5 shows the arrangement
of a number of HSV genes, discussed in this thesis. In all 
there are approximately 75 genes in the genome of HSV and 
these are found in both orientations and each gene has its own 
promoter. They are densely arranged, show some gene overlap 
and rarely have introns (reviewed by McGeoch, 1987). Families 
of 5 ’ co-terminal mRNAs occur relatively frequently in HSV 
(Wagner, 1985). Transcription of such genes starts 5 ’ to that 
gene coding sequence and continues through other genes of the 
family until a common distal polyadenylation site is reached. 
Only the 5 ’-proximal coding region of each transcript is 
translated (McGeoch, 1987).
7.
Figure 1.3; Organization of the HSV-1 genome. This diagram 
consists of a schematic representation of the HSV genome, with 
locations of the following indicated below it: (a) origins of
DNA replication (oriL and orig), (b) immediate early (IE) 
genes 1-5, (c) some virus induced enzyme activities including, 
ribonucleotide reductase subunits (RR-| and RR2) » protein 
kinase (PK), thymidine kinase (TK), DNA polymerase (pol), (d) 
major DNA binding protein (MDB), (e) the seven known 
glycoproteins (gB, gC, gD, gE, gG, gH, and gl), and (f) Vmw65 
or the 65kDa trans-inducing factor (65Krj.jp). The scale above 
the representation of the HSV-1 genome shows genome locations 
in map units (m.u.); (C. Maclean, thesis, University of
Glasgow).
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1.1.6 Replication of viral DNA
Semi-conservative HSV DNA replication at 37°C can be 
detected in the BHK cell nucleus 3h p.i., reaches a maximum 
between 9h and 11h p.i. and is virtually completed by I6h p.i. 
(Rixon, 1977). In the newly infected cell, incoming virus DNA 
accumulates in the nucleus and it is likely that it is quickly 
converted to a circular form (Poffenberger and Roizman, 1985; 
McGeoch, 1987). Late in infection, replicated DNA is in a 
very rapidly sedimentable form (Jacob et a l ., 1979) and there 
is a decrease in the number of terminal fragments detectable 
as compared with virion DNA (Jacob et a l ., 1979; Ben-Porat 
and Rixon, 1979). This evidence suggests that circularized 
unit-length molecules are replicated by a rolling circle 
mechanism yielding head-to-tail concatemeric DNA.
Concatameric DNA is further processed in the cell nucleus by 
packaging into nascent nucleocapsids and by cleavage to 
produce genome unit lengths (Vlazny et al ., 1982).
(a) Origins of replication: Evidence for at least 2 separate
origins of DNA replication in the viral genome, came 
originally from electron microscopy studies (Friedmann et al ., 
1977) and studies on the DNA of defective species of HSV 
(Frenkel et a l ., 1975). These studies suggested an origin of 
replication near the middle of (ori^) and also in the short 
repeat regions (orig). A plasmid replication system allowed 
detailed analysis of the cis-acting sequences needed for 
replication (Stow, 1982). A circular plasmid containing the 
HSV sequences under study was introduced into cells, together 
with virus/viral DNA to provide genes encoding proteins 
required for replication. Test plasmids containing sequences 
necessary for replication were amplified, and amplification
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was detected by the use of labelled parental vector DNA as a 
hybridization probe. This system allowed identification of a 
short segment origin of replication, "orig" which was 
localized by deletion analysis to a region of 90b.p. in the Rg 
sequences of HSV-1 between divergently transcribed genes, IE5 
and 4/5 (Stow and McMonagle, 1985). The orig sequence contains 
an imperfect palindrome with each arm consisting of 21 
residues and at the centre of the palindrome is a sequence 
(A-T)g which is essential for ori function (Stow, 1985). In 
Rg of HSV-2 strain HG52 there are sequences closely similar to 
HSV-1 orig (Whitton and Clements, 1984). A similar element 
termed "ori^M has been located in between divergently
transcribed genes for the major DNA binding protein and the 
DNA polymerase. Sequence analysis revealed a long perfect 
palindrome with arms of 72 residues bearing striking 
similarity to orig sequence (Gray and Kaerner, 1984; Quinn 
and McGeoch, 1985). The significance of the fact that both 
origins are located between divergently transcribed genes is 
unclear.
(b) Cleavage and packaging signals: The mechanism by which
concatemers are cleaved into unit-length genome molecules and 
packaged into viral capsids is not clearly understood, but 
cleavage and packaging are tightly linked (Deiss and Frenkel, 
1986; Stow et a l ., 1986). The "a" sequence contains signals 
for both cleavage (Varmuza and Smiley, 1985) and packaging 
(Stow et al., 1985).
(c) Trans-acting factors: The plasmid replication system has
been used to identify viral genes required for DNA replication 
(Challberg, 1986), various cloned fragments of HSV DNA being
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analysed by co-transfection with a orig- and ori^- containing 
plasmids. Using this assay in combination with data from 
large scale sequence analysis of the HSV-1 genome, seven HSV 
genes have been identified which are necessary for transient 
replication of plasmids containing orig or ori^ (Wu et a l ., 
1988). Two of the loci represent genes encoding DNA polymerase 
and the major DNA-binding protein, but the functions of the 
products of the remaining five genes are unknown (Wu et a l ., 
1988). By analogy to well characterized prokaryotic 
replication systems it has been suggested that these proteins 
may include a primase, a helicase, a topoisomerase, a protein 
which specifically binds to the HSV origins of replication and 
an accessory factor that increases the efficiency of DNA 
polymerase (Wu et al ., 1988). Sequence analysis of the five 
newly identified genes designated UL5 , UL8, UL9, UL42 and 
UL52, showed that all have counterparts in VZV, but only UL5 
and UL52 were detectably conserved in the more distantly 
related EBV (McGeoch et a l ., 1988). The UL42 gene product has 
recently been shown to be a previously recognized DNA-binding 
protein found in extracts of HSV-1 infected cells (Parris et_ 
a l ., 1988), but the remaining four genes do not correspond to 
any previously known proteins (McGeoch et a l ., 1988).
1.1.7 HSV transcription: viral and cellular transcription
compared
HSV transcription occurs in the cell nucleus (Wagner and 
Roizman, 1969). The sensitivity of viral transcription to 
alpha-amanitin indicates the involvement of the cellular 
enzyme RNA polymerase II throughout all stages of infection 
(Alwine et a l ., 1974; In common with most eukaryotic mRNAs, 
HSV transcripts are capped at their 5' termini (Moss et al .,
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1977) and most HSV transcripts are polyadenylated at 3' ends 
(Bachenheimer and Roizman, 1972). HSV genes have similar 
regulatory sequences to cellular genes, including 5* promoter 
elements such as the "TATA" box and "CAAT" box (Gannon et a l ., 
1979; Efstratiadis et a l ., 1980) and the 3' sequence AATAAA 
important for cleavage and polyadenylation of pre-mRNAs 
(Proudfoot and Brownlee, 1974; Zarkower et a l ., 1986). In 
addition a consensus sequence "YGTGTTYY" has been identified 
about 10 b.p. downstream from the polyadenylation site in a 
number of eukaryotic genes and this sequence has been shown to 
be required for the efficient formation of mRNA 3' termini 
(McLauchlan et al ., 1985). In contrast to cellular genes 
however, splicing is relatively rare for HSV genes (Wagner,
1985).
1.1.8 HSV transcription: sequential expression of viral
genes
Infection of permissive cells with HSV results in the 
sequential expression of three sets of viral genes termed 
immediate-early (IE), early (E) and late (L), (Honess and 
Roizman, 1974; Clements et a l ., 1977).
(a) IE genes and gene products: IE genes are expressed
immediately after virus infection and do not require de novo 
protein synthesis (Kozak and Roizman, 1974; Clements et al ., 
1977; Jones and Roizman, 1979). A summary of the 
nomenclature for these genes and the polypeptides they encode 
is shown in table 1.1.
With the exception of IE-5, all the IE genes encode 
phosphoproteins which are found mainly in the nucleus of 
infected cells and which are capable of binding to calf thymus
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Gene number Apparent MV ICP number
IE1 Vmw110 ICPO
IE2 Vmw63 ICP27
IE3 Vmw175 ICP4
IE4 Vmw68 ICP22
IE5 Vmw12 ICP47
Table 1.1; Nomenclature of HSV\ immediate-early (IE) gene
products. The products of the five IE genes have been named 
according to their apparent MW as indicated by migration rate 
on SDS-PAGE (Preston et a l ., 1978; Watson et al .t 1979). 
"Infectious cell polypeptide (ICP) numbers" (Honess and 
Roizman, 1974; Morse et al ., 1978), are also shown.
DNA (Pereira et a l ., 1977; Hay and Hay, 1980). The major 
function of IE gene products appears to be the transcriptional 
activation of later classes of viral genes (O'Hare and 
Hayward, 1985a; Everett, 1986).
In early studies on IE-3 gene ts_ mutants, it was found 
that all showed the same phenotype at non-permissive 
temperature (NPT). IE mRNAs and polypeptides were 
overproduced, while later classes of viral genes were not 
expressed at NPT (Courtney et al ., 1976; Marsden et a l ., 
1976). The conclusion from these studies was that the 
functional IE-3 gene product, Vmw175, is required for 
transcription of later classes of viral genes and is also 
involved in autoregulation of IE gene transcription (Preston, 
1979a; Dixon and Schaffer, 1980; Watson and Clements, 1980). 
Using a gel retardation assay Vmw175 has been demonstrated in 
complexes between infected cell polypeptides and the 
promoter/regulatory domains of 3 IE genes, a true L gene and 
the E thymidine kinase gene (Kristie and Roizman, 1986a). 
Vmw175 (and the HSV-2 equivalent) present in crude infected 
cell extracts, binds to both denatured and native DNA 
cellulose columns (Powell and Purifoy, 1976; Hay and Hay, 
1980). Partial purification of the equivalent HSV-2 
polypeptide causes loss of DNA binding, which is restored by 
mixing with infected or uninfected cell extracts (Freeman and 
Powell, 1982). These findings suggest that Vmw175 binds to 
DNA through an interaction with a host cell factor.
The IE-1 gene which encodes Vmw110 is diploid being 
encoded by both the TR^ and IR^ genomic regions. Virus 
mutants with deletions in both copies of this gene have been 
isolated (Stow and Stow, 1986; Sacks and Schaffer, 1987). 
Mutants were capable of replication in tissue culture, but
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with a 10-100 fold reduction in yield compared with wild type 
(w .t .) virus (Stow and Stow, 1986; Sacks and Schaffer, 1987). 
At low multiplicity of infection (m.o.i.) this reduction was 
most marked (Stow and Stow, 1986). Thus,Vmw110 appears to be 
essential for normal virus growth, particularly at low m.o.i.
A possible role for the protein is that it helps to ensure 
sufficient viral gene expression at low m.o.i. to commit the 
cell to a productive infection.
(b) E genes and gene products: E gene transcripts are
readily detectable by 2h p.i. and increase in abundance until 
6 to 8h p.i. after which the levels of individual early mRNAs 
either decrease or remain unaltered (McLauchlan and Clements,
1982). The expression of E genes depends on prior synthesis 
of IE gene products (Honess and Roizman, 1974; Watson and 
Clements 1980).
E polypeptides are synthesised prior to viral DNA 
replication and a number are involved in DNA synthesis. These 
include DNA polymerase, the major DNA-binding protein, 
thymidine kinase and ribonucleotide reductase (Maclean, 1987).
(c) L genes and gene products: L genes are expressed 
maximally following the onset of DNA replication about 2h p.i. 
and products reach peak levels by 10 - I6h p.i. (Swanstrom and 
Wagner, 1974; Holland et a l ., 1980). IE and E polypeptide 
synthesis as well as viral DNA replication are required for 
the efficient expression of L genes (Jones and Roizman, 1979; 
Holland et a l . , 1980). L genes can be divided into two 
groups. "Leaky late" genes (gamma 1 class) which are 
transcribed at low levels prior to DNA replication and "true 
late" genes (gamma 2 class) which are transcribed only after
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its onset (Jones and Roizman, 1979; Holland et al ., 1980).
A number of L gene products are structural proteins, 
including the major capsid protein (Vmw155, VP5) , glycoprotein 
C (gC) and the US11 gene product, Vmw21 (Marsden et a l ., 1976; 
Frink et a l ., 1983).
1.1.9 HSV transcription: regulation by trans-acting factors
and cis-acting elements
(a) IE gene regulation: IE gene transcription is
specifically trans-activated by the Vmw65 protein or 
trans-inducing factor (TIF), which is a major tegument 
phosphoprotein (Post et a l ., 1981; Campbell et a l ., 1984).
The consensus "TAATGARATTC" (R = purine) is found in the 
far-upstream region of all IE genes (up to -340 b.p.), but not 
E or L genes (Mackem and Roizman, 1982a; Whitton et a l .,
1983). The TAATGARATTC element has been shown to mediate 
responsiveness to Vmw65 (Preston et a l . , 1984; Gaffney et_ 
al_.,1985) and to have enhancer-like properties (Bzik and 
Preston, 1985). Attempts to demonstrate direct binding of 
Vmw65 to either calf thymus DNA or to the TAATGARATTC sequence 
have been unsuccessful (Marsden et a l ., 1987). However, more 
recently, using gel retardation assays and specific 
antibodies, it has been demonstrated that Vmw65 interacts with 
the TAATGARATTC element via cellular polypeptides (Preston et_ 
al. , 1988).
From the analysis of IE gene 5'-flanking sequences 
several cis-acting regulatory signals have been identified in 
addition to the TAATGARATTC consensus sequence (Gelman and 
Silverstein, 1987). These include a TATA homology located
approximately -25 b.p. 5' to the RNA start site, multiple Sp1
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binding sites (Jones and Tjian, 1985) and regions homologous 
to the SV40 enhancer core sequence.
IE genes are also subject to autoregulation and following 
the switch from IE to E mRNA synthesis, the abundance of IE 
polypeptides decreases (Dixon and Schaffer, 1980). IE, E and 
L proteins have been implicated in the negative regulation of 
IE polypeptide synthesis (Dixon and Schaffer, 1980; De Luca 
et a l ., 1984). Transfection assays and studies involving ts 
mutants suggest that Vmw175 has a strong suppressive effect on 
IE gene transcription (Dixon and Schaffer, 1980; Watson and 
Clements, 1980; Gelman and Silverstein, 1986), while in 
contrast Vmw110 appears to stimulate IE transcription (O’Hare 
and Hayward, 1985a; Gelman and Silverstein, 1986).
A binding site for partially purified Vmw175 has been 
identified by DNase I footprinting 100 nucleotides upstream 
from the HSV glycoprotein D (gD) mRNA cap site, as have two 
binding sites in the tet^ gene of the vector pBR322 (Faber and 
Wilcox, 1986). The authors propose that the sequence 
5'-ATCGTCNNNNYCGRC-3' (N = any base, Y = pyrimidine, R = 
purine), forms an essential component of the binding site for 
Vmw175 or for complexes between Vmw175 and cellular 
transcription factors. Using a gel retardation assay and 
crude infected cell extracts it has been shown that Vmw175 can 
interact with the promoter/regulatory region of IE genes 1, 2 
and 3 (Kristie and Roizman, 1986a, 1986b). The site of 
binding in IE1 and IE3 promoters was mapped by deletion 
analysis and exonuclease III protection. For IE1 the 
protected region is between 46 and 71 nucleotides upstream of 
the RNA start site and contains a sequence showing a high 
degree of homology to the consensus sequence of Faber and 
Wilcox. The complex with the IE3 promoter was found to be in
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the upstream regulatory region and was mapped to a fragment 
which does not contain the consensus (Kristie and Roizman, 
1986b). However, Muller (1987) has demonstrated Vmw175 
binding to its own transcription start site and found that the 
target sequence fits the consensus sequence of Faber and 
Wilcox. Binding of Vmw175 at this site could account for 
negative autoregulation of the IE3 gene expression. IE3 gene 
regulation and Vmw175 activity are summarized in figure 1.4.
(b) E gene regulation: Vmw175 is essential for E gene 
expression, but is not necessarily sufficient. Of seven E 
genes examined only two were almost fully expressed in 
response to Vmw175 alone while the others varied in expression 
from intermediate to very low levels (Persson et a l . , 1985). 
Vmw175 and Vmw110 can both independently stimulate E gene 
transcription, while in combination they seem to have a 
synergistic action (Everett, 1986; Gelman and Silverstein, 
1986; O'Hare and Hayward, 1985a).
The E gene tk has a promoter which contains binding sites 
for three cellular factors: TATA-box-binding protein, Sp1
and CAAT- binding protein (McKnight and Kingsbury, 1982;
Coen et al ., 1986). Promoters of the E genes gD and ICP8 also 
have sequence elements for binding of TATA-box-binding protein 
and Sp1, but not for the CAAT-binding protein (Su and Knipe,
1987). As the common promoter elements identified in HSV E 
genes all represent binding sites for cellular factors, it is 
likely that IE gene products interact with E gene promoters by 
modifying the binding properties of cellular transcription 
factors.
(c) L gene regulation: The greatly increased transcription
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Figure 1.4; Regulation of IE3 gene expression. The closed 
boxes in this diagram represent viral genes, immediate early 
(IE), early (E) and late (L). Regulatory and coding region 
sequences are denoted R and C respectively. MDB is the major 
DNA binding protein, which is encoded by an E gene.
Activating and inhibiting actions are represented by + and - 
signs.
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of L genes following initiation of DNA replication may be due 
to the resulting increase in gene copy number, to changes in 
viral genome structure and factor binding, or to changes 
resulting from cellular gene induction (Silver and Roizman, 
1985; Johnson and Everett, 1986a). Experiments with plasmid 
constructs containing the Ug11 promoter have shown that in the 
presence of a functional origin of replication, all sequences 
required for efficient expression of the L gene are contained 
within 51 b.p. of the RNA cap site. In addition, by deleting 
the distal promoter region of the E gene, gD and linking it to 
an origin of replication, its phenotype was changed to that of 
a L gene (Johnson and Everett, 1986b). These findings contrast 
with the upstream requirements of IE and E promoters and 
suggest that the three basic classes of HSV promoters may be 
distinguished by the extent of their sequence requirement, as 
shown in figure 1.5 (reviewed by Everett, 1987). Late 
promoters may consist simply of a TATA box and a capsite 
region on a replicating template.
Owing to the fact that many viral gene products are 
required for viral replication, it has not been possible to 
define the IE products required for late promoter activation 
in a normal replicating environment, but in the absence of DNA 
replication there is evidence that IE products are required 
for L promoter activation (reviewed by Everett, 1987).
(d) Conclusions: The understanding of eukaryotic gene
expression has been greatly advanced by studies on viruses 
(Preston et a l . , 1988). HSV encodes approximately seventy 
polypeptides and while at least five of these regulate gene 
expression, transcription of HSV DNA requires the cellular 
enzyme RNA polymerase II (Costanzo et al ., 1977). Evidence
17.
Figure 1.5; A proposed scheme for differentiating between the 
DNA sequences required for IE, E and L promoter activity
(Johnson and Everett, 1986). The top line indicates a scale 
in nucleotides upstream of the capsites.
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discussed above suggests that in order for Vmw65 and Vmw175 to 
interact with HSV DNA they must form complexes with cellular 
components. The levels of cellular transcription factors in 
different cells might therefore determine the course of HSV 
infection. Thus, if cellular factors important for the 
trans-activating functions of Vmw65 and/or Vmw175 are present 
at low abundance, (in certain HSV infected cells), latent 
infection or oncogenic transformation may occur instead of 
lytic infection.
The requirement for complex formation between 
transcription factors before interaction with DNA, might be 
important in a much broader context and may form the basis of 
eukaryotic gene control (Preston et a l ., 1988). Complex 
formation between protein transcription factors could be 
sensitive to changes in the intracellular environment and 
could produce rapid changes in transcription rate in response 
to appropriate stimuli (Preston et a l ., 1988). This would 
provide an efficient mechanism for the control of cellular 
transcription.
1.1.10 Effects of HSV infection on cell metabolism
Infection of cultured cells with HSV-1 or HSV-2 results 
in a rapid inhibition of the synthesis of cell DNA, the 
mechanism for which is unknown (Roizman and Roane, 1964). The 
synthesis of most species of cell RNA and protein is also 
rapidly inhibited (Roizman et a l ., 1965), but there are 
notable exceptions as described in the next section.
In the light of the interactions between viral and 
cellular transcription factors discussed above, it is not 
surprising to find that HSV infection affects cellular 
transcript ion. Infection of the adenovirus transformed 293
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cell line with HSV-1 has been shown to cause reduced 
transcription from the integrated adenovirus E1A gene and 
reduced synthesis of host ribosomal RNA (Stenberg and Pizer, 
1982) . These effects are not observed with ts mutants in IE 
gene 3, indicating that a functional Vmw175 may be required 
for decreased cell RNA synthesis following HSV infection 
(Stenberg and Pizer, 1982).
The shut-off of host protein synthesis can be divided 
into "early" and "delayed" phases. The early shut-off of host 
protein synthesis is mediated by an unidentified component of 
the infecting virion, while delayed shut-off depends on viral 
gene expression (Nishioka and Silverstein, 1977; Fenwick and 
Clarke, 1982). The delayed shut-off function is required for 
the full inhibitory effect on host protein synthesis and can 
occur in the absence of a functional virion component (Fenwick 
and Clark, 1982; Read and Frenkel, 1983). The mechanism(s) 
of shutoff of host protein synthesis are not clearly 
understood and appear to differ between cell types. Thus in 
HSV-infected Vero cells host mRNA degradation accompanies 
shutoff of host protein synthesis in the absence of viral gene 
expression (Schek and Bachenheimer, 1985), while in 
HSV-infected Friend erythroleukaemia cells, host mRNA 
degradation appears to require the expression of viral genes 
although globin synthesis is arrested by a virion function 
(Nishioka and Silverstein, 1978).
HSV-2 shut-off of host protein synthesis is generally 
more rapid and efficient than HSV-1 (Powell and Courtney,
1975; Pereira et a l ., 1977) and the virion function 
responsible for the diferential shut-off has been mapped using 
a battery of intertypic recombinant viruses to between 0.52 
and 0.59 m.u. (Morse et a 1., 1978). Such functions have also
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been mapped using virion-associated host shutoff (vhs) mutants 
like the vhs1 mutant of HSV-1 strain KOS. Unlike wt virus 
this is defective in function(s) responsible for the early 
phase of the shutoff of host protein synthesis but is normal 
with respect to the delayed shutoff function (Read and 
Frenkel, 1983). In cells infected with vhs1 viral mRNAs of 
IE, E and L classes also have a prolonged functional half-life 
(Read and Frenkel, 1983; Kwong et a l ., 1988). Mutation(s) 
affecting the functional half-lives of both host and viral 
mRNAs have been mapped by marker transfer assay to the same 
265 b.p. Nrul-Xmalll fragment spanning map coordinates 0.604 
to 0.606 of the HSV-1 genome (Kwong et a l ., 1988). This 
suggests that the shutoff of host protein synthesis is 
mediated by the same function that decreases the half-life of 
viral mRNA. The rapid shutoff function of HSV-2 and the 
defective function of the vhs1 mutant may represent the same 
gene since the 265 b.p. Nrul-Xmalll fragment lies at the 
right-hand border of the 11 k.b. region identified by Morse et_ 
al., (1978). The small discrepancy in map coordinates may 
reflect the way in which they were calculated (Kwong et al.,
1988). Interestingly the 265 b.p. Nrul-Xmalll fragment 
corresponds to one of the transforming regions of HSV-2 and 
the possible relationship between transformation and host 
shutoff functions will be discussed in section 1.2.6.
It has recently been proposed that HSV encodes a function 
which indiscriminately shortens the half-life of host and 
viral mRNAs (Kwong and Frenkel, 1987). Shutoff of host 
protein synthesis may allow the maximum translational capacity 
of the cell to be used in the expression of viral genes and 
the reduced viral mRNA half-life may lead to more economical 
use of the cell's translational machinery by IE and E mRNAs to
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allow for maximum synthesis of structural proteins when virion 
maturation begins (Kwong et a l ., 1988).
1.1.11 Activation of cellular genes by HSV
It has been shown that a number of cellular RNAs are 
induced by a mechanism that requires IE gene expression (Patel 
et a l ., 1986), while others may be induced by mechanisms that 
parallel activation of the IE genes by Vmw65, or simply by 
adsorption of the virus to the cell surface (Kemp et a l .,
1986).
Certain cellular genes are activated by HSV IE products 
in transfection experiments. The rabbit beta-globin gene 
promoter responds to viral activation when in a plasmid 
(Everett, 1983) and when integrated into the host chromosome 
of a biochemically transformed cell line (Everett, 1985). 
However, the endogenous beta-globin gene of rabbit kidney 
cells is not activated by virus infection which may be due to 
a densely packed chromatin configuration making the promoter 
unavailable for viral trans-activation (Everett, 1985). Many 
other cellular genes may fail to be activated on viral 
infection for the same reason.
Heat-shock proteins are induced in chick embryo 
fibroblasts (CEF) by tsK at NPT (Notarianni and Preston,
1982). This cellular response has been shown to be due to the 
presence of abnormal Vmw175 protein rather than the 
overproduction of IE proteins (Russell et a l ., 1987). However 
natural isolates of HSV-1 frequently show mutations in the 
gene encoding Vmw175 (Knipe et a l ., 1981; Post et al ., 1981). 
Thus, the induction of heat-shock proteins by HSV may be 
important in vivo.
Infection of human embryo fibroblasts with HSV-2 induces
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the synthesis of a minor cellular stress protein of 57kDa MW, 
which is synthesised in a growth regulated manner (LaThangue 
et a l ., 1984). By the analysis of cDNA libraries made before 
and after HSV infection, it has been demonstrated that the 
gene encoding this protein is induced at the level of 
transcription (Patel et a l ., 1986).
The induction of stress proteins in viral infection may 
represent an attempt by the cell to protect itself. 
Alternatively, it may result from the viral induction of 
cellular functions which facilitate viral multiplication 
(Patel et al . , 1986). Heat-shock proteins might be induced to 
mediate the repression of cellular biosynthesis which is seen 
in heat-shocked cells (Peterson and Mitchell, 1981)
The induction of heat-shock genes also occurs in cells 
infected with the DNA tumour viruses adenovirus (Nevins,
1982), polyoma virus and SV40 (Khandjian and Turler, 1983). 
This has led to the suggestion that the activation of such 
genes might be involved in transformation.
Western blotting studies have shown that TG7A recognizes 
a 35 - 40kDa polypeptide induced on HSV-1 infection and a 
90kDa polypeptide induced on HSV-2 infection (La Thangue and 
Latchman, 1988). Cellular polypeptides investigated in this 
study have been immunoprecipitated from HSV-2 transformed 
cells using the same monoclonal antibody and have similar 
molecular weights (MW) to both HSV induced polypeptides 
(Macnab et a l ., 1985a). These authors suggested that 
induction of these cellular polypeptides in cells infected by 
HSV might be an important step in initiation of oncogenic 
transformation by the virus (see section 1.2.7).
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1.1.12 Possible outcomes of infection with HSV
The possible outcomes of HSV infection are lytic
infection with the production of infectious progeny, latent 
infection, cell transformation producing an oncogenic 
phenotype, cjoorhOe of
(a) Infection with HSV in vitro; Infection of permissive 
cells in vitro usually results in productive lytic infection, 
whilst abortive infection with defective virus can result in 
cell transformation as will be discussed in section 1.2.5.
(b) Clinical features of HSV infection: HSV-1 infections are
usually first manifest as an acute stomatitis (inflammation of 
the mucous membrane of the mouth) contracted in early 
childhood (Burnet and Williams, 1939), although infection is 
usually asymptomatic. Typically, at intervals of months or 
years after recovery from the primary infection, vesicles from 
which the virus can be recovered appear around the lips and 
nose and are triggered by a variety of stimuli, including 
exposure to UV light, fever, menstruation, nerve injury and 
emotional disturbances (Fenner et a l ., 1974). HSV-2 causes a 
sexually transmitted genital infection in man, characterized 
by the occurrence of vesicles which break down to give painful 
superficial ulcers persisting for two weeks or more. Genital 
lesions may occur in both sexes and like the "fever blisters" 
of HSV-1 infection, they may recur at intervals (Passmore and 
Robson, 1974). The link between HSV-2 infection and cervical 
cancer is discussed in section 1.2.
(c) HSV latency: The consistent failure of researchers to
isolate HSV from biopsies of tissues at the site of recurrent
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infections between the recurrences, as well as other studies, 
led Goodpasture to postulate that the virus persists in 
ganglia in a latent state after the local lesion has healed 
(Goodpasture, 1929). The persistence of latent HSV in the 
sensory neurones of trigeminal ganglia has since been 
demonstrated both in the mouse model (Stevens and Cook, 1971, 
1973; MacLennan and Darby, 1980) and in man (Baringer and 
Swoveland, 1973; Lonsdale et a l ., 1979), latent virus being 
recoverable by co-cultivation of ganglionic tissue with 
susceptible cells in tissue culture.
HSV-1 DNA in latently infected mouse neurones has been 
found by Fraser and coworkers to exist as a non-linear endless 
form which may be either a circular molecule or a concatamer. 
Further, they have found that the viral DNA does not appear to W  
integrated into the host DNA (Mellerick and Fraser, 1987). It 
remains to be established whether the HSV-1 genome in latently 
infected neurones exists as a supercoiled plasmid as does 
latent EBV (Baichwal and Sugden, 1988). The search for HSV 
functions related to latency has involved the analysis of 
virus mutants for their ability to establish latent infection 
and the analysis of latently infected cells for the presence 
of viral gene products. Recent studies using the latter 
approach have yielded particularly interesting results. 
Transcripts from the HSV-1 genomic region encoding the IE 
protein Vmw110, but encoded by the opposite DNA strand, have 
been detected in latently infected mouse sensory neurones 
(Stevens et a l ., 1987). These were the only transcripts 
readily detected by in situ hybridization and were localized 
mainly in the neuronal nuclei. It has been suggested that the 
latency-associated transcript may function as an antisense 
RNA, regulating IE1 gene expression and thereby influencing
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entry into the lytic cycle (Stevens et a l ., 1987)
(d) Conclusions: A subject of great importance in
Herpesvirology is the molecular basis for the very different 
virus : cell interactions that can occur following infection, 
and recent advances in the understanding of HSV latency are 
therefore encouraging.
In the next chapter, current knowledge of the oncogenic 
properties of HSV will be reviewed, following a preliminary 
account of the properties of oncogenes and DNA tumour viruses 
other than HSV.
1.2 Oncogenes, DNA tumour viruses and HSV oncogenesis
1.2.1 Oncogenes
(a) The role of oncogenes in oncogenesis: Cellular oncogenes
(c-onc) or protooncogenes and their viral counterparts, viral 
oncogenes (v-onc) which were first discovered as the 
transforming genes of retroviruses, have been established as 
critical elements in the neoplastic transformation of 
mammalian cells (reviewed by Bishop et al., 1984). In 
transformed cells oncogenes may be overexpressed or may 
express proteins that function abnormally or inappropriately 
(table 1.2), resulting in the by-passing of normal cellular 
controls that regulate cell division and differentiation.
The human ras oncogenes (Ha-ras, Ki-ras and N-ras) all 
code for highly related proteins of 189 amino acid residues 
known collectively as p21, and it has been demonstrated that 
these genes acquire oncogenic potential by single point
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Table 1.2; Oncogenes and their products
A. Some viral oncogenes and their products. Abbreviations 
sarcoma virus, SV; Murine leukemia virus, MuLV; protein 
kinase, PK; macrophage stimulating factor (CSF-1).
B. Some cellular homologues to viral oncogenes
A.
Viral
oncogene
v-src
v-yes
v-fps
v-fes
v-ros
v-abl
v-mil
v-fms
v-erb-A
v-erb-B
v-sis
v-myc
v-myb
B. 
Viral 
oncogene
v-erb-A
v-erb-B
v-fms
v-sis
Viral Subcellular location Activity
origin of v-onc product
Rous SV 
Y73 avian SV 
Fujinami SV
Snyder-Theilen 
feline SV
UR2 avian SV
Abelson MuLV
Avian S V ,
MH2
plasma memb.
plasma memb.?
cytoplasm/ 
plasma memb.
cytoplasm
plasma memb. 
cytoplasm
tyrosine kinase 
tyrosine kinase 
tyrosine kinase
tyrosine kinase
tyrosine kinase
tyrosine kinase
serine/threonine 
kinase
Feline S V ,
McDonough
strain
Avian erythro­
blastosis
Avian erythro­
blastosis
Simian SV
Avian myelo- 
cytomatosis 
virus, MC29
Avian myelo­
blastosis 
virus
plasma memb., 
ER and Golgi 
apparatus
cytoplasm
plasma memb.
cytoplasm
nucleus
nucleus
activation of 
CSF-1 receptor 
PK domain
activation of 
oestrogen PK 
domain
activation of 
EGF receptor 
PK domain
PDGF activity
binds DNA, 
thought to 
activate 
transcription
binds DNA?
v-onc product cellular homologue
p75gaS”erkA oestrogen receptor
gp65er^ ”B truncated EGF
receptor
gp120fms CSF-1 receptor
p28sis PDGF B chain
mutations at two specific hot spots (codons 12 and 61). 
Further, it has been demonstrated that ras oncogenes can be 
activated in tumours induced by a variety of chemical 
carcinogens (Sukumar et a l ., 1984) however, the activation of 
oncogenesis by mutation does not appear to be a characteristic 
feature of spontaneous tumours (Slamon et a l ., 1984). A more 
common finding is the increased expression of c-onc genes due 
to changes like gene amplification (Dalla-Favera, 1982) or 
chromosome translocation. In some cases of Burkitt's lymphoma 
for example, the c-myc gene on chromosome 8 is translocated to 
the immunoglobulin heavy chain locus on chromosome 14, which 
contains enhancer elements which increase c-myc expression 
(Taub et a l ., 1984). Such changes are however, far from 
universal (Slamon et a l ., 1984).
"Acute" transforming retroviruses can deliver a dominant 
transforming v-onc gene to susceptible cells that can 
transform cells in one step (Klein and Klein, 1986). The 
genome structure and replication cycle of these viruses are 
shown in figure 1.6. They are assumed to have evolved by 
recombination between non-oncogene-containing retrovirus and 
c-onc genes. The recombined oncogenes exert their oncogenic 
effect in the viral genome where they are under the influence 
of a strong promoter in the long terminal repeat region (fig 
1.6). Similarly, DNA constructs containing a mutated ras 
allele under the control of a strong promoter, can induce both 
immortalization and transformation of RE cells (Spandidos and 
Wilkie, 1984). While such rapid one-step transformations are 
interesting and important models for studying carcinogenesis, 
it must be remembered that naturally-occurring spontaneous 
cancers arise by slow multiple steps (Klein and Klein, 1985). 
In contrast to most retroviruses, oncogenic DNA viruses appear
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Figure 1.6; Retrovirus life cycle. Following infection, 
reverse transcription of retroviral genomic RNA takes place 
and synthesis of the complementary DNA strand also occurs.
The double-stranded DNA then circularizes and recombines into 
the cellular genome, where transcription occurs producing 
viral mRNA and genomes.
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mRNA and genomes
in general to require more than one gene to establish and 
maintain neoplastic transformation (Glaichenhaus et a l .,
1985).
Retroviruses and their nonessential transforming v-onc 
genes, have been placed repeatedly under strong selection 
pressures yielding rare recombinational events that are 
probably encountered infrequently in the wild (Duesberg,
1985). In the wild selection pressures act against parasites 
which frequently cause fatal disease (e.g. malignant tumours) 
in members of the host species (Mims, 1977). A virus that is 
too pathogenic is a poorly adapted parasite, as by killing the 
host, it reduces its own chances of transmission.
(b) Classification of oncogenes: Oncogenes can be divided
into two groups according to their ability to cooperate with 
either c-myc or c-ras in the transformation of rat embryo 
fibroblasts (Land et a l ., 1985). Group 1 oncogenes cooperate 
with c-ras, and include adenovirus E1a, polyomavirus large T 
and c-myc. These proteins which are found associated with 
nuclear structures have an immortalizing action on RE cells 
and are thought to act by modifying cellular transcription 
(Glaichenhaus et a l .,1985). The gene encoding the cell 
protein p53 also belongs to this group and has been shown to 
cooperate with the ras oncogene in malignant transformation 
(Jenkins et a l .,1984.).
Group 2 oncogenes, in contrast, cooperate with c-myc in 
the transformation of rat embryo fibroblasts, and include 
c-Harvey-ras, c-N-ras and polyoma middle T. The proteins 
encoded by this group are found attached to the inner surface 
of the plasma membrane. The ras gene product, p21 ras, is 
thought to be involved in signal transduction into the cell
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following the binding of hormones to cell surface receptors 
(review, Newbold, 1984).
A group of viral oncogenes, not included in this 
classification are the tyrosine protein kinases, v-src, v-yes, 
v-fgr, v-abl and v-fps (review, Hunter, 1984). Sequence 
homologies provide strong evidence that these protein kinases 
comprise a single divergent gene family (Kamps et al ., 1984; 
Hunter, 1984). The main substrate for viral protein kinases 
appears to be a 36kDa cellular polypeptide, which has been 
found in the terminal web of intestinal columnar epithelial 
cells and may have a structural function. In addition the 
v-src gene product, p60v_src, has been shown to phosphorylate 
phosphatidyl inositol which is thought to lead to activation 
of a serine-specific protein kinase.
Sequence analysis of the viral oncogenes v-mil, v-mos, 
v-fms and v-erb-B suggests that they may also encode protein 
kinases (Kamps, 1984). The cellular homologue of v-erb-B 
encodes the epidermal growth factor receptor. Simian sarcoma 
virus encodes another interesting viral oncogene, v-sis, which 
encodes a product almost identical with platelet-derived 
growth factor (Waterfield, 1983). In addition, feline 
leukaemia virus transduction of the gene encoding the beta 
chain of the T cell antigen receptor has recently been 
detected (Fulton et a l ., 1987) and it has been suggested that 
this v-tcr gene is a novel viral oncogene.
(c) The immortalized phenotype: REF cells immortalized by
group 1 oncogenes like c-myc are phenotypically similar but 
not identical to in vitro established cells (Glaichenhaus et 
al., 1985., Land et al .,1985.). In both cases cells show
unlimited growth in culture and are able to grow as isolated
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colonies at low cell density. However, in contrast to low 
passage cells established in vitro, oncogene-immortalized 
cells are also capable of growth at low serum concentration 
and show susceptibility to transformation by chemical 
promoters like TPA (Glaichenhaus et al ., 1985). At high 
passage however, in vitro established cells become less serum 
dependent and more like oncogene-immortalized cells, showing 
increased growth rate on treatment with TPA. (Glaichenhaus et 
al., 1985).
Cells of a primary culture transformed by a combination 
of myc and ras oncogenes produce tumours that usually reach a 
large but static size. In contrast, established cells 
transformed by the ras oncogene produce tumours with 
apparently unlimited growth capacity (Land et al ., 1985).
Thus, there may be a third distinct gene which cooperates with 
myc and ras to produce the full tumourigenic phenotype (Land 
et al ., 1985).
Thus, the phenotype of oncogene immortalized cells 
differs from that of low passage established cells, 
which suggests that the immortalized phenotype is complex and 
not always reached by a single step. There may be a number of 
undiscovered cellular genes responsible for induction of the 
immortalized phenotype, which have escaped detection because 
the assays used have only detected oncogenes which complete 
the entire immortalization process (Glaichenhaus et al .,
1985).
(d) Oncogene expression in early development: Differential 
transcriptional activity of c-onc genes, during the prenatal 
and early postnatal development of the mouse has been 
demonstrated (Muller et al . ,1982). Slamon & Cline (1984)
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reported appreciable levels of transcription of five c-onc 
genes, between days 7 and 18 of murine prenatal development. 
These included c-src, c-myc, c-Ha-ras, c-erb, and c-sis. The 
expression of c-src was not marked until after day 10, and at 
day 17 c-myc expression was 2-5 times greater than at other 
stages tested. These results indicate that c-onc gene products 
may have important physiological functions in the 
developmental processes of embryogenesis.
(e) Antioncogenes: The antioncogenes comprise a new class of
genes important in oncogenesis, and they were detected through 
the study of hereditary human cancers like retinoblastoma and 
Wilm's tumour (reviewed by Knudson, 1985). For a given 
antioncogene locus, the presence of one normal allele is 
sufficient to protect a cell against neoplastic change. 
Therefore, in a heterozygous individual with one normal allele 
for a particular antioncogene, tumour formation only occurs if 
this normal allele is lost from a cell by somatic mutation or 
recombination (Knudson, 1985).
1.2.2 DNA tumour viruses: some oncogenic mechanisms
In this section, an account will be given of some 
oncogenic mechanisms of a few well characterized and 
intensively investigated DNA tumour viruses. This will 
provide a background against which possible oncogenic 
mechanisms for HSV will be described.
Both DNA and RNA tumour viruses are capable of causing 
tumours in animals, but while oncogenic potential among the 
RNA viruses is restricted to one genus (Leukovirus), oncogenic 
viruses are found in four of the six genera of DNA viruses.
RNA tumour viruses are the causative agents of natural
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leukaemias and sarcomas in a large number of animal species, 
whereas DNA tumour viruses with the exception of the
Herpesviruses, do not in general cause tumours in their hosts
\ ,
under natural conditions (Fenner et a l ., 1974).
The oncogenic properties of the DNA tumour viruses SV40, 
polyoma virus and adenovirus have been thoroughly investigated 
in vitro and these properties will now be described briefly.
In addition, the results of some interesting studies on 
transforming proteins of the Herpesvirus, Epstein-Barr virus 
(EBV) will be outlined.
(a) Transformation by SV40 and polyoma virus: SV40 and
polyoma virus are members of the Polyomavirus genus and both 
are small viruses containing about 3X10 daltons of dsDNA.
Both viruses are oncogenic for rodents and cause 
transformation of cells in culture (Fenner et al ., 1974).
SV40 and polyoma virus may cause either productive or 
non-productive infection depending on whether the cell type is 
permissive for viral multiplication. The productive response 
yields viral progeny and results in cell death, while 
non-productively infected cells which produce little or no 
virus survive and may become stably transformed (reviewed by 
Sambrook, 1972).
In cells transformed by SV40 or polyoma virus, viral DNA 
containing a functional early region is invariably found 
integrated into cellular chromosomal DNA (Sambrook et a l ., 
1968; Basilico et a l ., 1980; Lania et a l ., 1980a). No 
common sequence or structural features are found in either 
viral or cellular DNA sequences at integration sites. 
Transformation by polyoma virus and SV40 does not appear to be 
due to the integration event itself (Lania et a 1., 1980b), but
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rather to the addition of a specific viral oncogene to the 
cellular genome. If a viral life cycle is completed, 
infectious virus particles are released and cell lysis occurs. 
However, rare transformation events are likely to arise in 
cells nonpermissive for viral DNA replication, when viral DNA 
happens by chance to become integrated into the host 
chromosome, thereby ensuring viral persistence in progeny 
cells. The expression of SV40 large T or polyoma middle T 
induces cell DNA synthesis and cell division (Stoker and 
Dulbecco, 1969; Fried, 1970). Thus, if these viral genes are 
integrated, cancer cells could result which would continue to 
divide under conditions where normal cell division is 
inhibited (Fried and Prives, 1986).
i. SV40 large T antigen: The large T antigen of SV40 can
trans-activate certain genes. This was first demonstrated by 
the ability of SV40 large T to activate the late SV40 promoter 
in transient transfection assays (Keller and Alwine, 1984). 
More recently, it has been shown to activate a number of other 
promoters, including certain cellular promoters and the 
adenovirus E2 promoter. The fact that purified large T 
antigen shows no affinity for the E2 promoter DNA sequence, 
suggests an indirect mechanism of action (Alwine, 1985). In 
non-simian (non-permissive) cells, SV40 large T forms a tight 
complex with a cell-encoded nuclear phosphoprotein, p53 (Lane 
and Crawford, 1979). A lower affinity complex can be detected 
in simian (permissive) cells (Crawford et a l ., 1981). It has 
recently been shown that p53 competes with DNA polymerase 
alpha for binding to the SV40 T antigen (Gannon and Lane,
1987) and to inhibit SV40 origin-dependent DNA replication 
(Braithwaite e t a l  . , 1987). Further, p53 from non-permissive
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species binds to the large T more tightly than p53 from 
permissive species (Lane et al ., 1982). The outcome of 
competition between p53 and DNA polymerase alpha for the large 
T could be a determinant of host cell permissiveness (Gannon 
and Lane, 1987).
The oncogene encoding SV40 large T has properties of both 
group 1 and group 2 oncogenes. The large T antigen is a 
complex multifunctional protein which is found both in the 
nucleus where it binds to DNA and at the cell membrane. It is 
sufficient for both immortalization and transformation of 
primary RE cells (reviewed by Livingston and Bradley, 1987). 
SV40 mutants that have lost their nuclear location signal and 
whose large T is predominantly in the cytoplasm, can still 
efficiently transform cell lines but not primary cells 
(Kalderon et a l ., 1984. This indicates that either the amount 
of large T is required for transformation is small, or that 
transformation is mediated by a non-nuclear form of the large 
T.
A small proportion of SV40 large T antigen has been 
detected in association with cell membranes (Deppert et al., 
1980; Gooding et al ., 1984) . Highly purified large T has an 
associated autokinase activity and can catalyse the 
phosphorylation of multiple, unrelated protein substrates 
(Griffin et a l ., 1979; Livingston and Bradley, 1987).
Thus, SV40 large T antigen is found both in nuclear and 
extranuclear locations, which would appear to be consistent 
with the general pattern, by which immortalizing oncogenes 
like c-myc are located mainly in the cell nucleus, and 
transforming oncogenes like the protein kinase c-src are 
located in the cytoplasm and plasma membrane (table 1.2).
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ii. Polyoma virus T antigens: Three T antigens are expressed
by integrated polyoma virus sequences in transformed rodent 
cell lines: the chromatin-associated large T, the membrane
associated middle T and the cytosolic small T antigens (Ito,
1980). Polyoma large T like SV40 large T, represses early 
promoters and activates late gene expression (Brady et al.,
1984). A tyrosyl-specific protein kinase activity is found 
associated with the middle T antigen, which is thought to be 
due to a small amount of c-src complexed to the middle T 
antigen (Courtneidge and Smith, 1984). However, it is 
possible that complex formation with the middle T antigen 
leads to activation of c-src by increased phosphorylation 
(Yonemoto et a l ., 1985). Expression of middle T antigen is 
sufficient to transform established cell lines (Triesman et 
a l ., 1981) and the small T antigen cooperates with middle T in 
this action. Polyoma virus large T antigen is not required 
for maintenance of the middle T antigen induced transformed 
phenotype in established cells, but is required for 
maintenance of transformation for primary cells. This is due 
to the immortalizing action of the polyoma virus large T 
antigen (Land e t a l . , 1983a; Rassoulzadegan et al., 1983).
(b) Transformation by adenoviruses: Mammalian adenoviruses
have a linear dsDNA of MW 20-25X10^ daltons which for 
comparison, is approximately 1/4 the DNA content of 
Herpesviruses (Fenner et a l ., 1974). Like Polyomaviruses and 
Herpesviruses, adenovirus genes are expressed in temporally 
regulated groups during lytic, productive infections. Early 
(E) RNAs appear prior to DNA synthesis while late (L) RNAs 
only appear in significant amounts after viral DNA synthesis 
(reviewed by Green et a l ., 1970).
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Different human adenovirus serotypes vary in their 
tumourigenic capacity in rodents and while some like 
adenovirus 12, 18 and 31 are highly tumourigenic, others like 
types 2 and 5 are non-tumourigenic. It is interesting to find 
that non-tumourigenic strains of human adenovirus transform 
rat cells in vitro as efficiently as the highly tumourigenic 
adenovirus 12 (reviewed by Fenner et al ., 1974).
Cell lines derived from adenovirus-transformed 
non-permissive cells do not usually maintain a complete copy 
of the viral genome, but only a subgenomic fragment from the 
left-hand 8-12% of the viral genome, which contains genetic 
information sufficient for transformation of primary cells in 
culture (Sambrook et a l ., 1975). This region contains two 
transcription units, E1A and E1B which are both responsible 
for oncogenic transformation by the virus (Graham et al .,
1974; Gallimore et a l ., 1974). E1A products transcription­
ally activate other E genes in the adenovirus genome (Nevins,
1981) as well as certain cellular genes including HSP70 
(Nevins, 1982). The E1A gene gives rise to three distinct 
mRNAs by differential splicing (Berk and Sharp, 1978) and the 
products of two of these are transcriptional activators, both 
being required for full transformation in combination with E1B 
(Winberg and Shenk, 1984). The E1B gene product, E1B-p58 
complexes with p53 in adenovirus transformed cells (Sarnow et_ 
al., 1982) as does large T antigen in SV40 transformed cells.
Transfection of primary RE cells with the E1A gene 
promotes the establishment of immortalized non-tumourigenic 
clones (Houwelling et al ., 1980), while E1B expressed in the 
absence of E1A produces no detectable effect (Van den Elsen et_ 
al., 1983). These results suggest a two step transformation 
pathway, as do the studies with polyoma virus large and middle
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T antigens.
(c) Transformation by EBV: Like HSV, EBV is a member of the
Herpesvirus genus. EBV readily infects human B cells in 
culture transforming them into permanent cell lines in which 
every cell carries multiple episomal copies of the viral 
genome (reviewed by Dambaugh et a l ., 1986). Only the 
so-called latent viral genes are constitutively expressed in 
transformed cells and these include the EBV nuclear antigens 
(EBNAs) and the latent membrane protein (LMP).
EBNA is invariably associated with EBV-transformed cells 
as well as Burkitt’s lymphoma and nasopharyngeal carcinoma 
both of which are human tumours thought to be caused by EBV 
(Pope et a l ., 1969; Reedman and Klein, 1973). Initially EBNA 
was found to be a high MW basic protein of 170-230kDa composed 
of a 48kDa subunit in an oligomeric complex with a 53kDa 
polypeptide of probable cellular origin (Luka et al., 1978,
1980). It was later shown that the 48kDa protein is the 
degradation product of a larger component of EBNA (Luka e_t 
al ., 1983) and it was demonstrated by immunoblotting studies 
that the major component of EBNA has a MW of 65kDa to 70kDa 
depending on the strain of the resident virus genome in the 
cell type under investigation (Strnad et al ., 1981). This 
form of EBNA, termed EBNA1, is important in episomal 
maintainence of the viral genome in transformed cells (Reisman 
et al., 1985). A second type of EBNA termed EBNA2 with a MW 
of 82kDa has been identified (Strnad et al ., 1981) and there 
is now direct evidence from the comparison of natural EBV 
isolates with differing EBNA2 allelles, that this protein 
plays a continuing role in the expression of the transformed 
phenotype (Rickinson et a 1 ., 1987).
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LMP is expressed in latently infected proliferating 
lymphocytes and can convert Rat-1 cells (which are 
immortalized cells) to a tumourigenic phenotype (Wang et al. , 
1985). Thus, EBV posesses more than one transforming function, 
in the same way as SV40, polyoma virus and adenovirus.
(d) Summary: From the above account it can be seen that
SV40, polyoma virus, adenovirus and EBV all encode more than 
one transforming function. The viral sequences encoding these 
37functions are retained by the transformed cell, which 
suggests that their continued expression is important for 
maintenance of the transformed phenotype. No single 
transforming function appears to be sufficient for oncogenic 
transformation of primary cells in culture.
1.2.3 Oncogenic herpesviruses
Marek’s disease virus (MDV), herpesvirus saimiri (HVS) 
and EBV all produce tumours in animals and all are members of 
the gammaherpesvirus sub-family. MDV induces malignant 
lymphomas in chickens (Kato and Hirai, 1985) and HVS isolated 
from squirrel monkeys induces lymphomas on inoculation of 
marmosets (Melendez et a l ., 1970). EBV also induces lymphomas 
in marmosets and is believed to be involved in the aetiology 
of Burkitt's lymphoma and nasopharyngeal carcinoma in man 
(Dambaugh et al ., 1986). Herpesviruses which may be causative 
agents of cancer of the cervix include the alphaherpesvirus, 
HSV and the betaherpesvirus, human cytomegalovirus (HCMV).
A potential role for HCMV in the aetiology of cervical 
cancer is suggested by the fact it is a sexually transmissible 
cause of cervicitis and urethritis (Evans, 1976), and has 
oncogenic potential in vitro (Fletcher et al ., 1986).
37.
Seroepidemiological studies of the association between HCMV 
infection and cervical neoplasia have produced conflicting 
results but HCMV DNA, RNA and antigens have all been detected 
in HCMV transformed cells and in tumours (reviewed by Macnab,
1987). Strong evidence for the retention of integrated HCMV 
sequences in cervical neoplasia has been obtained by Fletcher 
et a l ., (1986), who detected sequences hybridizing to HCMV DNA
in 2/43 biopsies taken from patients with cervical 
intra-epithelial neoplasia (CIN). In one of these biopsies 
the DNA sequences detected contained four restriction sites 
colinear with those of the prototype strain AD169 (Fletcher et_ 
al ., 1986). Subsequent identification of HCMV DNA sequences 
in clones of an EMBL3 library constructed from the CIN DNA 
further confirmed the association (Macnab and Fletcher, 
unpublished results). Interestingly, HCMV sequences detected 
represented the major enhancer and the region responsible for 
the initiation of morphological transformation (reviewed by 
Macnab, 1987) .
1.2.4 The role of HSV in the aetiology of cervical cancer
Cervical cancer is the most common malignant disease of 
the female reproductive tract, second only to carcinoma of the 
breast as a cause of death from neoplasia for women and it is 
also a disease of relatively young women with a peak incidence 
in the 45 to 49 year age group (Parker, 1969).
Much clinical and laboratory data exists to link both HSV 
and human papillomavirus (HPV) with the causation of cervical 
cancer (reviewed by: Baird, 1985; Macnab, 1987) and it has
been suggested that HSV and HPV may have a synergistic effect 
in oncogenesis (zur Hausen, 1982). The evidence that HPV is a 
causative agent of human genital cancer has been strengthened
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by detection of specific types (HPV-16 and HPV-18) in a high 
percentage of genital cancer biopsies (Durst et al., 1983; 
Scholl et a l ., 1985; Macnab et a l ., 1986; Murdoch et a l .,
1988). It has been demonstrated recently that an enhancer in 
the upstream regulatory region of HPV-16 shows specificity for 
cervical carcinoma cells (HeLa cells) as compared with MCF-7 
cells (Gloss et a l . , 1987). The significance of this 
interesting finding is not yet clear, but it may relate to 
HPV16 tissue tropism which may have an important bearing on 
the role of HPV16 in the aetiology of cervical cancer.
Early evidence of a causative role for HSV in cervical 
cancer came from the demonstration of an increased incidence 
of abnormal cervical smears showing premalignant change in 
women with genital HSV-2 infection (Naib et a l ., 1966).
Subsequent seroepidemiological studies added to the evidence 
of an association between HSV-2 infection and cervical cancer, 
as will now be described.
(a) Seroepidemiological studies: A major problem in
demonstrating a cause-effect relationship between HSV-2 
infection and cervical cancer is that there is an association 
between genital HSV-2 infection, a range of other venereal 
infections, promiscuity and smoking. Many of these factors 
may be important in the aetiology of cervical cancer. If an 
epidemiological study is to be meaningful therefore, control 
groups must be carefully matched with test groups for many 
factors including age, sexual behaviour and smoking habits 
(Baird, 1985). While there are some studies which suggest 
that HSV-2 infection may be an aetiological agent of cervical 
cancer (Nahmias et a l ., 1974; Aurelian et a l ., 1975), not all 
studies agree with this conclusion (Vonka et al ., 1984a,
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1984b) .
(b) Evidence of retained HSV information: RNA homologous to
HSV DNA has been demonstrated in pre-malignant cervical cells 
but not in matched control biopsies and it was shown using 
specific cloned fragments of the HSV genome that Rg regions 
and a region with map units 0.07-0.4, hybridize preferentially 
(McDougall et a l . , 1980; Eglin et al ., 1981). As mentioned 
in section 1.2.4, Rg regions of the HSV genome show 
considerable homology to regions of human DNA. In addition, 
cellular DNA sequences in tumour cells with homology to the 
plasmid vector pBR322, have been found to undergo 
amplification in tumour cells (Park, 1983; Macnab et a l ., 
1984; Cameron et a l ., 1985). Thus, the detection of RNA 
homologous to HSV DNA in cervical neoplasia does not 
necessarily indicate the persistence of viral sequences in the 
cell (Macnab, 1987).
HSV antigens have been demonstrated in exfoliated 
cervical cells from 60-90% of cases of cervical dysplasia, CIN 
and invasive cervical cancer (Royston and Aurelian, 1970). In 
addition the major HSV DNA binding protein has been detected 
by monospecific antisera in over 30% of cervical tumor 
specimens and CIN biopsies (Dreesman et a l ., 1980).
HSV-2 DNA sequences have been detected in biopsies of 
cervical carcinoma in situ (CIN) and invasive cervical cancer 
and almost all studies reveal the presence of Bgllln fragment 
sequences in a small proportion of cases (Galloway and 
McDougall, 1983; Park et a l ., 1983; Macnab et a l ., 1985b, 
1986; Prakash et al., 1985). Overall, approximately 10% of 
cervical cancer or CIN biopsies show detectable HSV sequences. 
The authenticity of these results was reinforced by the
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demonst rat ion of five rest riot ion sites characteristic of the 
Bgllln fragment of HSV-2, in a restriction fragment of 
cervical cancer cell DNA which had been detected using the 
Bgllln fragment to probe Southern blots (Park et a l ., 1983). 
The detection of HSV DNA in cervical cancer specimens is 
circumstantial evidence that HSV has an aetiological role. 
Significance is added however, by the fact that the retained 
HSV DNA fragment most frequently detected is from one of the 
two regions of the HSV-2 genome with in vitro transforming 
activity (see below).
An animal model for HSV-induced cervical cancer has been 
developed, which adds to the evidence for a causative role of 
HSV in the human disease (Wentz et a l ., 1981). In one study 
24/40 mice to which UV inactivated HSV-2 was administered 
intra-vaginally, developed invasive carcinoma of the cervix as 
compared with 0/25 of a control group exposed to uninoculated 
culture medium (Wentz et a l ., 1981). Using a similar system 
it has been shown that the Skinner vaccine (Skinner et al.,
1987) protects mice against development of carcinoma of the 
cervix following exposure to HSV-2, reducing the incidence to 
less than half (Chen et a l . , 1986).
1-2.5 Morphological transformation of cultured cells by HSV
(a) Morphological transformation regions of HSV: While the
link between HSV infection and cervical cancer remains 
controversial, it is now well established that abortive 
infections with defective HSV can transform normal rodent 
embryo cells with a finite lifespan and give rise to 
tumorigenic transformed cell lines (Galloway and McDougall, 
1983; Cameron et al ., 1985; Jariwalla e t a l . , 1986). Three
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regions of the HSV genome are associated with morphological 
transformation of cultured cells, one in HSV-1 and two in 
HSV-2 (figure 1.7). The morphological transformation region 
(MTR) of HSV-1 (MTRI) maps in Bgllli (Camacho and Spear, 1978; 
Reyes et a l ., 1979). In HSV-2, one morphological transforming 
region MTRII maps in Bgllln (Reyes et al., 1979; Macnab and 
McDougall, 1980; Galloway and McDougall, 1981; Cameron et 
a l ., 1985), while the other, MTRIII maps in Bglllc (Jariwalla 
et al ., 1983). The transforming activity mapping in Bgllln 
was subsequently further localized to a 737 b.p. subfragment 
of the left half region of Bgllln (Galloway et al ., 1984).
(b) The "hit and run" hypothesis: By analogy with other DNA
tumour viruses like SV40, polyomavirus and adenovirus, one 
might expect that HSV DNA fragments from the MTRs would be 
integrated into the cell chromosome and encode transforming 
viral proteins. However, in HSV transformed cell lines the 
quantity of viral DNA present is always less than one copy per 
cell and varies with passage in culture (Galloway et a l .,
1980; Cameron et al ., 1985). Southern blotting analysis on a 
range of HSV-transformed rat cell lines, showed that no HSV 
sequences of 1 k.b. or more were detectable even if present at 
only 0.1 copies per cell (Cameron et a l ., 1985). Thus, it is 
very unlikely that sufficient HSV DNA could be retained in 
most HSV-transformed cell lines, to encode a protein 
responsible for maintenance of the transformed phenotype.
This does not exclude the possibility that active 
recombination of HSV sequences into the host cell chromosome 
might be important for HSV oncogenesis (Galloway and 
McDougall, 1983). Short HSV DNA sequences might be difficult 
to detect by Southern blotting analysis because they are
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Figure 1.7; Transforming regions of HSV. Diagram to show the 
location of genomic regions associated with transformation by 
HSV-1 (MTR-1) and HSV-2 (MTR-2 and Bglllc) as described in 
section 1.2.5.
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rearranged after integration so that they are not in a 
homologous position in all cells. Alternatively, they may act 
in a "hit and run" manner, activating an oncogene perhaps and 
then being rapidly excised from the host cell chromosome 
(Galloway and McDougall, 1983).
A system favouring stable integration of viral sequences 
was produced by co-transfection of NIH 3T3 cells with the 
HSV-2 Bgllln fragment and the pAG60 plasmid which confers 
resistance to the antibiotic G418 (Saavedra and Kessous-Elbaz, 
1985) . Co-transfection with the complete Bgllln fragment gave 
colonies of both normal and transformed morphology, but an 
overall reduction in efficiency of colony formation in G418 as 
compared with pAG60 alone. This suggests that the Bgllln 
fragment has an inhibitory effect on cell proliferation, 
perhaps due to a lethal mutagenic action. The inhibitory 
effect may account for rapid excision of the Bgllln fragment 
from the genome of transformed cells. Sub-fragments 
corresponding to each end of Bgllln will transform NIH 3T3 
cells when co-transfected with pAG60 and no inhibitory effect 
on colony formation is seen (Saavedra and Kessous-Elbaz,
1985). Thus, Bgllln appears to be required in its entirety 
for the inhibitory effect, which could result from the 
combined actions of the three proteins totally encoded by 
Bgllln which have MWs of 38kDa, 58kDa and 6lkDa (Galloway et 
al.., 1982).
The failure of HSV-transformed cells in tissue culture to 
retain viral sequences contrasts with the presence of HSV 
sequences in a small but significant proportion of cervical 
cancer and CIN biopsies. The differences observed are not 
understood, but may result from the fact that cervical cancers 
are generally of epithelial origin while the rat cells
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examined in tissue culture are predominantly fibroblastic 
(Macnab, 1987).
1.2.6 Possible mechanisms of HSV oncogenesis
(a) Trans-activation of cellular genes: Evidence for the 
trans-activation of cellular genes by HSV is presented in 
section 1.1.11. No HSV genes have as yet been shown to 
function as oncogenes in the same way as the adenovirus E1A 
gene or the SV40 gene for large T antigen. This may be 
because HSV-coded transcriptional activators are too vigorous 
in their activity and cause lethal alterations in the cell 
(Nevins, 1986). The pseudorabies IE gene for example is very 
toxic to cells and when co-transfected with a selectable 
marker produces a marked reduction in the number of surviving 
colonies. Attenuated strains of HSV with mutant IE genes 
might therefore have immortalizing/transforming activity 
(Nevins, 1986). This possibility seems more likely in the 
light of reports that natural isolates of HSV-1 frequently 
have ts_ mutations in the IE gene encoding Vmw175 (Knipe et_ 
al., 1981; Post et a l ., 1981).
(b) Activation of cellular genes by reduced methylation:
Experiments with mouse retroviruses have provided strong 
evidence that transcript ion is increased by demethylation of 
certain DNA sequences (Jahner et al ., 1982). In addition, a 
number of examples are known in which tumour cells show 
reduced DNA methylation when compared with normal control 
cells (Adams and Burdon, 1983).
Rat embryo cells show a marked reduction in the 
methylation of cellular DNA synthesised following infection
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with HSV-2, while in HSV transformed cells, DNA shows reduced 
levels of methylation compared with control rat embryo cells 
(Dr J. Macnab, personal communication). It has been 
postulated that transformed cells resulting after an abortive 
HSV infection, may have been selected as a result of 
HSV-induced undermethylation and possible consequent 
expression of a cellular protooncogene.
(c) Mutagenesis and amplification of cellular genes:
Chromosomal aberrations, including both random damage and 
specific gaps have been reported in HSV infected cells 
suggesting a mutagenic effect of the virus (Stich et a l ., 
1964). The virus was subsequently demonstrated to have a 
mutagenic effect on a specific cellular gene. Treatment of 
permissive cells with UV inactivated HSV-1 and infection of 
non-permissive cells with wild-type HSV-2 have both been found 
to increase the mutation frequency in the cellular 
hypoxanthine-guanine phosphoribosy1 transferase (HGPRT) gene 
(Schlehofer and zur Hausen, 1982; Pilon et a l ., 1985). In 
cells infected with HSV-2, the transcription rate for the 
HGPRT gene and the size of transcripts are similar to 
uninfected cells, suggesting that the mutagenic effect is due 
to point mutations rather than gene rearrangements (Pilon £t_ 
al., 1986). Such mutations could have oncogenic effects if 
they activated oncogenes like c-ras or inactivated 
antioncogenes for which an individual is heterozygous.
Expression of the BamHIg fragment of the HSV-1 MTRI 
region in bacterial cells, using expression vectors puC7, 8 
and 9 with the viral DNA fragment inserted in both 
orientations, has allowed assessment of the mutagenic effects 
of the encoded peptide (Shillitoe et al ., 1986). Expression
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of the fragment in E.coli C resulted in the increased 
reversion rate of a bacterial frameshift mutation for only one 
of the constructs. This suggests that the BamHIg fragment 
encodes a mutagenic peptide which may perhaps be involved in 
cell transformation. The peptide is thought to consist of 37 
amino acids, 6 of which are encoded by the vector (Shillitoe 
et al ., 1986).
Evidence also exists for gene amplification by HSV. A 
wide range of chemical and physical carcinogens have been 
shown to selectively amplify integrated SV40 sequences in an 
SV40-transformed Chinese hamster cell line (Lavi, 1981) and 
both HSV-1 and HSV-2 have been found to amplify integrated 
SV40 genes in the same way (Schlehofer et a l ., 1983). Further 
studies indicated that HSV DNA polymerase is important in 
amplification. DNA polymerase negative mutants of HSV-1 e.g. 
tsH, do not induce amplification (Matz et a l ., 1984) and 
inhibitors of DNA polymerase alpha e.g. aphidicolin, inhibit 
the gene amplification effect of HSV (Heilbronn et al ., 1985). 
As described in section 1.2.1, amplified and mutated cellular 
oncogenes have been found in many tumours. This suggests that 
the mutagenic and gene amplifying properties of HSV, may be at 
least partly responsible for its oncogenic actions.
(d) Activation of cellular genes by promoter or enhancer 
insertion: The insertion of an HSV promoter into the cellular
genome is one mechanism by which HSV could induce a cellular 
gene. Sequences as little as 100 b.p. long can have promoter 
function (McKnight and Kingsbury, 1982; Everett, 1983). Such 
sequences would escape detection by the Southern blot analysis 
of Cameron et a l ., (1985).
Homology between viral and cellular DNA sequences allows
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for viral integration into cellular DNA by homologous 
recombination. Rs and RL regions of the HSV-1 and HSV-2 
genomes and the centre of UL for HSV-2 only, show 
considerable homology to regions of both human and mouse cell 
DNA (Peden et a l ., 1982; Gomez-Marquez et a l ., 1985; Spector 
et a l ., 1987).
Part of the 757 b.p. transforming fragment within MTRII 
is an IS-like sequence element and does not correspond to a 
similar sequence in HSV-1 (Galloway et a l ., 1984). This 
sequence element may be important in transformation perhaps 
functioning as an enhancer or as a mutagen and activating a 
cellular oncogene (Galloway et a l ., 1984). IS-like sequence 
elements have also been found in MTRIII but not in the 
corresponding HSV-1 region (Jones et a l . , 1986). The 
significance of IS elements is less clear however, following 
the discovery that these sequences are common and widely 
dispersed in the HSV genome (reviewed by Macnab, 1987).
(e) Activation of endogenous viruses: HSV infection has been
shown to activate endogenous C-type virus (MuX) from a feline 
cell line (F81) transformed by the Moloney strain of murine 
sarcoma virus (Hampar et a l ., 1976; Boyd et al., 1978). This 
activation of MuX may be the result of mutagenesis or of 
integration of an HSV promoter or enhancer element near to the 
integrated endogenous virus (Macnab, 1987). HSV-1 sequences 
responsible for the induction of MuX map in the MTR1 and have 
been found to be inactivated by digestion with endonucleases 
cutting in the thymidine kinase (TK) gene (Boyd et al ., 1980). 
However, other investigators have found the inducing sequences 
in MTR1 to be distinct from the TK gene and also distinct from 
the mutagenic BamHIg fragment and the DNA polymerase gene
47.
(Shillitoe et a l ., 1986).
(f) Expression of virus-encoded transforming proteins: The
expression of virus-encoded enzymes involved in DNA synthesis 
or degradation would be likely to interfere with cellular DNA 
replication and repair mechanisms. It has been suggested that 
by creating an imbalance in cellular deoxyribonucleotide 
pools, HSV might enhance mutagenesis (Huszar and Bacchetti, 
1983).
i. Ribonucleotide reductase: The HSV encoded ribonucleotide
reductase (RR) is of interest because the smaller of the two 
subunits composing this enzyme is encoded by the Bgllln 
fragment of the HSV-2 genome and the larger subunit is mostly 
encoded by the adjacent Bglllc fragment. The RR subunits are 
encoded by two transcripts with colinear 3' ends that map 
within the Bgllln fragment of HSV-2 (McLauchlan and Clements,
1983). Both Bgllln and Bglllc fragments have their own 
transforming activity.
The RR small subunit of 38kDa MW is termed Vmw38 
(Bacchetti et a l ., 1984; Frame et a l ., 1985) and the large 
subunit of 140kDa MW is termed Vmw136 (also known as ICP6 for 
HSV-1 and ICP10 for HSV-2). There is evidence suggesting that 
RR enzyme activity depends on formation of a complex 
containing both small and large subunits (Frame et al ., 1985; 
Dutia et a l ., 1986; Bacchetti et al., 1986) and this suggests 
that viral RR activity does not account for the oncogenic 
properties of the Bgllln fragment of HSV-2. Further, the 737 
b.p. transforming sub-fragment of Bgllln does not lie within 
the RR coding sequences (Galloway et al., 1984). In addition, 
the 481 b.p. fragment of Bglllc which transforms established
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Rat-2 cells does not encode the carboxy terminal of the large 
subunit of RR which is the region to which the enzyme's 
catalytic function has been mapped (Jariwalla et a l ., 1986).
Cells transformed by the Bgllln fragment of HSV-2 have 
not been found to show any increase in RR activity (Cameron et 
al ., 1985). However, it is possible that transient expression 
of the RR small subunit may occur after transfection with the 
Bgllln fragment and that this could interfere with cellular 
nucleotide metabolism and initiate oncogenic transformation 
(reviewed by Macnab, 1987).
ii. Protein kinase: DNA sequence analysis of the US3 genes
of HSV-1 and HSV-2 and the corresponding gene of varicella 
zoster virus indicated that they encode proteins which are 
homologous with members of the protein kinase family of 
eukaryotes and the v-src oncogene (McGeoch and Davison, 1986). 
These observations were interesting since a number of 
oncogenes including v-src, v-yes, v-abl and v-fos are known to 
encode protein kinases (Hunter 1984).
A protein kinase has recently been identified as the 
product of the HSV-1 US3 gene (Purves et al ., 1987; Frame et 
a l ., 1987). The novel protein kinase differs from that in 
uninfected cells with respect to substrate specificity and 
chromatographic properties and was absent from cells infected 
with a virus mutant from which a major portion of the US3 open 
reading frame was deleted (Purves et al., 1987). In addition, 
a monospecific antiserum raised against a synthetic 
oligopeptide corresponding to the carboxy-terminal eight amino 
acids encoded by US3, reacts on immunoblotting with a 68kDa 
polypeptide in HSV-1 infected cell extracts and in a purified 
preparation of HSV-1 protein kinase (Frame et a 1 ., 1987) •
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The conserved nature of the US3 gene indicates that its 
product must have an important function in vivo, despite the 
fact that mutant studies show it is not essential for virus 
growth in cell culture (Purves et a l ., 1987). It is well 
established that phosphorylation is a major mechanism for the 
regulation of activity of cellular enzymes (Krebs, 1985) and 
the phosphorylation of cellular or viral enzymes by the viral 
protein kinase may facilitate viral multiplication in certain 
cell types.
(g) Expression of virion-associated host shutoff (vhs) 
functions: It has recently been shown that an HSV-1 
virion-associated host shutoff function maps within a region 
which corresponds to Bgllln sequences of HSV-2 which have 
transforming activity (Kwong et a l ., 1988). The transforming 
sequences within the Bgllln fragment have been shown to reside 
in an open reading frame encoding a 6lkDa protein (Galloway et 
al ., 1984) and this is homologous to the HSV-1 open reading 
frame to which the vhs protein has been mapped (Kwong et al.,
1988). The significance of the co-mapping of transforming and 
host shutoff functions is not yet known, but it is possible 
that the cellular stress of protein synthesis inhibition may 
lead to amplification and other rearrangements of oncogenes 
and cell cycle regulatory genes, which may in turn lead to 
transformation (Kwong et a l ., 1988).
(h) General considerations: Oncogenic DNA viruses appear in
general to require more than one gene to establish and 
maintain neoplastic transformation, which seems likely to be a 
two step process at least, of which the first step is
immortalization (Glaichenhaus et a1 ., 1985). Consistent with
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this is the report that neoplastic transformation of Syrian 
hamster embryo cells by the Bglllc HSV-2 fragment involves at 
least two steps (Jariwalla et a l ., 1983). The left 64% of the 
Bglllc fragment is sufficient to induce immortalization but 
DNA sequences from the whole of the Bglllc fragment are 
required for tumorigenic transformation. It is interesting to 
find that functions important for immortalization and 
transformation are closely linked on the HSV genome just as 
they are for adenovirus, polyomavirus and SV40 genomes. From 
sections 1.2.1 and 1.2.2 it is seen that these appear to be 
distinct functions; immortalization occurring due to 
transcriptional changes in the nucleus and transformation 
occurring due to changes in the cytoplasm or cell membrane.
The reason these functions are closely linked on the viral 
genome is not clear, but it would seem unlikely to be a chance 
association. Neither is it clear how a virus would benefit 
from causing a fatal neoplastic disease in its host. One 
explanation is that the immortalizing and transforming 
activities of viral genes are functions important in latency, 
which will, under certain unusual circumstances, produce 
oncogenic transformation (Livingston and Bradley, 1987). One 
such circumstance might be the occasional emergence of a 
mutant virus with lethal oncogenic effects. Although the 
relationship between a wild-type virus and its natural host 
may be the product of millions of years of evolution towards a 
state of balanced pathogenicity (Mims, 1977), mutant viruses 
will not necessarily display the appropriate behaviour.
As described in section 1.1, complex virus-host cell 
interactions occur in HSV infection so that HSV oncogenesis in 
nature may well involve a highly complex interplay between 
numerous viral and host cell factors. Adding to the
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complexity, the large size of the HSV genome suggests that it 
may encode a much greater number of potentially oncogenic 
functions than small DMA viruses like SV40 and polyoma virus, 
as the HSV genome is approximately 30 times larger than the 
genomes of either of these viruses.
1.2.7 Evidence for virus-induced cellular polypeptides in HSV 
transformed cells
Although Cameron et a l .,(1983) showed by Southern 
blotting analysis on HSV-transformed rat embryo (RE) cells, 
that no HSV sequences of 1 k.b. or more were detectable, even 
if present at levels of only 0.1 copies per cell, other 
evidence indicated that virus-induced antigens continued to be 
expressed in HSV transformed cells. Stable post-crisis 
cultures of transformed cells showed cytoplasmic and 
perinuclear immunofluorescence with sera raised against HSV 
infected cells (Macnab, 1974; Macnab et al ., 1980). To 
identify these virus-induced antigens, direct and indirect 
immunofluorescence tests were carried out using a battery of 
monoclonals directed against specific HSV-coded polypeptides. 
However, no HSV coded polypeptides could be consistently 
detected in the transformed cells. The possibility was 
therefore considered that virus induced cell-coded 
polypeptides might account for the immunofluorescence results 
(Macnab et a l ., 1985a).
Immunoprecipitation (i.p.) assays were used to define the 
virus-induced polypeptide species. Analysis of immunoprecip- 
itates by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
showed that antiserum raised against HSV infected cells 
recognizes a group of HSV transformed cell polypeptides that 
are not detected in untransformed control primary or secondary
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rat embryo (RE) cells. Comigrating polypeptides of 40kDa and 
90kDa molecular weight (MW) can be i.p. with the serum of 
tumour bearing rats (TBS), from transformed but not 
untransformed RE cells (Macnab et al ., 1985a).
A number of monoclonal antibodies were tested in i.p. 
assays, for reactivity against the 40kDa and 90kDa HSV 
transformed cell polypeptides in i.p. assays in an effort to 
identify the molecules. A positive result was obtained with 
the TG7A monoclonal (generated by Dr N.B. LaThangue,
University College, London), an antibody raised against 
affinity purified DNA binding proteins from HSV-2 infected 
cells (Macnab et al ., 1985a). Western blotting studies showed 
that TG7A recognizes polypeptides of 40kDa and 90kDa in 
uninfected baby hamster kidney (BHK) cells. HSV infection 
resulted in the induction of either 40kDa or 90kDa 
polypeptides depending on the serotype of virus used 
(LaThangue and Latchman, 1988). Screening of a panel of HSV 
strains suggested that as a general rule HSV-2 infection 
causes the 90kDa polypeptide accumulation, while HSV-1 
infection causes 40kDa polypeptide accumulation. 
One-dimensional V8 protease peptide maps of polypeptides i.p. 
by TG7A appear to show that the virus-induced polypeptides are 
related to those constitutively synthesised in uninfected 
cells (LaThangue and Latchman, 1988).
TG7A was shown to recognize polypeptides of 40kDa and 
90kDa present in HSV transformed but not control primary RE 
cells cultures. From one-dimensional peptide mapping studies 
using V8 protease, the 40kDa and 90kDa polypeptides i.p. by 
TG7A appear to be highly similar to those i.p. by TBS (Macnab 
et a l ., 1985a). TG7A also recognized polypeptides of 40 and 
90kDa in all transformed and immortalized rat cells tested but
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not in primary or secondary RE cell cultures (Macnab et a 1 . , 
1985a). Thus, the TG7A monoclonal antibody recognizes 
polypeptides which are a feature characteristic of 
immortalized cells as well as polypeptides of the same or 
similar MW which are induced on HSV infection. The 
relationship between these polypeptides is of great interest. 
It has been suggested that HSV may initiate oncogenic 
transformation by increasing the expression of immortalizing 
cellular polypeptides (Macnab et a l ., 1985a). It is therefore 
most important to identify these polypeptides and the genes 
which encode them.
1.3 Tumour antigens
Tumour antigens can be defined as immunological 
determinants present in tumour tissue, which elicit an 
antibody response in a tumour bearing animal (Maltzman et al .,
1981). They may represent macromolecules with a causative 
role in oncogenesis, or may simply be a reflection of 
differences between the metabolism of normal and tumour cells.
1.3-1 Tumour progression and tumour antigens
Each tumour cell exists in a competitive microenvironment 
surrounded by other tumour cells as well as normal cells which 
infiltrate the tumour (Nicolson, 1987). During the 
progression of tumours, neoplastic cells are thought to 
accumulate genetic alterations generated by random somatic 
mutational events (Nowell, 1986). Cytogenetic studies show 
that chromosome abnormalities become progressively more 
pronounced as tumours advance to more malignant phenotypes, 
which is evidence of the decreased genetic stability of
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cancers (Nowell, 1986; V/olman, 1983). Tumour evolution 
occurs rapidly, with host selection pressures acting to enrich 
those tumour cell subpopulations which are most adept at 
survival and growth (Nowell, 1986; Nicolson, 1987).
Virtually any characteristic of neoplastic cells should 
be subject to independent variation, selection and evolution 
leading to tumours of increasing autonomy from host regulation 
and increasing resistance to host immune surveillance 
mechanisms (Nowell, 1976, 1986; Fidler and Hart, 1982). The 
period for which a tumour cell would continue to express a 
tumour antigen in vivo would therefore be expected to depend 
on the survival advantage it conferred.
1.3.2 Explanations for tumour antigen expression
(a) Increased levels of a normal cellular protein; i. The 
cellular tumour antigen, p53: This is an example of a normal
cellular protein expressed at increased levels in many 
tumours. As mentioned in section 1.2.1, p53 has been shown to 
be the product of an immortalizing oncogene (Jenkins et al., 
1984; Eliyahu et a l ., 1984; Parada et al ., 1984) and has 
been shown to compete with cellular DNA polymerase alpha for 
binding to T antigen (Gannon and Lane, 1987) and to inhibit 
SV40 DNA replication (Braithwaite et al., 1987). This 
suggests p53 may have a physiological role in cellular DNA 
replication. p53 was first observed in SV40 transformed 
cells, forming a stable complex with the viral large T antigen 
(Lane and Crawford, 1979; Linzer and Levine, 1979). In 
immunoprecipitation assays, monospecific antibodies prepared 
against the viral large T antigen co-immunoprecipitated the 
cellular p53 protein with the viral antigen in a constant
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precipitation ratio (Lane and Crawford, 1979).
Increased synthesis of p53 occurs in a wide range of 
transformed and tumour cells, of rodent and human origin 
(Crawford et a l ., 1981; Dippold et al ., 1981; Maltzman et 
al., 1981). In addition to an increased rate of synthesis, 
the amount of steady-state p53 evaluated by radioimmunoassay, 
is higher in tumour cells than normal cells (Benchimol et a l .,
1982). Cells transformed by DNA and RNA viruses as well as 
chemical carcinogens, all appear to contain the same p53 
molecule (DeLeo et al ., 1979; Linzer and Levine, 1979;
Rotter et a l ., 1981). This suggests that the increased 
synthesis of p53 is a common secondary event following a 
primary signal that induces malignant transformation.
p53 has been shown to be expressed phase-specifically in 
mouse prenatal development, being present in cultures from 
12-14 day embryos, but not 16 day embryos (Mora et al.,1980; 
Chandrasekaran et al., 1981). Thus, p53 is a candidate 
oncofoetal antigen (see section 1.3.2).
It has been suggested that p53 is stabilized by complex 
formation with SV40 large T antigen, as the half-life of p53 
is much longer in mouse 3T3 cells after transformation with 
SV40 (Oren et a l ., 1981). p53 also forms a complex with the
viral tumour antigen E1B-p58, in adenovirus transformed cells 
(Sarnow et a l ., 1982) and with the mammalian HSP70 
(Pinhasi-Kimbi et al ., 1986). However, p53 does not appear to 
form complexes in a number of transformed cell types. In 
chemically transformed cells for example, p53 has only been 
demonstrated in unbound form (DeLeo et al ., 1979). The 
accumulation of p53 in these cells is probably mediated by 
some mechanism other than stabilization through the formation 
of protein:protein complexes.
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ii. Reasons for autoantibody production: By definition, a
tumour cell protein must elicit an immune response in the 
tumour bearing animal to be termed a tumour antigen. In some 
circumstances at least, p53 satisfies this criterion. Mice 
bearing syngeneic SV40-induced and Abelson-MuLV-induced 
tumours have been shown to produce anti-p53 antibodies (Lane 
and Crawford, 1979; Rotter et al ., 1980). In addition, a 
survey of human serum has shown that a proportion of cancer 
patients have anti-p53 antibodies unlike healthy controls 
(Crawford et a l ., 1982).
There are several ways in which antibodies might be 
induced to a normal cellular component. The production of 
antibody against many antigens is dependent on cooperation 
between T and B lymphocytes. If autoreactive T lymphocytes 
are tolerized and thereby unable to cooperate with B 
lymphocytes in generating autoantibodies, the provision of new 
carrier determinants could enable non-tolerized T lymphocytes 
to cooperate in the process of antibody production (Roitt,
1984). A carrier-hapten-like association between a foreign 
protein and the normal cell protein could have this effect. 
Thus complex formation between SV40 large T antigen and p53 
may explain the production of antibodies against p53 by mice 
bearing SV40-induced tumours (Lane and Crawford, 1979).
Another way immunological tolerance can be bypassed is 
when a foreign antigen, bearing a similar epitope (hapten) to 
a self antigen but with a different carrier moiety, induces 
the synthesis of a cross-reacting antibody (Roitt, 1984).
Thus rabbits bearing Rous sarcoma virus (RSV) induced tumours, 
have been shown to produce antibodies to the viral pp60v_src 
which cross-react with the rabbit pp60c-src (Collett et al., 
1978).
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(b) Re-expression of antigens normally restricted to
pre-natal life: Transformed cells may re-express genes
normally only expressed pre-natally in order to gain 
competence for survival in the tumour environment (Gerhards & 
Mehnert, 1986). Antigens which are normally expressed either 
exclusively or predominantly during foetal development, may be 
recognized as foreign by the mature immune system and 
therefore constitute tumour antigens.
There are two clinically important examples found in man. 
One is alpha foetoprotein (AFP), a protein found in human 
malignant hepatomas. Detection of AFP in the blood of a 
patient strongly suggests this condition is present (MacLeod, 
1978). Another is carcinoembryonic antigen (CEA), which is 
found in some human colonic carcinomas (Neville and Laurence, 
1974). Serial estimations of CEA levels may allow the earlier 
detection of recurrence after operative removal of colonic 
cancers (MacLeod, 1978).
Oncofoetal antigens (OFA) have been defined as "antigenic 
substances expressed exclusively as phase-specific 
autoantigens in the developing embryo or foetal tissues, of 
metazoans and their tumours" (Coggin, 1986a). Using this 
precise definition it is incorrect to classify AFP and CEA as 
OFAs, as they have been discovered in some diseased non-tumour 
tissue and show some limited expression in normal adult 
tissues. They would be more correctly classified as 
differentiation antigens (Coggin, 1986b).
Polypeptide antigens of 44kDa and 200kDa which appear to 
fulfill all the requirements of the above definition, have 
been detected in a range of cell lysates using a monoclonal 
antibody immunoaffinity column (Payne and Coggin, 1985).
These are expressed in mouse, hamster and human foetal tissues
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as stage-dependent antigens, being detected in mouse embryo 
fibroblast (MEF) cultures prepared from embryos of 12 to 13 
days gestation but not embryos of 19 to 21 days. These are 
present in a range of neoplasms (including mouse sarcomas, and 
human colonic, rectal and ovarian carcinomas), but have not 
been detected in any normal tissue examined to date. They are 
immunogenic in mouse, hamster and man, both in pregnancy 
(where the pregnant animal is immunized by foetal antigens) 
and in neoplastic disease.
Similar polypeptides of 35kDa and 40kDa have been 
identified in MEF cell cultures prepared from embryos of 16 
days, but not 12 or 18days gestation (Gerhards and Mehnert
1986). These are referred to as stage-dependent embryonic 
antigens (SDEAs). A rabbit antiserum raised against the 
detergent solubilized fraction of an SV40- transformed MEF 
cell line was used to i.p. these SDEAs. Comigrating 
polypeptides on SDS-PAGE were also i.p. from SV40 transformed 
cells of hamster, rat, monkey and human origin, from polyoma 
virus transformed cells of rat and mouse origin and also from 
cell lines derived from human tumours (HeLa and 
rhabdomyosarcoma cell lines). No comigrating polypeptides 
were i.p. from primary mouse kidney cell cultures of 12 day 
old mice, or from nontransformed cell lines of hamster, monkey 
or human origin (Gerhards and Mehnert 1986). As yet, no 
evidence has been presented suggesting that these polypeptides 
are autoantigenic. It is therefore not yet possible to 
classify them as oncofoetal antigens using the definition of 
Coggin, (1986a) .
There have been many other reports of embryonic antigens 
that are expressed in tumours, including a rat embryonic 
antigen maximally expressed at 14-16 days gestation, which has
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been isolated from chemically induced hepatomas and 
corresponds to a 65-70kDa polypeptide (Price, 1974). A 
further human example is a sarcoma associated 102kDa 
polypeptide present in melanoma, osteogenic sarcoma, 
colorectal cancer and 1st trimester foetal membranes (Brown,
1983). The numerous examples of antigens expressed in both 
embryogenesis and neoplasia, suggest that the re-expression of 
embryonic genes may be advantageous for tumour cell survival.
(c) Antigenic changes due to mutations and rearrangements of 
cellular genes: This can occur following retrovirus
infection, evidence of recombination between viral and 
cellular genes to produce novel proteins being seen in the 
case of Abelson murine leukaemia virus (A-MuLV). The 
defective genome of A-MuLV encodes the genetic information for 
a 120-160 kDa protein (p120) which consists of the N-terminal 
portion of the viral gag protein linked to a gene segment of 
the host genome (Reynolds et al ., 1978). Some deletion 
mutants in p120 fail to transform cells which suggests an 
important role in the transformation process for this protein 
(Rosenberg and Witte, 1980).
It is likely but as yet unproven, that tumour antigens 
expressed by some carcinogen-induced tumours result from 
mutations and rearrangements in cellular genes. Each 
individual tumour induced by a chemical carcinogen expresses 
its own unique tumour antigen or tumour-specific 
transplantation antigen (TSTAs), so named because expression 
of TSTAs by the cells of transplanted tumours results in 
transplant rejection (Levine, 1982). The TSTAs induced by 
chemical carcinogens (eg methylcholanthrene) are highly 
polymorphic and are specific to the tumour rather than the
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transforming agent. Thus, animals immunized with the TSTA 
prepared from a tumour induced by methylcholanthrene are 
protected against transplants of the same tumour, but not 
against transplants of other tumours also induced by 
methylcholanthrene (Baldwin and Price, 1982; Law et al .,
1980).
The antigenic diversity of the TSTAs of chemically 
induced tumours may arise because of pre-existing antigenic 
diversity of normal cells (Burnet, 1964). According to this 
view, transformation leads to clonal expansion of cell 
populations that were originally marked by distinct antigens. 
Equally possible, is the alternative that unique TSTAs arise 
as a consequence of mutational events induced by chemical 
carcinogens (Srivastava et al., 1987). Whether the antigenic 
diversity originates pre- or post- transformation, there is 
likely to be some mechanism for its generation. The mechanism 
may be similar to that for generation of antibody diversity, 
which involves somatic mutational events and rearrangements of 
the cellular genome (Honjo, 1983; Roitt, 1984).
The TSTAs of two methylcholanthrene-induced tumours, Meth 
A and CI-4, have been purified (DuBois et al ., 1982; Dubois 
and Law, 1986) and have been shown to be similar to eachother 
and to a TSTA purified from the SV40-induced mKSA sarcoma 
(DuBois, 1984). All are acidic proteins of 75-86kDa, and are 
predominantly cytosolic, although they are present at the cell 
surface (DuBois, 1984). They are not glycoproteins, viral 
antigens or histocompatibility antigens (DeLeo et al ., 1977; 
Appella et al ., 1978; DuBois et al., 1982, 1984). Despite 
their similarities, not one of these TSTAs offers 
cross-protection in in vivo tumour rejection assays (DuBois et_ 
al., 1982, 1984; DuBois and Law, 1986).
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The Meth A TSTA consists of two phosphorylated 
polypeptide isoforms with similar MW (84kDa and 86kDa) and pi 
(Ullrich et a l . , 1986). Mouse HSP90 also exists as two 
isoforms and on two-dimensional gel electrophoresis these 
comigrate exactly with the two TSTA isoforms. The two 
isoforms of HSP90 are referred to as HSP84 and HSP86 (Moore et 
a l ., 1987). Both HSP84 and HSP86 are i.p. from normal and 
heat-shocked cells by antisera to Meth A TSTA. This evidence 
suggests that the Meth A TSTA is either related or identical 
to the mouse HSP90 (Ullrich et a l ., 1986). The authors state 
that they have determined the nucleotide sequence of a mouse 
HSP84 cDNA (Moore et a l ., 1987), yet from the preceding 
publication it appears that Meth A TSTA amino acid sequence 
data, not HSP90 data, was used to prepare the oligonucleotide 
probes for cDNA library screening (Ullrich et al ., 1986). 
Although they may be closely related or perhaps even 
identical, a distinction between HSP90 and Meth A TSTA should 
be maintained in view of the subtle but important differences 
between different TSTAs.
(d) Antigenic changes due to differences in tumour cell 
physiology: Tumour-associated carbohydrate antigens are
frequently altered in malignancy as a result of differences in 
tumour cell physiology. They include: (a) carbohydrates
bound to ceramides inserted in the lipid bilayer (glycolipids 
and glycosphingolipids); and (b) carbohydrates bound to cell 
surface proteins (glycoproteins) like fibronectin (reviewed by 
Hakomori, 1984) .
Glycolipid tumour antigens include blood group A-like 
antigen in human cancer (gastric, colonic and hepatic 
adenocarcinoma) of blood group 0 individuals. Blood group
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antigens are present on blood cells and various epithelial 
cells and since the majority of human cancers are derived from 
epithelial cells, changes in blood group antigens are an 
important topic in human tumour immunology (Hakomori, 1984). 
The Forssman antigen is another glycolipid antigen which is 
expressed in a variety of human cancers (gastrointestinal, 
lung and breast). The enzyme activity for synthesis of the 
Forssman glycolipid has been found to be greatly increased for 
the majority of squamous carcinomas of the lung (Taniguchi et_ 
al., 1981).
The monoclonal antibody Ca1 which distinguishes between 
various malignant and non malignant human cells, is directed 
against a glycoprotein tumour antigen (Bramwell et al ., 1983). 
The carbohydrate chains of this glycoprotein show no novel 
structure and it has been suggested that recognition by Ca1 
occurs because the carbohydrate groups attached to the protein 
moiety are densely spaced (Bramwell et a l ., 1983).
In general, the dominant factors affecting the 
antigenicity and immunogenicity of tumour-associated 
carbohydrates are: (a) uniqueness of carbohydrate structures;
(b) the density of distribution of carbohydrate chains; and
(c) the degree of exposure of carbohydrate structures to the 
immune system (reviewed by Hakomori, 1984).
(e) Virus-induced antigens; i. RNA tumour viruses: The
transforming gene of Rous sarcoma virus (RSV) encodes a 60kDa 
polypeptide designated pp60v_src (Brugge and Erikson, 1977; 
Purchio et al ., 1978), which has protein kinase activity 
specific for tyrosine residues (Collett and Erikson, 1978). 
pp60v_src is detectable in RSV-transformed chicken cells and 
RSV-induced hamster tumour cells by immunoprecipitation of
63.
radiolabelled cell extracts with serum from rabbits bearing 
RSV-induced tumours (Brugge and Erikson, 1977). pp60v-src 
forms a complex with two co-precipitating cellular proteins. 
One is a 50kDa phosphotyrosine containing protein which is a 
potential substrate for pp60v-src (Brugge and Darrow, 1982) 
and the other is the HSP90 (Opperman et a l . , 1981; Schuh et_ 
al .t 1985; Sanchez et al ., 1985). The purpose of complex 
formation with HSP90 is not known, but it may be involved in 
the regulation of activity, processing or transport of the 
pp60v_src (Schuh et al ., 1985). Studies on RSV strains 
encoding mutant src gene products have shown that they induce 
a partially transformed phenotype, which suggests that 
pp60v-src must interact with multiple cellular targets to 
elicit a fully transformed phenotype (review, Sefton and 
Hunter, 1984).
Abelson murine leukaemia virus (A-MuLV) will transform 
bone marrow-derived lymphoid cells and the transformed cells 
express three different tumour antigens. These include a 
cellular developmental antigen, the p53 tumour antigen which 
is not associated with any other proteins (Rotter et al. ,
1981) and the virus encoded p120 protein described above 
(Levine, 1982). The cellular developmental antigen is also 
expressed in normal cells of the pre-B lymphocyte sub-class, 
which are the target cells of A-MuLV (Rosenberg and Baltimore,
1976). A-MuLV may only transform cells expressing this 
developmental antigen, perhaps because this plays an important 
role in oncogenesis.
MuLV infection is widespread in mice, as are antibodies 
to surface MuLV antigens (DeLeo et al., 1977; Nowinski and 
Kaehler, 1974). In one study on a series of BALB/c and 
C57BL/6 cell lines, 7/17 different cell lines expressed cell
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surface antigens associated with MuLV (DeLeo et al. , 1977). 
With the widespread occurrence of MuLV in the mouse the 
possible contribution of MuLV antigens must always be 
considered in interpreting results of immunological analysis 
of mouse cells whether normal or malignant (DeLeo et al . ,
1977). RE cells derived from some breeds of rat eg. Sprague 
Dawley, have high levels of endogenous C-type viruses readily 
detected by reverse transcriptase assays (Rasheed et al. , 
1976). The colony of Hooded Lister rats used to provide RE 
cells for the author’s experiments, was previously tested for 
endogenous C-type virus infection and no evidence of infection 
was found. Cells were assayed for reverse transcriptase after 
both infection and transformation by HSV and Sprague Dawley RE 
cells were used as a positive control (A. Bunce, J.C.M.
Macnab, and I. Pragnell, unpublished results). Hooded Lister 
RE cells were also examined by electron microscopy and no 
C-type virus particles were found (Macnab, unpublished 
results) .
(ii) DNA tumour viruses: Viruses like SV40, adenovirus and
EBV express immunogenic viral proteins in the cells they 
transform (see section 1.2.2).
1.3.3 Tumorigenicity, immunogenicity and resistance to 
natural killer cell lysis
Transformed cells do not need to be resistant to either 
cellular or humoral immune responses when growing in tissue 
culture, but they do require such resistance if they are to 
survive and produce tumours following injection into an 
animal. Perhaps as a consequence, many transformed cell lines 
fail to produce tumours in vivo, despite showing the
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characteristic transformation-related properties in vitro 
(Lewis and Cook, 1985).
The oncogenicity of transformed rat cell lines induced by 
different adenoviruses has been correlated with loss of 
expression of a 45kDa cellular polypeptide, identified as the 
class I major histocompatibility complex (MHC) heavy chain 
(Schrier et a l ., 1983). Tumour cell lysis by cytotoxic T 
cells is MHC-restricted (Zinkernagel and Doherty, 1979) and 
therefore tumour cells expressing viral antigens unaccompanied 
by class I MHC antigens, will escape immune surveillance by 
cytotoxic T cells (Schrier et a l . , 1983). Cells transformed 
by the highly oncogenic adenovirus 12 do not express the 45kDa 
polypeptide which may be an effect of the virus, or may be due 
to viral transformation of only those cells lacking the class 
I MHC (Schrier et al ., 1983).
There is evidence that the tumorigenicity of transformed 
cells depends on their resistance to lysis by natural killer 
(NK) cells. A direct correlation has been shown between 
resistance of transformed cell lines to lysis by NK cells and 
their ability to induce tumours in immunocompetent animals 
(Cook, 1982; Raska and Gallimore, 1982). By the use of 
hybrids between SV40-transformed and adenovirus type
2-transformed cells, it has been possible to show that 
adenovirus early gene expression governs the cytolytic 
susceptibility of the hybrid cells (Cook et al ., 1983). It 
has been suggested that one of the functions of the early gene 
products of DNA tumour viruses might be to regulate the level 
of susceptibility of virus-induced neoplasms to the host's 
immune defences (Lewis and Cook, 1985). The expression of 
immunogenic viral tumour antigens may be a viral mechanism for 
protecting the host, in case oncogenesis should occur
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"accidentally" following infection. Thus, certain viruses may 
actively participate in the destruction of any tumour cells 
which they induce, by the expression of tumour antigens which 
can be recognized by the host's immune surveillance system.
1.4 Stress proteins
Stress proteins will be defined here as cell proteins 
produced in response to a variety of stressful stimuli 
including exposure to raised temperature (heat-shock proteins) 
and glucose deprivation (glucose regulated proteins). Raised 
levels of some stress proteins have been detected in virus 
infected cells and in transformed and tumour cells, suggesting 
that they may have a role in viral oncogenesis.
1.4-1 The heat-shock response
The response of cells to raised temperature is termed the 
heat-shock response. Heat-shock proteins (HSPs) expressed in 
this response are highly conserved indicating an essential 
function. They have been observed in most organisms and cell 
types examined to date including bacteria, protozoans, yeasts, 
higher plants, Drosophila and mammalian cells (reviewed by 
Schlesinger, 1982a). The major species of HSP in mammalian 
cells are in three size classes of 80-90kDa, 70-73kDa and 
27-28kDa (Hickey et al ., 1986). Much attention has been 
focussed on the 70-73kDa proteins which are generally the most 
abundant. In Drosophila and yeast cells a multigene family 
related to HSP70 has been identified (Ignolia and Craig, 1982; 
Ignolia et al ., 1982). The HSP70-related genes in this family 
are referred to as cognate genes. In most mammalian cells 
there appear to be two forms of HSP70; a constitutive 73kDa
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form present at appreciable levels under normal conditions and 
an induced 72kDa form which is only prominent after exposure 
to physiological stress. Peptide mapping and immunological 
studies show that 72kDa and 73kDa forms are similar but not 
identical (Welch and Feramisco, 1984).
(a) Regulation of the heat-shock response: Expression of 
HSP70 is controlled at both transcriptional and translational 
levels (Lindquist, 1981; Schlesinger et al ., 1982a).
Deletion analysis of the Drosophila HSP70 gene established 
that sequences between -10 and -66 nucleotides upstream from 
the RNA start site are essential and sufficient (in these 
assay systems) for heat-shock induction (Pelham, 1982;
Mirault et al ., 1982). This region contains a TATA box and a 
short conserved sequence element found in a similar location 
in most Drosophila heat-shock genes (Pelham, 1982). The 
consensus sequence is protected in footprinting experiments by 
a transcription factor which shows increased activity in 
heat-shocked cells (Parker and Topol, 1984).
HSP70 mRNA is efficiently translated during heat-shock, 
while most pre-existing cellular mRNAs are poorly translated. 
This preferential translation of HSP mRNA is at least in part 
due to features of the 5' noncoding region of the mRNA 
(Bonner et a l ., 1984; McGarry and Lindquist, 1985). In 
addition, the stability of HSP70 mRNA in heat-shocked cells 
appears to be greater than in control cells (Theodorakis and 
Morimoto, 1987).
(b) Developmental activation of HSP genes: In addition, to
transient induction by various stresses, HSPs and related 
proteins are expressed at certain stages of development. Two
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HSP70 related proteins are induced during the sporulation of 
yeast (Kurtz and Lindquist, 1984). Several HSPs are induced 
during oogenesis in Drosophila, including HSP26 and HSP84 
(Zimmerman et al ., 1983) and an HSP70-like protein is one of 
the first proteins synthesised in mouse embryogenesis 
(Bensaude et a l ., 1983). HSPs and related cognate proteins may 
therefore have important functions in development as well as 
in the response to stress.
(c) HSP induction by viruses and oncogenes: HSP70 is induced
in eukaryotic cells by SV40, polyomavirus infection (Khandjian 
and Turler, 1982), adenovirus (Nevins, 1982) and HSV infection 
(Notarianni and Preston, 1982). Expression of the adenovirus 
E1A gene induces HSP70 at the transcriptional level (Nevins, 
1982; Kao and Nevins, 1983). HSV infection also induces 
HSP90 (Notarianni and Preston, 1982).
Several of the E .coli HSPs induced on Bacteriophage 
lambda infection, are used by the virus for its own 
replication (Friedman et a l ., 1984). In the same way, 
eukaryotic HSPs induced by viruses may be used in viral 
replication, or their induction may just reflect the stress of 
infection. Induction of HSP70 by the adenovirus E1A gene 
product, argues for a positive role of HSP70 in the viral 
life-cycle (Schlesinger, 1986). In 293 cells, which are an
adenovirus type 5 transformed human cell line, there is a very
high level of expression of HSP70 (Nevins, 1982; Kao and 
Nevins, 1983). The expression of HSP70 and E1A genes 
fluctuate during the cell cycle, with peaks of E1A expression 
just prior to peaks of HSP70 expression. This implies that in
293 cells, the E1A gene product may regulate the HSP70 gene in
a cell cycle-specific manner (Nevins, 1986). The expression
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of the myc oncogene may also activate the HSP70 gene (Kingston 
et al ., 1984).
1.4.2 Functions of major HSPs
Heat-shock proteins (HSPs) are produced when cells are 
stressed by exposure to raised temperature and a wide range of 
seemingly unrelated stimuli like amino acid analogues, 
arsenite and hydrogen peroxide. Most inducing stimuli are 
either known or thought to cause denaturation of cellular 
proteins, as indicated in table 1.3 (review, Ananthan et a l ., 
1986). The physiological function of the heat-shock response 
is still unclear, but it has been shown for a variety of cell 
types that brief exposure to elevated temperatures renders 
them more resistant to further thermal insult (Landry et al ., 
1982; Tanguay, 1983).
(a) HSP70 functions: A number of HSP70 functions have been
identified including: (i) binding to nucleolar proteins
following heat induced damage (Lewis and Pelham, 1985), (ii) 
binding to a number of proteins including the p53 tumour 
antigen (Pinhasi-Kimhi et a l ., 1986), and (iii) disruption of 
the clathrin coat of coated vesicles (Ungewickel1, 1985).
The binding activities are ATP-reversible and disruption 
of the clathrin coat of vesicles is ATP-dependent. A general 
model formed on the basis of these findings is that HSP70 
binds to hydrophobic regions of proteins which are either 
naturally exposed or revealed because of faulty synthesis or 
denaturation. HSP70 binding prevents or disrupts 
inappropriate protein-protein interactions and reversal of 
binding requires the hydrolysis of ATP (Lewis and Pelham, 
1985; Pelham, 1986). Hence, HSP70 may have a "chaperoning"
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Inducing agent/treatment Proposed effects
heat-shock
amino acid analogs (eg.puromycin) 
arsenite, iodoacetamide
ethanol
return from anoxia, hydrogen 
peroxide, superoxide ions
ammonium chloride
hydroxylamine
increased unfolding of 
proteins
abnomal proteins
binding to sulfhydryl 
groups, conformational 
changes in proteins
translation errors
oxygen toxicity, free 
radical fragmentation 
of proteins
inhibition of 
proteolysis
cleavage of 
asparagine-glycine 
bonds in proteins
Table 1.3; Agents or treatments that activate HSP genes, and 
their proposed effects. (Ananthan et a l ., 1986).
role, binding to incorrectly or incompletely folded proteins 
and preventing their aggregation (Pelham, 1986).
Newly synthesised secretory and organellar proteins need 
to be maintained in an unfolded state for translocation across 
membranes (Eilers and Schatz, 1986). Post- translational 
transport of some mitochondrial and secretory proteins 
requires both cytosolic factor(s) and ATP hydrolysis, which 
perhaps indicates the need for an ATP-dependent "unfoldase" to 
create and maintain the loosely folded configuration of the 
precursor proteins (Eilers and Schatz, 1986; Rothman and 
Kornberg, 1986).
The ATP-reversible protein binding properties of HSP70 
suggest that it might be such a protein. Recent studies 
indicate that HSP70 is a cytosolic factor involved in 
translocation of proteins across membranes. In one study on 
translocation, an in vitro assay was used which involved the 
uptake of a yeast protein (prepro-alpha-factor) into 
microsomal vesicles (Chirico et a l ., 1988). An activity was 
purified from yeast cytosol which stimulates protein 
translocation across the microsomal membranes and was found to 
consist of two constitutively expressed members of the HSP70 
family (Chirico et a l ., 1988). Substrate which had been 
denatured with urea was translocated 10X faster in this assay, 
indicating that conformation influences translocation (Chirico 
et al ., 1988 ).
The role of HSP70 in vivo has been studied using 
nonviable strains of yeast with mutated HSP70 genes, rescued 
by plasmids expressing the HSP70 gene placed under the control 
of the GAL1 promoter (Deshaies et a l ., 1988). In this system 
the HSP70 gene is repressed when glucose is added to the 
culture. Effects of HSP70 depletion that were detected
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include accumulation of prepro-alpha factor and of a 
mitochondrial F^ATPase subunit. This implies that HSP70 has a 
physiological role in the import of proteins into endoplasmic 
reticulum and mitochondria (Deshaies et al ., 1988). However, 
the exact function of HSP70 and whether it interacts directly 
with the translocated protein has not yet been shown.
(b) Interactions of HSPs with oncogene products: Complex
formation has been detected between p53 and the constitutive 
73kDa form of HSP70 in a cell line derived by 
co-transformation of RE cells with murine p53 and activated 
Ha-ras, but similar complexes were not detected in normal 
cells (Pinhasi-Kimhi et al ., 1986; Hinds et a l ., 1987). It 
has been suggested that HSP70 may stabilize p53 in the same 
way as the SV40 large T antigen (Pinhasi-Kimhi et a l ., 1986).
A mutant p53 cDNA clone which yields up to thirty five fold 
more transformed cell foci when co-transfected with Ha-ras, 
encodes a product that binds the constitutive HSP70 more 
effectively than non-mutant p53 (Hinds et al ., 1987). This 
suggests that formation of this complex could have functional 
significance in transformation. HSP70 might therefore be 
involved in cell proliferation, which is in keeping with the 
apparent cell cycle dependance of the expression of the human 
HSP70 gene (Kao et a l ., 1985).
The RSV transforming oncogene pp60v“src forms a complex 
with two co-precipitating cellular proteins in RSV transformed 
cells. One is a 50kDa phosphotyrosine containing cellular 
protein which is a potential substrate for pp60v_src (Brugge 
and Darrow, 1982) and the other is the HSP90 (Opperman et al., 
1981; Schuh et a l ., 1985; Sanchez et al ., 1985). HSP90 and 
the 50kDa polypeptide also co-precipitate in i.p.s of v-fps,
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v-yes, v-ros and v-fes oncogene products which all have 
tyrosine protein kinase activity (Brugge et al .t 1983). In 
chick cells transformed by nondefective strains of RSV the 
complex between pp60v_src, HSP90 and the 50kDa polypeptide, 
has a half life of 9 to 15 min. (Brugge et al ., 1983).
However, when cells were infected with a src gene ts_ mutant of 
RSV and grown at NPT, the half-life of the complex was 
increased to well over 3 h. Thus, the transforming activity 
of pp60v“src is reduced by a mutation in the v-src oncogene, a 
mutation which also increases the stability of complexes 
between pp60v-src and two cellular polypeptides (Brugge et_ 
al., 1983). The purpose of pp60v”src-HSP90 complex formation 
is not known, but may be involved in transport or processing 
of the oncogene product or in the regulation of its activity 
(Schuh et a l ., 1985).
(c) Interaction of HSP90 with steroid receptors:
Non-transformed (non-activated) steroid receptors have a 
sedimentation coefficient of 8 Svedberg units (S) and a MW of 
250-300kDa (Gorski et a l ., 1968; Baulieu et al., 1971). When 
in the 8S form, chick oviduct steroid hormone receptors (for 
progesterone, oestrogen, androgen and glucocorticosteroid) all 
contain a 90kDa non-hormone binding protein (Joab et al .,
1984; Groyer et al., 1985). Transformation (i.e. activation) 
of the progesterone receptor includes acquisition of DNA 
binding properties, enhanced hormone binding and conversion to 
the 4S form of the receptor. This implies separation of the 
90kDa protein from the steroid binding component (Wolfson et_ 
al ., 1980). In chick oviduct cells the 90kDa component of the 
untransformed progesterone receptor has been shown to be the 
HSP90 (Catelli et al ., 1985). In addition, the untransformed
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glucocorticoid receptor of L-929 mouse fibroblasts appears to 
contain the HSP90 (Sanchez et a l . , 1985).
As in the case of the pp60v_src, steroid receptor 
complexing with HSP90 may be important in receptor transport 
or processing, or may regulate activity by keeping the steroid 
receptor in its inactive form (Catelli et a l ., 1985; Schuh et_ 
al., 1985).
(d) HSP90 and TSTAs: Murine HSP90 appears very similar if
not identical to a TSTA of a methylcholanthrene-induced 
sarcoma (Ullrich et al ., 1986). Thus, another function of 
members of the HSP90 family may be to act as a TSTA (see 
section 1.5.2.
1-4-3 Ublquitin
Ubiquitin is an 8kDa heat-shock inducible polypeptide 
(Bond and Schlesinger, 1985) which appears to play a role in 
chromatin structure and in ATP-dependent proteolytic 
degradation of unstable cellular proteins (Busch and 
Goldknopf, 1981; Hershko, 1985).
The amino acid sequence of ubiquitin is very highly 
conserved in eukaryotic cells indicating an important function 
(Ozkaynak et a l ., 1984). It has been found as part of an 
unusual Y-shaped protein species in which the C-terminal 
glycine residue of ubiquitin is joined to the epsilon-amino 
group of an internal lysine residue of histone H2A (Busch and 
Goldknopf, 1981; Levinger and Varshavsky, 1982). Another 
unusual feature of ubiquitin is that it is translated as a 
polyprotein precursor which is cleaved proteolytically to 
generate the mature protein. The number of ubiquitin coding 
units varies from six in yeast (Ozkaynak et a 1 ., 1984) to nine
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in man (Wiborg et al . , 1985).
There are two distinct types of ubiquitin-protein 
conjugate detected from studies with reticulocyte extracts: : 
(i) ubiquitin joined at the epsilon amino group of internal 
lysine residues to give Y-shaped molecules (Busch and 
Goldknopf, 1981; Hershko and Ciechanover, 1982), and (ii) 
ubiquitin joined at the N-terminal amino group of the 
substrate protein (Hershko et al ., 1984). Currently available 
indirect evidence is consistent with N-terminal ubiquitination 
being both necessary and sufficient for ubiquitin-dependent 
selective degradation of protein substrates (Hershko et al .,
1984). N-terminal acetylation appears to block ubiquitination 
both in vivo and in vitro and may therefore have a 
physiological role in protecting polypeptides from proteolysis 
(Hershko et a l ., 1984).
The mouse mutant cell line ts85 is defective with respect 
to ubiquitination and studies using ts85 suggest that the 
turnover of most short-lived proteins in higher eukaryotes, 
proceeds through a ubiquitin-dependent pathway (Ciechanover e_t 
al. , 1984).
1.4.4 A TG7A-recognized bacterial HSP is a proteolytic enzyme
The monoclonal antibody TG7A recognizes the 94kDa Lon 
gene product of E .coli, La protease (Chung & Goldberg., 1981), 
which is induced by heat-shock and bacteriophage T7 infection 
(Latchman et a l ., 1987). TG7A also recognizes mammalian cell 
polypeptides of approximately 90kDa which are induced by 
heat-shock and HSV infection (Latchman et al., 1987) and 
polypeptides of similar MW, present at raised levels in 
immortalized cells (Macnab et al., 1985a). The significance 
of these cross-reacting epitopes is heightened by the fact
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that the bacterial and eukaryotic polypeptides recognized by 
TG7A are both induced by heat-shock treatment and viral 
infection (Latchman et al . , 1987). This suggests that the 
TG7A-recognized epitope is highly conserved and may be 
functionally important.
TG7A recognition of an abundant polypeptide of 
immortalized eukaryotic cells (Macnab et a l . , 1985) is 
particularly interesting in the light of evidence suggesting 
that La protease is a regulator of bacterial cell division 
(Mizusawa & Gottesman, 1983). La protease proteolytically 
degrades the sulA protein which is an inhibitor of septation 
(Charette et al ., 1981., Chung & Goldberg., 1981). La 
protease action is ATP-dependent and as ATP concentration 
increases in the cell cycle towards the time of cell division, 
it has been suggested that the degradation of a division 
inhibitor by La protease may increase simultaneously (Charette 
et al., 1981). Hence, La protease may regulate cell division 
by controlling the stability of the sulA protein (Mizusawa and 
Gottesman, 1983).
It is interesting to note that ubiquitin, a eukaryotic 
heat-shock protein, functions in proteolysis as does La 
protease (Hershko et al ., 1984). Further, it has recently 
been shown that the HSV-1 IE protein Vmw175, specifically 
induces transcription of the human ubiquitin B gene (Kemp and 
Latchman, 1988). These findings suggest that the protein 
recognized by TG7A in heat-shocked and HSV-infected mammalian 
cells may be either ubiquitin, a ubiquitinated protein or a 
protein related to ubiquitin.
Heat-shock genes of E. coli are under the control of the 
htpR gene product, sigma^ which is a short half-life RNA 
polymerase sigma factor (Grossman et al ., 1984; Goff et a 1. ,
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1984; Goff and Goldberg, 1985). The production of abnormal 
proteins in E. coli following treatment of cells with 
canavanine or puromycin stimulates the transcription of Lon 
and other heat-shock genes (Goff and Goldberg, 1985). It has 
been suggested that abnormal proteins may compete with a 
positive regulator of heat-shock genes (e.g. sigma^2 ) for 
degradation by proteolytic enzymes (Goff and Goldberg, 1985). 
By increasing the level of the positive regulator, heat-shock 
gene expression would be increased. A similar model for 
regulation of eukaryotic heat-shock gene transcription has 
been proposed (Ananthan et al ., 1986). In support of this 
model the mouse cell line, ts85» which is ts_ in both 
ubiquitin-protein conjugation and the degradation of abnormal 
proteins, produces HSPs at elevated rates on temperature- 
shift up to the NPT (Finley et al ., 1984). Further, HSP gene 
activation occurs in the absence of protein synthesis 
(Ashburner and Bonner, 1979) and genes are positively 
regulated by binding of a heat-shock gene-specific factor to 
defined promoter sequences in HSP genes (Wu, 1984).
Proteolytic mechanisms involving heat-shock proteins may 
therefore be important in regulation of prokaryotic and 
eukaryotic cell division. The sigma-^2 factor of E. coli and 
p53 of mammalian cells, are both metabolically unstable 
proteins and both have been implicated in growth control. The 
stabilization of p53 against selective degradation, probably 
involving the ubiquitin system, has been associated with the 
neoplastic transformation of eukaryotic cells (Croy and 
Pardee, 1983; Oren and Levine, 1983).
1.4.5 Glucose regulated proteins
Glucose regulated proteins (GRPs) are a class of stress
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proteins similar to HSPs. The GRPs are cellular proteins 
synthesised constitutively at detectable levels under normal 
tissue culture conditions (Hightower and White, 1982). The 
two major GRPs observed in mammalian and avian species have 
MWs of 78-80kDa and 94-100kDa (Shiu et a l ., 1977; Pouyssegur 
et al., 1977; Lee, 1981). Their level is markedly increased 
when cells are starved of glucose or exposed to glycosylation 
inhibitors such as 2-deoxyglucose, glucosamine or tunicamycin 
(Pouyssegur et al., 1977; Lee, 1981). In addition, treatment 
of chicken and rat cells with the calcium ionophore A23187 has 
been reported to increase the level of the two major GRPs (Wu 
et al., 1981; Welch et a l ., 1983).
Chick embryo fibroblasts (CEF) transformed by various 
strains of Rous sarcoma virus (RSV) show a significant 
increase in two membrane associated proteins of 78 and 95kDa 
in MW (Stone et al ., 1974). These proteins were originally 
thought to be transformation- specific, but were later shown 
to be induced by low glucose concentration, due to rapid 
glucose utilization by transformed cells (Shiu et al ., 1977; 
Peluso et a l ., 1978). Due to the influence of glucose on the 
level of these proteins, they have become known as the glucose 
regulated proteins (GRP) and are designated GRP78 and GRP95 
according to MW (Shiu et al., 1977).
GRP78 is related to HSP70 and is found within the 
endoplasmic reticulum. GRP78, also called BiP, associates in 
an ATP-reversible manner with immunoglobulin heavy chains 
(Pelham, 1986). GRP78 only binds to the test substrate yeast 
invertase if the enzyme has not been glycosylated, which 
suggests that GRP78 interacts preferentially with incorrectly 
processed proteins, in a similar manner to the related HSP70 
(Kassenbrock et a 1., 1988).
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While HSPs and GRPs are distinct protein species, they 
share some homologies and are both induced by a variety of 
stresses. Under some conditions the induction and suppression 
of these two sets of proteins bear a reciprocal relationship. 
For example, while prolonged oxygen deprivation triggers the 
synthesis of GRPs, recovery from oxygen deprivation triggers 
synthesis of HSPs (Sciandra et a l ., 1984). Similarly, low 
extracellular pH induces GRPs, while high extracellular pH 
induces HSPs (Whelan and Hightower, 1985). These observations 
imply that cells respond to different adverse conditions by 
synthesising different sets of stress proteins.
2 MATERIALS
2.1 Animals
Hooded Lister rats from a closed colony maintained at the 
Institute of Virology for over 20 years, were used to prepare 
rat embryo (RE) fibroblast cultures and tumour bearing serum 
(TBS).
2.2 Cells
RE fibroblast cultures were prepared from 16-20 day 
sibling embryos. Primary or secondary RE cultures were used. 
Bn5 cells are RE cells transformed by transfection with the 
Bgllln clone of the HSV-2 (HG52 strain) genome, which encodes 
the small subunit of the ribonucleotide reductase. The tumour 
cell line Bn5T was cultured from tumours induced by Bn5 cells 
(Cameron et a l .,1985) . The Hood cell line was one of several 
obtained by continuous passage of RE cells in culture 
(Macnab, 1979). These cell lines were provided by Dr Macnab.
Rat-1 and Rat-2 are continuous contact inhibited rat cell 
lines and LA24 cells are Rat-1 cells transformed by a 
temperature-sensitive (;ts) mutant of RSV. These cell lines 
were provided by Dr J. Wyke (Department of Oncology, St. 
Bartholomew's Hospital, London), LA90 cells are Rous 
sarcoma virus (RSV) transformed mouse 3T3 cells and were 
supplied by Dr J. Brugge (Department of Microbiology, Stony 
Brook, New York, USA).
The embryonal carcinoma cell line PC1315 and in vitro 
differentiated cell lines EB28/5, EB28/10n, EB26/1A and 
EB37/19D (Morgan et al.,1983) were provided by Dr M.L.Hooper 
(Department of Pathology, University Medical School,
Edinburgh).
Baby hamster kidney (BHK) cells, established by
Macpherson and Stoker (1962) and maintained in this Institute,
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were used in preparation and titration of virus stocks.
2.3 Virus
Virus stocks were supplied by Mrs M. Murphy (Institute of 
Virology, Glasgow). Wild-type viruses used included HSV-2 
strain HG52 (Timbury, 1971), and HSV-1 strain 17 syn+
(Brown et a l . , 1973). The ts_ mutant of HSV-1 strain 17, tsK, 
was initially isolated in the syncytial (syn) plaque 
morphology by Crombie (Marsden et al ., 1976). The tsK syn+ 
form was produced by Dr V.G.Preston (Institute of Virology, 
Glasgow).
2.4 Tissue culture media and solutions
Cells were grown in Glasgow modified Eagle’s medium, 
supplemented with 100 units/ml penicillin and 100ug/ml 
streptomycin all supplied by Gibco Ltd., Paisley, Scotland, 
Mycostatin (Squibb & Sons, Houndslow, Middlesex, England) 
was added to a concentration of 10U/ml. The following media 
and solutions were used for tissue culture:
(a) EFX: Eagle’s medium containing X% foetal calf serum and 
1%(v/v) non-essential amino acids, both from Gibco Ltd.
(b) EF2-met: Eagle’s minus methionine, prepared at the
Institute of Virology, Glasgow.
(c) EF2-Pi: Eagle's minus phosphate, prepared at the
Institute of Virology, Glasgow.
(d) ETCX: Eagle's medium containing 10%(v/v) tryptose 
phosphate broth (Difco Laboratories, West Molesley, England) 
and X% calf serum, prepared at the Institute of Virology using 
blood obtained from the abattoir in Dumfries, Scotland.
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(e) EHuX: Eagle's medium, containing X % pooled human serum 
prepared at the Institute of Virology using pathogen-free 
blood obtained from the Blood Transfusion Service, Glasgow.
(f) Versene: 0.6mM disodium ethylenediaminetetraacetate 
(EDTA) dissolved in phosphate buffered saline (PBS) containing 
0.002$(w/v) phenol red.
(g) Trypsin: Trypsin (Difco Laboratories, West Molesley, 
England), was used as a 0.25%(w/v) solution in tris-saline.
2.5 Chemicals
Analytical reagent grade chemicals were supplied by the 
following companies:
(a) Aldrich Chemical Company, Gillingham, Dorset, England: 
N,N'- diallyltartardiamide (DATD)
(b) BCL, Boehringer Mannheim, Lewes, E. Sussex, England: 
calf thymus transfer RNA (tRNA)
(c) BDH Chemicals Ltd., Poole, Dorset, England: ammonium 
bicarbonate, bromophenol blue, disodium ethylenediamine- 
tetraacetate (EDTA), disodium hydrogen phosphate (Na2HP0^), 
glycine, magnesium chloride (MgC^) , 2-mercaptoethanol, 
potassium chloride (KC1), sodium chloride (NaCl), sodium 
deoxycholate, sodium dihydrogen phosphate (Nal^PO^), sodium 
dodecyl sulphate (SDS), tris(hydroxymethyl)aminomethane (Tris)
(d) Bethesda Research Laboratories (UK) Ltd., Cambridge, 
England: sucrose (ultra-pure)
(e) Biorad Laboratories, Richmond, California, USA: ammonium 
persulphate, Coomassie brilliant blue R-250, N,N,N',N'-tetra
-methylethylenediamine (TEMED)
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(f) Fluka Chemie Ag., CH-9470, Buchs, Switzerland: 
guanidinium isothiocyanate
(g) James Burroughs Ltd., London, England: ethanol
(h) Koch-Light Laboratories, Haverhill, Suffolk, England: 
acrylamide, cyanogen bromide, dimethylsulphoxide (DMSO), 
L-methionine, trichloracetic acid (TCA)
(i) May & Baker Ltd., Dagenham, Essex, England: acetic acid 
(glacial), chloroform, hydrochloric acid, methanol
(j) Pharmacia Ltd., Milton-Keynes, England: Ficoll (type
400)
(k) Pierce and Warriner, Chester, England: trifluoracetic 
anhydride (TFA)
(1) Rathburn Chemicals Ltd., Walkerburn, Scotland: 
acetonitrile (HPLC grade)
(m) Sigma Chemical Company Ltd, London, England: agarose
(type 1), antifoam A, benzamidine, cycloheximide, diethylpyro- 
carbonate (DEPC), heparin, methionine, N-2-hydroxyethy1- 
piperazine-N’-2-ethanesulphonic acid (HEPES), phenanthroline, 
phenylmethylsulphony1 fluoride (PMSF), potassium thiocyanate, 
protein-A sepharose CL-4B, Sarkosyl, triton X-100
2.6 Standard buffer solutions
(a) General use:
phosphate 0.17M NaCl, 3.4mM KC1, 1mM Na2HP0» ,
buffered 2mM KH2P0^ pH7.2
saline (PBS)
(b) Total cell RNA preparation:
lysis buffer 4M guanidinium isothiocyanate, 100mM
2-mercaptoethano1, 0.5%(w/v) Sarkosyl, 
0.33^(v/v) antifoam A, 2mM EDTA, 50mM
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tris-Cl pH 7.5
extraction
buffer
0.5%(w/v) SDS, 5mM EDTA, 10mM tris-Cl 
pH7 .4
(c) Cytoplasmic RNA preparation:
lysis buffer
TSE
0.14M NaCl, 2mM MgCl2 , 0.5% NP40, 
10ug/ml cycloheximide, 0.2M tris-Cl 
pH8 .5
0.5% SDS, 5mM EDTA, 10mM tris-Cl pH8.5
(d) Oligo(dT)-cellulose chromatography:
binding buffer 0.5M NaCl, 1mM EDTA, 10mM tris-Cl pH7.5
elution buffer 1mM EDTA, 10mM tris-Cl pH7.5
(e) Polysome preparation and immunoselection: 
buffer A”
resuspension
buffer
elution
buffer
25mM NaCl, 5mM MgCl2 , 1ug/ml 
cycloheximide, 0.2mg/ml heparin, 25mM 
tris-Cl pH7.5
0.15M NaCl, 5mM MgCl2 , 1ug/ml 
cycloheximide, 0.2mg/ml heparin, 10mM 
HEPES pH7.6
20mM EDTA, 0.2mg/ml heparin, 20ug/ml 
calf thymus tRNA, 25mM tris-Cl pH7.4
(f) DNA studies:
Hind III 
restriction 
enzyme buffer
TBE buffer (10X)
iMinigel 
sample buffer
Alkaline
electrophoresis
buffer
Alkaline
loading
buffer
50mM NaCl, 10mM MgCl2 , 50mM tris-Cl 
pH8.0
8.9mM boric acid, 0.3mM EDTA, 8.9mM 
tris-Cl pH8.3
5X TBE buffer containing 10#(w/v) 
Ficoll, 0.2%(w/v) bromophenol blue, 
1OOmM EDTA
30mM NaOH, 1mM EDTA
50mM NaOH, 1mM EDTA, 2.5% Ficoll, 
0.025% bromophenol blue
(g) Immunoprecipitation assays:
RIP A 0.1%(w/v) SDS, 1%(w/v) sodium deoxy' 
cholate, 1%(v/v) triton X-100, 1mM
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tris-saline
(h) Peptide mapping:
rehydration
buffer
MgCl2 , 150mM NaCl, 1OmM tris-Cl pH7.4
14OmM NaCl, 30mM KC1, 280mM Na2HP04 , 
1mg/ml glucose, 25mM tris-Cl pH7.4
0.1%(w/v) SDS, 1mM EDTA, 0.125M tris-Cl 
pH6.8
(i) SDS-Polyacrylamide gel electrophoresis (SDS-PAGE):
electrophoresis 0.1%(w/v) SDS, 53mM glycine, 53mM tris 
tank buffer
stacking gel 
buffer (final 
concentration)
separating gel 
buffer (final 
concentration)
0.1%(w/v) SDS, 0.125M tris-Cl pH6.7 
0.1%(w/v) SDS, 0.375M tris-Cl pH8.9
electrophoresis 2%(w/v) SDS, 10% glycerol, 700mM
sample buffer 2-mercaptoethanol, 50mM tris-Cl pH6.7,
0.001%(w/v) bromophenol blue
(j) Electrophoretic transfer of polypeptides to immobilon 
membranes:
transfer buffer 0.05%(w/v) SDS, 10mM phosphate buffer
pH6.8
2.7 Radiochemicals
The following radiolabelled compounds were obtained from 
Amersham International pic., Amersham, Buckinghamshire, 
England:
alpha-^2P-deoxyadenosine > 3 ,000Ci/mmol 
triphosphate (dATP)
2,6 ^H-mannose 
^^S-methionine 
131 x
^2P-orthophosphate
30-60Ci/mmol 
> 800Ci/mmol 
200mCi/ml 
1OmCi/ml
2.8 Enzymes
Hind III and Klenow fragment from Bethesda Research
Laboratories (UK) Ltd, Cambridge, England.
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RNase A from Sigma Chemical Company Ltd., London.
V8 protease and chymotrypsin were from Miles Scientific, 
Naperville, Illinois, USA.
Trypsin from Worthington Biochemicals Corporation, New 
Jersey, USA.
2.9 Immunological reagents
Protein-A sepharose from Sigma Chemical Company Ltd., 
London.
Rabbit anti-mouse immunoglobulin from Sera-lab, Crawley 
Down, W.Sussex, England.
TG7A monoclonal antibody was supplied by Dr N.B. La 
Thangue (NIMR, Mill Hill, London). TG7A hybrid.oma was 
prepared using mice immunized with DNA-binding proteins from 
HSV-2 infected cells (Macnab et al ., 1985a).
AC88 monoclonal antibody was supplied by Dr D.O.Toft 
(Department of Biochemistry, Mayo Clinic, Rochester,
Minnesota, USA). AC88 monoclonal is directed against an 88kDa 
polypeptide from the aquatic fungus Achyla ambisexualis. This 
88kDa polypeptide complexes with steroid receptors as does the 
mammalian 90kDa heat-shock protein which is also recognized by 
AC88 (Riehl et al ., 1985).
2.10 Miscellaneous materials
Eppendorf reaction vials: Starstedt Ltd., Leicester,
England.
Falcon plastic centrifuge tubes, 15ml and 50ml; Falcon 
rotating plastic 850 cm^ culture bottles: Becton Dickinson
Labware, New Jersey, USA.
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Plastic tissue culture flasks: Nunclon Ltd., Roskilde,
Denmark.
Plastic petri dishes, 50mm: Sterilin Ltd., Feltham,
Middlesex, England.
01igo(dT)-cellulose: Collaborative Research Inc.,
Lexington, Massachusetts, USA.
In vitro translation kit; Canine pancreatic microsomal 
membranes; Human placental ribonuclease inhibitor (HPRI): 
Amersham International pic., Amersham, Bucks, England.
Protein molecular weight standards: Bethesda Research 
Laboratories (UK) Ltd., Cambridge, England.
Silver staining kit: Bio-Rad Laboratories Ltd., Watford,
Herts, England.
PD-10 columns containing Sephadex G-25 M: Pharmacia Fine
Chemicals, Uppsala, Sweden.
Centricon microconcentrating tubes: Amicon Corp.,
Danvers, Massachusetts, USA.
Immobilon transfer membrane: Millipore Corp., Bedford,
Massachusetts, USA.
Ecoscint scintillation fluid: National Diagnostics,
Manville, New Jersey, USA
EN^HANCE: New England Nuclear, Boston, Massachusetts,
USA.
Photographic film: Kodak Ltd., London, England.
87.
3 METHODS
3.1 Cell culture
3-1-1 RE cell cultures
Embryos were removed from a pregnant rat at 16-20 days 
gestation. They were eviscerated to remove blood forming 
organs, finely minced and washed in PBS. Fragments of tissue 
were trypsinized for 30 min. at 37°C, and remaining lumps of 
tissue trypsinized a further 30 min. Foetal calf serum was 
added to the suspension of dissociated cells to a 
concentration of 10$. Cells were pelleted by centrifugation 
at 1000 revolutions per min. (r.p.m.) in an MSE Coolspin, 10 
min. at 4°C. They were resuspended in EF10 and counted in a 
haemocytometer. Cells were seeded in EF10 into rotating
? oplastic 850cm culture bottles at a density of 2X10° cells per 
bottle. Cells used for assays were harvested from culture 
bottles by washing monolayers twice with 20ml trypsin, 
resuspending the detached cells in EF5 and then pipetting up 
and down to dissociate cell aggregates. Cells were seeded in 
50mm petri dishes at a density of 1.5X10 cells per dish and 
these secondary cultures used when subconfluent.
3.1.2 Cell lines
Cultures of Bn5T cells and other rat cell lines were 
grown at 37°C in rotating plastic 850cm^ culture bottles, 
containing 150ml EF5. Culture bottles were split 3:1 when 
confluent. Cells were harvested as described above and if 
required for assays, seeded in 50mm petri dishes at a density 
of 2X106 cells per dish. For BHK cells ETC10 was the medium 
used and C02 added to culture bottles giving an atmospheric
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concentration of 5%. Mouse embryonal carcinoma cell lines 
were harvested using a solution called TVP (0.025% trypsin,
1mM EDTA, 1% v/v chick serum) and were cultured in EF10.
3-1-3 Cell storage
Cells were harvested by trypsinization, pelleted by 
centrifugation and resuspended in EF15 containing 10%(v/v)
DMSO, at a concentration of 10^ cells/ml. Cells were 
aliquoted into black-cap vials, placed in an insulating 
polystyrene container for gradual cooling, stored overnight at 
-70°C and subsequently at -140°C.
For recovery cells were thawed rapidly and 5ml of EF10 
added per ml of cell suspension to dilute the DMSO. Cells 
were grown in tissue culture flasks and culture medium changed 
the following day.
3-2 Production of virus stocks
Stocks of HSV-2 strain HG52 were prepared by infecting 
subconfluent BHK cells in 80oz bottles at a multiplicity of 
infection (m.o.i.) of approximately 0.003 plaque forming units 
(p.f.u.) per cell. Virus was absorbed for 1 h in 5ml ETC2 per 
culture bottle and cells incubated in 25ml ETC5 at 31°C for 3 
days until extensive cytopathic effect (c.p.e.) had developed. 
Infected cells were harvested into the medium by shaking 
(glass beads added if necessary) and were pelleted by 
centrifugation at 1000 r.p.m. in an MSE Coolspin, 15 min. at 
4°C. Cell associated virus was released by sonicating the 
cell pellet in 2 volumes of ETC5 and cell debris pelleted by a 
further low speed spin. The supernate was aliquoted in 1ml 
volumes and stored at -70°C. Sterility checks were performed 
routinely by streaking virus stocks on blood agar plates.
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3.2.1 Titration of virus stocks
Virus was titrated on subconfluent monolayers of BHK 
cells in 30mm petri dishes. Serial ten-fold dilutions of 
virus were made in complete PBS containing 5$ calf serum. For 
the different virus dilutions, inocula of 0.1ml were added to 
BHK monolayers from which growth medium had been removed.
After adsorption of virus for 1 h at 37°C, cells were overlaid 
with EHu5 to neutralize unadsorbed virus and de novo 
synthesised virus to prevent formation of secondary plaques. 
Plates were incubated at 31°C for 3 days. Monolayers were 
then overlaid with Giemsa stain for 10 min., the stain washed 
off with water and virus plaques counted under a dissecting 
microscope.
3.3 Preparation of tumour bearing serum
To prepare tumour bearing serum (TBS), Hooded Lister rats 
were injected subcutaneously with Bn5T cells (fig 3.1). Adult 
rats (over 8 weeks) injected with 5X10^ cells developed 
palpable tumours within 1-2 months. Pre-weaned rats being 
immunologically immature, required fewer cells for tumour 
induction, but usually gave poorer antisera. Rats with 
palpable tumours were anaesthetized and bled by cardiac 
puncture. Blood was incubated in a 37°C waterbath for 1 h, 
which allowed clotting to occur. After incubation for 30 min. 
the clot was freed at the sides of the container with a 5m 1 
pipette, to encourage its retraction. After incubation for 1 
h the overlying liquid was transferred to a Falcon 15ml 
conical tube and centrifuged at 1000 r.p.m. in an MSE 
Coolspin, 5 min. at 4°C. Serum supernate was aliquoted and 
stored at -20°C.
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Figure 3.1; The origins of Bn5T cells and tumour bearing 
serum (TBS). The Bn5 cell line was derived from RE cells by 
transformation with the Bgllln fragment of HSV-2 (Cameron et 
al., 1985). The Bn5T cell line was derived from a tumour 
induced in a rat by injection of Bn5 cells. TBS is obtained 
from rats bearing tumours induced by Bn5T cells.
RE cells
Bgl II n
Bn5 cell line
Bn5T cell line
3.4 Preparation and analysis of RNA and polysomes
3-4.1 Preparation of total cellular RNA
A modification of the method of Chirgwin et al.(1979), 
was used in the preparation of total cellular RNA.
Monolayers of cells grown in rotating plastic 850cm^ 
culture bottles, were washed 3X with cold PBS, then harvested 
by the addition of 5ml of lysis buffer to each culture bottle. 
One gram of caesium chloride was added to each 2.5ml of lysate 
and dissolved. The lysate was layered onto a 1.2ml cushion of 
5.7M caesium chloride in a 12ml polyallomer tube and 
centrifuged at 55,000 r.p.m. on a Sorvall TST41 rotor, 18 h at 
20°C. Following centrifugation the supernate was discarded 
and the RNA containing pellet dissolved in extraction buffer. 
This was extracted with an equal volume of a 4:1 mixture of 
chloroform and 1-butanol. The organic phase was extracted 
again with fresh extraction buffer, then the two aqueous 
phases were combined. Finally RNA in the aqueous phase was 
ethanol precipitated and then redissolved in DW for estimation 
of the RNA concentration.
(a) Ethanol precipitation: 0.1 volumes of 3M sodium acetate
pH7.2 and 2.5 volumes of ethanol were added to the RNA 
containing solution and mixed thoroughly. After storage 
overnight at -20°C, RNA was pelleted by centrifugation at
10,000 r.p.m in a Sorvall SS34 rotor, 10 min. at 4°C. RNA was 
dissolved in distilled water and precipitated with sodium 
acetate and ethanol. The precipitating RNA was stored at 
-70°C until required. Before use, RNA was pelleted as before 
and the pellet lyophilized prior to dissolving in distilled 
water.
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(b) Estimation of RNA concentration: The absorbance of an
aqueous solution of RNA at 260nm was used to estimate 
concentration. An absorbance of 1.0 unit was taken to 
indicate an RNA concentration of 40ug/ml.
3-4.2 Preparation of cytoplasmic RNA
A method provided by Dr C. Preston was used to prepare 
cytoplasmic RNA. The steps described below, between cell 
lysis and the first phenol/chloroform extraction, were carried 
out very rapidly at 4°C. This minimizes RNA degradation by 
the cellular RNases which are released on cell lysis.
Burrlers of cells were washed 3X with cold PBS and 
scraped into 25ml PBS per burrler. Cells were pelleted in an 
MSE Coolspin at 1,000 r.p.m. for 5 min. at 4°C. Each pellet
was resuspended in 5ml lysis buffer, pipetted up and down 4X
through a wide bore 10 ml pipette and then centrifuged in an 
MSE Coolspin at 2,500 r.p.m. for 3 min. at 4°C. The supernate
was then poured into a 100ml conical flask containing 5ml TSE,
10ml DW and 15ml of an equal mixture of phenol and chloroform 
at room temperature. The solutions were mixed rapidly and 
left for 5-10 min. with occasional mixing, after which they 
were transferred to a 50ml tube and centrifuged in an MSE 
Coolspin at 1,000 r.p.m. for 10 min. at 4°C. Subsequently the 
aqueous layer was transferred to another 100ml flask to which 
10ml of phenol/chloroform was added. As before the solutions 
were mixed, left 10 min. and then spun to collect the aqueous 
phase. A third phenol/chloroform extraction was then carried 
out and the final aqueous phase was then extracted in the same 
way with 10ml of chloroform, but without phenol. RNA present 
in the final aqueous phase was ethanol precipitated as 
described in section 3.4.1.
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3.4.3 Preparation of poly(A+)mRNA
Poly(A+)mRNA was prepared by oligo(dT)-cellulose column 
chromatography. Each column was washed with 10 bed volumes of 
binding buffer prior to use. An equal volume of 2X binding 
buffer was added to the sample solution which was then heated 
to 65°C and cooled to room temperature before loading. The 
flow-through was reloaded twice. The column was washed with 5 
bed-volumes of binding buffer and poly(A+)mRNA was then eluted 
with 2 bed-volumes of elution buffer. Poly(A+)mRNA was 
ethanol precipitated and stored at -70°C until required.
3.4.4 Preparation of total cell polysomes
Polysomes were prepared by the magnesium precipitation 
technique of Palmiter (1974) with some modifications.
RNases are a major problem in studies involving 
polysomes. They are released on cell lysis and are difficult 
to remove completely from contaminated glasswear, and the 
following measures were therefore taken to minimize RNase 
contamination (Palacios et a l ., 1972; Shapiro and Young, 
1981). All glassware was filled with 0.1% DEPC in water, 
incubated at 37°C overnight, then emptied and autoclaved. A 
stock of glasswear treated this way was reserved for polysome 
work. Sterile plastic tubes and pipettes were used whenever 
possible, and gloves worn at all times. Solutions were made 
with distilled water, and unless they contained heat-labile 
components (eg. heparin, sucrose and detergents), were 
autoclaved before use.
p
Monolayers of Bn5T cells grown in rotating plastic 850cm^ 
culture bottles were used in preparation of polysomes. The 
culture medium was replaced with EF5 containing 20ug/ml
eye 1oheximide 15 min. prior to harvesting, to reduce polysome
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run-off. After 3 washes with cold PBS containing 20ug/ml 
cycloheximide, cells were scraped into a small volume of PBS, 
transferred into pre-weighed tubes and pelleted by 
centrifugation at 1000 r.p.m. in an MSE Coolspin, 5 min. at 
4°C. After removal of the supernate the weight of the cell 
pellet was determined, and cells resuspended in 6ml/g buffer 
A".
The following steps were carried out within 4 min., to 
minimize polysome degradation by RNases released on cell 
lysis. Cells suspended in buffer A” were transferred into a 
30ml Dounce homogenizer and 10% Triton X-100 was added to a 
concentration of 2.5%. Homogenization was carried out with 10 
strokes of the pestle. The resulting lysate was centrifuged 
at 16,000 r.p.m. on a Sorvall SS34 rotor, 30 seconds at 4°C, 
to spin out cellular debris. 1M MgCl2 was then added to the 
supernatant to give a concentration of 100mM MgCl2 .
The cell lysate was incubated on ice for 1 h. During 
this time a cloudy polysome flocculate appeared. The 
suspension was layered onto a 10ml pad of 0.5M sucrose in 
buffer A” , in a 36ml polyallomer centrifuge tube. Polysomes 
were pelleted through the sucrose pad by centrifugation at
13,000 r.p.m. on an AH627 rotor, 15 min. at 4°C. The polysome 
pellet was resuspended in 10mM HEPES pH7.6. 1ml of HEPES 
buffer was added per gram of cells used in the preparation.
The suspension was transferred to a 1ml Dounce homogenizer and 
given 10 strokes with the pestle. Unless polysomes were to be 
in vitro translated, the following were added to the given 
concentration and mixed gently: 0.1mg/ml heparin, 1ug/ml
cycloheximide, 5mM MgCl2 , 0.5%(v/v) triton X-100, 0.5%(w/v) 
sodium deoxycholate and 150mM sodium chloride. Polysome 
aggregates were then removed by centrifugation at 13»000
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r.p.m. in an MSE Microcentaur microfuge, 5 min. at 4°C and the 
supernate stored at -70°C until required.
3-4.5 Polysome sedimentation profiles
The quality of a polysome preparation was assessed from 
its sedimentation profile (Gough and Adams, 1978; Shapiro and 
Young, 1981). Between 0.5 and 2.0 &260 units polysomes in 
0.5ml HEPES pH7.6 were layered on top of a continuous 0.5 - 
1.5M sucrose gradient. The two sucrose solutions used to pour 
the gradient were 0.5M and 1 .5M sucrose in buffer A". The 
gradients were poured in 12ml polyallomer tubes using a 
proportioning pump. When samples were loaded, tubes were 
centrifuged at 40,000 r.p.m. on a TST41 rotor, 90 min. at 4°C. 
The sedimentation profile was then determined by pumping 
gradient fractions through a spectrophotometer flow cell and 
recording the changes in A2^  with a Cecil CE500 control 
record module.
3.4.6 Immunoselection of polysomes
Bn5T polysomes were immunoselected with TBS and TG7A by a 
modification of the method of Kraus and Rosenburg 
(1982) .
Polysomes prepared from 1 gram of cells were diluted to a 
concentration of 15 A2^0 units/ml with resuspension buffer. 
Protein-A sepharose affinity column purified TBS or TG7A 
antibody (see section 5.1.2) was added to polysomes at a ratio 
of 1mg antibody per 160 A2^0 units. After 18 h incubation at 
4°C, the polysome/antibody mixture was applied at a flow rate 
of 5ml/h to a protein-A sepharose column of 0.2ml bed volume 
which had been previously equilibriated with buffer A“ . The 
flow-through fraction was passed over the column once more,
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then collected. The column was washed with 100 column volumes 
of buffer A" (Benchimol et a l ., 1984). Specifically bound 
polysomes were then eluted with 5 column volumes of elution 
buffer. Each column volume of eluate was collected separately 
in an Eppendorf tube containing an equal volume of 
phenol/chloroform, then vortexed immediately for 2 seconds. 
After phenol/chloroform extraction poly(A+)mRNA was prepared 
on a 0.2ml oligo(dT)-cellulose column followed by ethanol 
precipitation (see section 3.4.1). Flow-through fraction 
polysomes were adjusted to 20mM EDTA and 1.5# SDS and 
poly(A +)mRNA prepared as before.
3-4-7 In vitro translation of RNA and polysomes
Reticulocyte lysate obtained from Amersham International 
pic., was used for in vitro translation (IVT) reactions. 
Reticulocyte lysate and - ^ S - m e t h i o n i n e  used in this procedure 
were stored in liquid nitrogen.
For each small-scale IVT reaction 12ul lysate and 1.5ul 
•^S-methionine were added to 1 ,5ul of a solution of RNA or 
polysomes, in a 1.5ml Eppendorf tube. 1ug - 4ug total 
cel1/polysomal RNA or 0.05ug to 0.25ug poly(A+)mRNA were added 
per tube and the contents vortexed 2 seconds then incubated in 
a 30°C waterbath for 1 h. The reaction was stopped by the 
addition of 15ul of a solution of 1#(w/v) methionine, 100ug/ml 
RNase A and 100mM EDTA, followed by a 15 min. incubation at 
30°C. Samples were centrifuged at 13,000 r.p.m. in an MSE 
Microcentaur microfuge, 10 min. at 4°C. Supernates were 
collected and pellets discarded. For electrophoretic analysis 
of total in vitro translated polypeptides, 0.5 volumes of 3X 
electrophoresis sample buffer was added to supernates, which 
were then heated 3 min. in a boiling water bath prior to
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counting. For i.p. assay, an equal volume of 2X RIPA buffer 
was added to supernates prior to counting. Samples were 
counted as described in section 3.6.6.
3.5 Analysis of cDNA prepared from Bn5T RWA
For the electrophoretic analysis of radiolabelled cDNA 
radiolabelled DNA size markers were prepared from Hind III 
restriction fragments of phage lambda DNA.
3.5.1 Preparation of agarose minigels
Minigels were prepared to estimate DNA concentration and 
to check that phage lambda DNA was properly digested by Hind 
III before radiolabelling. They were prepared using a 0.6% 
solution of agarose in TBE buffer and 2ul ethidium bromide was 
added to each 30ml aliquot of this solution to allow 
visualization of DNA under long wave UV illumination. Gels 
were run with TBE electrophoresis buffer at 10V/cm until the 
sample dye-front had migrated the appropriate distance.
3.5.2 Estimation of phage lambda DNA concentration
Approximate estimations of DNA concentration were 
obtained by visual comparison with a DNA standard of known 
concentration, after electrophoresis on ethidium stained 
agarose gels visualized under long wave UV illumination.
3.5.3 Preparation of end-labelled lambda Hind III DNA 
fragments
Lambda DNA was incubated with 10U/ug Hindlll restriction 
in 20ul Hind III restriction enzyme buffer (REB) for 1 h at 
37oC. The products of this reaction were analyzed on a
minigel before proceeding further.
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End-labelling of restriction fragments was achieved by- 
incubation of 0.5ug of digested DNA with 1uCi dATP and 0.5U 
Klenow fragment in a total volume of 20ul Hind III REB for 10 
min. at room temperature. Samples for electrophoresis were 
prepared by adding 1ul of reaction products to 20ul alkaline 
loading buffer.
3-5.4 Alkaline agarose gel electrophoresis
The sizes of first and second cDNA strands synthesised by 
reverse transcriptase were checked by alkaline agarose gel 
electrophoresis (McDonnell et a l . , 1977). A 156 agarose 
solution was prepared by adding 2g agarose to 200ml of a 
solution containing 50mM NaCl and 1mM EDTA and heating in a 
microwave oven until the agarose dissolved. The solution was 
cooled to 50oC and then poured to give a horizontal slab gel, 
which when set was mounted in an electrophoresis tank.
Alkaline electrophoresis buffer was then added to the tank 
covering the gel to a depth of 5mm and buffer was allowed to 
soak into the gel for at least 30 min. before loading the 
samples of DNA.
Samples of cDNA corresponding to 20,000 c.p.m. were 
ethanol precipitated (see section 3.4.1) and then dissolved in 
20ul of alkaline loading buffer for electrophoretic analysis. 
Before loading excess electrophoresis buffer was removed from 
above the surface of the gel leaving a 1mm layer of buffer 
covering the gel. Electrophoresis was carried out at 1.5V/cm 
for 18h, after which the gel was carefully placed on a piece 
of filter paper and dried under a vacuum. The gel was then 
autoradiographed using an intensifying screen.
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3.6 Radiolabelling and immunoprecipitation of polypeptides
3-6.1 In vivo radiolabelling of polypeptides
Polypeptides were radiolabelled in vivo to allow for 
autoradiograph detection following SDS polyacrylamide gel 
electrophoresis (SDS-PAGE).
3.6.2 Radiolabelling of polypeptides with ^ S - m e t h i o n i n e
Uninfected cell monolayers in 50mm petri dishes were 
overlaid with 4ml EF2-met and incubated at 37°C for 4 h to 
deplete cells of methionine. Culture medium was then replaced 
with 2ml EF2-met containing 100uCi/ml ^S-methionine ancj cells 
incubated for the required time, usually 18h, before 
harvesting.
To radiolabel infected cell polypeptides, subconfluent 
monolayers were depleted of methionine as before. The culture 
medium was removed and the virus applied in 0.2ml PBS and 
absorbed for 1 h at the required temperature. The overlay was 
replaced by 2ml EF2-met containing 100uCi/ml - ^ S - m e t h i o n i n e  
and the infected cells incubated for the appropriate time 
period.
3.6.3 Pulse-chase labelling of polypeptides with 
^S-methionine
Uninfected cell monolayers were labelled with 
35s-methionine as before. After a 10 min. or 60 min. pulse, 
radiolabel was removed and the monolayer washed 3X with EF5. 
Cells were overlaid with 4ml of EF5 and incubated at 37°C. 
After varying chase periods, plates of cells were harvested.
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3.6.4 Radiolabelling of polypeptides with ^2P-orthophosphate
Cells were depleted of phosphate by incubation in EF2-Pi 
for 4 h. They were labelled for 18 h in EF2-Pi containing 
150uCi/ml -^P-orthophosphate.
3.6.5 Harvesting radiolabelled cells
Monolayers of uninfected cells were washed 3X with PBS 
and stored at -70°C until required. Infected cells were 
scraped into the culture medium and pelleted by centrifugation 
at 1000 r.p.m. in an MSE Coolspin, 10 min. at 4°C. Pelleted 
cells were washed by resuspension in PBS, repelleting and 
removal of the supernate. Cell pellets were stored at -70°C.
For preparation of samples of total infected/uninfected 
cell polypeptides, cells were lysed in electrophoresis sample 
buffer (0.25ml/2X10^ cells), followed by heating at 100°C for 
3 min. Cell debris was removed by centrifugation at 13,000 
r.p.m. in an MSE Microcentaur microfuge, 15 min. at 4°C, and 
the supernate aliquoted and stored at -70°C.
For preparation of lysate for immunoprecipitation (i.p.)
c
assays, cells were suspended in RIPA buffer (0.5ml/2X10 
cells) containing protease inhibitors (0.030mg/ml benzamidine, 
0.100mg/ml phenanthroline, 0.034mg/ml PMSF). Protease 
inhibitors were stored as a stock solution in ethanol at 
-20°C, and were added to RIPA buffer immediately before use, 
to minimize inactivation by hydrolysis in aqueous solution. 
Crude lysate was sonicated for 3 min. to disrupt cell 
aggregates, incubated for 30 min. on ice, then centrifuged to 
remove cell debris and the supernate stored at -70°C.
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3-6.6 Scintillation counting
To quantify incorporation of radioactivity into 
polypeptides, 5ul samples of lysate were placed on Whatman's 
filter discs which were washed 2X with 10% Trichloracetic acid 
and 2X with 5% Trichloracetic acid, thus precipitating 
polypeptides onto the filter discs and removing unincorporated 
radiolabel. Filter discs were then washed 2X with ethanol, 
dried under a heat lamp, placed in vials with 3ml 
scintillation fluid and counted in a scintillation counter.
For the electrophoretic analysis of total 
infected/uninfected cell polypeptides, samples were loaded in 
volumes corresponding to 70X10^ counts per minute (c.p.m.).
For standard i.p. reactions a volume of lysate corresponding 
to 4X10° c.p.m. was used. For peptide mapping analysis a 
volume corresponding to 4X10^ c.p.m. was used to get a 
stronger signal.
3.6.7 Immunoprecipitation of polypeptides
The i.p. procedure was based on a method described by 
Kessler (1975). For each reaction a volume of lysate 
corresponding to the appropriate number of radioactive counts 
(see section 3.6.6) was diluted with RIPA buffer to a volume 
of 100ul. Antibody was added and the mixture incubated for 1 
h at 4°C. For i.p.s with TBS, 5ul of antibody were added per 
1OOul of lysate, giving a dilution of approximately 1/20(v/v). 
For mouse monoclonals TG7A and AC88, 2.5 to 5ul antibody were 
added. For mouse monoclonals only, a second antibody (rabbit 
anti-mouse immunoglobulin) was added at the end of the first 
incubation and the antigen-antibody mixture incubated a 
further 1 h.
Immune complexes were precipitated by addition of 60ul
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protein-A sepharose (12.5%(w/v) suspension in RIPA), and 
incubation for 1 h on a rotating mixer at 4°C. Next, i.p.s 
were washed 3X with RIPA, then 1X with tris-saline. In each 
wash cycle the pellet was resuspended in 0.5ml of buffer, 
vortexed 2 seconds, centrifuged at 13,000 r.p.m. in an MSE 
Microcentaur microfuge, 2 min. at 4°C and the supernate 
discarded. The final pellet was resuspended in 30ul of 
electrophoresis sample buffer and heated at 100°C for 3 min. 
to dissociate antigen, antibody and protein-A sepharose. The 
latter was removed by a further 2 min. microfuge spin and the 
supernate containing antigen and antibody, collected and 
stored at -70°C until required.
3.6.8 In vitro radiolabelling of polypeptides
The chloramine-T method was used to radiolabel 
polypeptides in vitro (Greenwood et al., 1983). 10ul of a 
1mg/ml solution of polypeptide was placed in an Eppendorf tube 
kept on ice. 10ul of 0.1M sodium phosphate pH7.5 was added 
followed by 200uCi of ^ 1  j an(j ioul of 1mg/ml chloramine-T. 
After 20 seconds incubation, 20ul of a 1mg/ml solution of 
sodium metabisulphite was added to stop the reaction. After a 
further 20 seconds incubation 1ml of PBS was added and the 
iodinated polypeptide separated from unreacted iodide by 
desalting on a Pharmacia PD-10 column (Sephadex G-25 M).
3.7 Electrophoretic analysis of polypeptides
3 .7.1 SDS polyacrylamide gel electrophoresis
Polypeptides were separated by SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) on either single concentration or 
gradient slab polyacrylamide gels (Laemmli, 1970). Single
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concentration gels contained 7.5% or 9% acrylamide and 
gradient gels 6-15% acrylamide in resolving gel buffer. 
Acrylamide was cross-linked with 1 part in 40 (w/w)
N-N*-methylenebisacrylamide. Gels were polymerized by the 
addition of ammonium persulphate to 0.04%(w/v) and TEMED to
0.04%(v/v). Gradients were poured with a proportioning pump 
and overlaid with a few drops of butan-2-ol to produce a level 
surface. After polymerization the butan-2-ol was removed by 
washing with deionized water. The upper surface of the gel 
was overlaid with 1X stacking gel buffer which prevented 
drying out and allowed gel storage for up to 2 weeks at 4°C.
The stacking gel was prepared on the day the gel was run. 
This contained 5% acrylamide in stacking gel buffer. The 
acrylamide was cross-linked with 1 part in 40(w/w)
N-N'-Diallyl-tartar-diamide. Wells were formed using teflon 
combs.
Tank buffer was prepared from a 10X stock. Samples for 
analysis were loaded in electrophoresis sample buffer. Gels 
were run at 0.45mA/cm^ for 3-4 h at room temperature until the 
bromophenol blue dye front reached the bottom of the 
separating gel.
3-7.2 Peptide mapping
One-dimensional peptide mapping was used as a test of 
polypeptide relatedness and a modified version of the method 
of Cleveland et al ., (1977), was used. Polypeptides were 
labelled in vivo with 35g_methionine and resolved by 
electrophoresis on 7.5% SDS-polyacrylamide gels. Gels were 
fixed and dried down onto Whatmans 3MM filter paper. Direct 
autoradiography was carried out overnight at room temperature, 
using flashed Kodak XS film. Marks made with radioactive dye
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allowed accurate alignment of autoradiograph and gel. 
Polypeptide bands located by autoradiography were excised from 
the gel with a scalpel blade. Excised gel slices were 
rehydrated for one h in rehydration buffer. Polypeptides were 
digested without prior elution by placing gel slices in the 
sample wells of a second SDS-polyacrylamide gel (the peptide 
mapping gel), then overlaying each slice with proteolytic 
enzyme. Digestion proceeded in the stacking gel during 
subsequent electrophoresis.
In preparing the peptide mapping gel the separating gel 
was cast allowing for a long stacking gel (4cm in length from 
the bottom of the sample wells). The separating gel was 
single concentration 15% acrylamide gel, cross-linked by 
N-N’-methylenebisacrylamide present at a ratio of 1 part in 40 
(w/w). Gel slices were pushed to the bottom of empty wells in 
the stacking gel with a toothpick, taking care to avoid 
trapping air bubbles underneath. The spaces around each slice 
were filled by overlaying with 10ul rehydration buffer 
containing 20% glycerol (v/v). The upper chamber of the gel 
kit was filled with tank buffer prior to loading the 
proteolytic enzyme. A stock solution of enzyme was diluted to 
the required concentration with rehydration buffer containing 
10% glycerol (v/v) and bromophenol blue dye. Enzyme was then 
added to sample wells in 20ul aliquots.
Electrophoresis was performed in the usual manner at room 
temperature, with the exception that the current was turned 
off for 1 h when the dye-front reached a point 3-4mm from the 
bottom of the stacking gel. When electrophoresis was 
completed, gels were examined by fluorography as described in 
section 3.7.3. For peptide mapping gels films were exposed 
first for 3 weeks and then 2 months.
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3-7.3 Autoradiography
Gels were fixed in a solution containing 50% methanol and 
7% acetic acid for a minimum of 15 min., but were often stored 
in this overnight. Gels were next soaked in a 5% methanol, 7% 
acetic acid solution for a minimum of 15 min. or longer if 
necessary, until swollen to the original size, then washed in 
water for 30 min. Unless bands were to be excised for peptide 
mapping, they were then soaked in EN^HANCE for 1 h and then 
washed for a further 30 min. in water. However, if bands were 
to be peptide mapped, all washes were kept to 15 min. and gels 
were not EN^HANCED in order to minimize acid hydrolysis. Gels 
were dried under vacuum at 80°C onto a sheet of Whatman 3MM 
filter paper and then autoradiographed with flashed Kodak 
X-Omat XS-1 film which was exposed at -70°C if gels were 
EN^HANCED or room temperature if not.
3.7.4 Coomassie blue staining
Gels were stained in a solution of 0.25% Coomassie blue 
in 50% methanol, 7% acetic acid. Standard slab gels of 1.5mm 
thickness were stained for at least 2 h, while gels 0.5mm 
thick (used for polypeptide blotting) required only 15 min.
Destaining was carried out in a shaking water bath at 
37°C. Destaining was faster if 50% methanol, 7% acetic acid 
was used for the first 3-4 washes of 15 min. each. Over the 
following 24 h gels were given 3-4 washes in 5% methanol, 7% 
acetic acid.
3.7.5 Silver staining
The Bio-Rad silver staining kit was used according to the 
protocol supplied by the manufacturers. Silver staining was 
carried out following Coomassie blue staining if increased
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sensitivity was required.
3.8 Amino acid sequence analysis
Amino acid analysis and sequencing was carried out in Dr
J. Walker’s laboratory at the MRC Laboratory of Molecular 
Biology (L.M.B.), Hills Road, Cambridge, England.
At least 20pmol of a polypeptide are usually required for
successful amino-acid sequencing. Results given in section
9.1.1 indicate that less than 0.5pmol of the 90kDa polypeptide 
to be sequenced in this study, are i.p. in a standard i.p. 
reaction. It was therefore decided to increase the scale of 
the reaction and make a number of other modifications.
3.8.1 Large-scale immunoprecipitation reactions
The author devised the following protocol, which proved 
to be simpler and more effective than a theoretically 
equivalent number of standard i.p. reactions.
1ml TBS and 2ml protein-A sepharose (12.5%(w/v) 
suspension) were added to 7ml RIPA buffer in a 50ml conical 
flask, and incubated at room temperature for 2 h. The 
protein-A sepharose was kept in suspension during incubations 
by mixing gently on a magnetic stirrer with a small magnet. 
10ml of Bn5T cell lysate was added and the reaction mixture 
incubated at room temperature for a further 2 h. Two 
modifications were made to the standard technique of lysate 
preparation (section 3.6.5). Lysate concentration was 
increased 10X by lysis of 4X10^ cells/ml of RIPA buffer, and 
10X more protease stock solution was added per ml of lysate.
The reactants were next introduced into a column 
consisting of a 5ml pipette plugged at the bottom with glass 
wool. During washing stages this retained the protein-A
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sepharose with attached antibody and antigen. This simplified 
washing to the application of 3ml RIPA, followed by 3ml 
tris-saline at the top of the column while unbound material 
was run out at the bottom. No centrifugation step was 
required.
Bound molecules were eluted with 2.5ml 3M potassium 
isothiocyanate. The eluate was immediately desalted by 
passing over a Pharmacia PD-10 column containing Sephadex 
G-25M, previously equilibriated with 10mM ammonium 
bicarbonate. When all the sample had run into the column, 
polypeptides were eluted with 3.5ml 10mM ammonium bicarbonate. 
The sample was concentrated to about 300ul by freeze-drying 
followed by centrifugation in a Centricon microconcentrator 
(5,000 r.p.m. in a Sorvall SS34 rotor, up to 6 h at 4°C), 
which reduced the volume to approximately 50ul. Finally 0.5 
volumes of 3X electrophoresis sample buffer were added to 
concentrated sample, which was stored at -70°C. Immediately 
prior to electrophoresis the sample was heated to 100°C for 3 
min.
3.8.2 Transfer to Immobilon membrane
Following electrophoresis on a 0.5mm thick 7.5% SDS- 
polyacrylamide slab gel, polypeptides were electrophoretically 
transferred from gels onto Immobilon polyvinylidine difluoride 
(PVDF) transfer membranes. These are mechanically strong 
solid phase supports that bind proteins hydrophobically and do 
not need to be chemically activated (Matsudaira, 1987). The 
polyacrylamide gel was first soaked for 20 min. in transfer 
buffer. A piece of Immobilon membrane, cut to the same size 
as the gel, was immersed in methanol for 2 seconds, washed for 
2 min. in de-ionized water and for a further 5 min. in
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transfer buffer. The gel was placed on top of the membrane, 
then sandwiched with two pieces of Whatmans 3MM paper on 
either side. This sandwich was put into a Bio-Rad 
electroblotting kit, with the membrane on the +ve side of the 
gel. The kit was filled with transfer buffer and 
electro-transfer carried out at 300mA for 1 h.
On completion of transfer the membrane was washed for 5 
min. in deionized water. The membrane was stained in a 
solution of 50% methanol and 0.1% Coomassie Blue, destained in 
50% methanol and washed in water. The membrane was then 
allowed to dry. The stained band of interest was excised with 
a scalpel blade and stored at -20°C. For sequencing of intact 
polypeptide the excised strips of Immobilon membrane were 
placed directly into the reaction chamber of the automated 
sequencer. When the polypeptide was to be cleaved into 
peptide fragments the membrane was not stained with Coomassie 
blue as this dye interferes with the separation and 
purification of peptides on the type of gradient used.
Instead the polypeptide band was located by autoradiography 
and then excised.
3.8.3 Polypeptide elution
This step was only necessary if the polypeptide was to be 
cleaved into peptides before sequencing.
Polypeptide was eluted from excised strips of Immobilon 
membrane by placing the strips in 1ml 70% formic acid in an 
Eppendorf tube and incubating for 1 h at room temperature 
while vortexing for 10 seconds every 5 min. The supernate was 
dried down to a pellet in a speedivac, then twice resuspended 
in 200ul of distilled water (DW) and dried to remove any trace 
of formic acid.
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3.8.4 Cleavage with trypsin
The sample pellet was dissolved in 200ul 50mM ammonium 
bicarbonate and trypsin added in the ratio 1ug trypsin : 50ug 
sample polypeptide. Incubation for 4 h at 37°C was followed 
by drying in a speedivac and the pellet was then twice 
resuspended in 200ul DW and dried down in a speedivac. The 
final pellet was dissolved in 15ul of 6M guanidine 
hydrochloride, 0.1% trifluoroacetic anhydride (TFA) 
immediately before HPLC.
3.8.5 Cleavage with cyanogen bromide
Polypeptides were dissolved in 70% formic acid and a 
10-fold excess (by weight) of cyanogen bromide added. The 
digest was stirred for 4h at room temperature, in the absence 
of light. The reaction was terminated by dilution with 10 
volumes of water and the solution was then freeze dried.
3.8.6 Peptide purification
Peptides were purified using an Applied Biosystems 130A 
separation system which separates by microbore HPLC. The 
system used for separation was a 0% - 80% acetonitrile 
gradient in 0.1% TFA. Peptides were detected by absorbance at 
225nm as the column was automatically fractionated. Fractions 
were collected in Eppendorf tubes and were dried down in a 
speedivac, resuspended in 200ul D.W., then dried down again.
3.8.7 Amino acid sequence determination
Amino acid sequencing was carried out on an Applied 
Biosystems 470A gas phase sequencer, operated by Mr 
F.Northrop, (L.M.B .,Cambridge). Automated protein sequencers 
work on the Edman degradation principle (Edman, 1950), by
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which the N-terminal amino acid is coupled with phenylisothio- 
cyanate (PITC) and the derivatized amino acid is then cleaved 
from the polypeptide. Sequential removal of N-terminal amino 
acids occurs with repeated coupling/cleavage cycles. Amino 
acid derivatives are converted to the more stable phenylthio- 
hydantoin (PTH) form.
PTH-amino acids were analyzed sequentially on an Applied 
Biosystems Model 120A PTH analyzer. This identifies PTH-amino 
acids according to their elution characteristics on high 
performance liquid chromatography (HPLC) using a sodium 
acetate/acetonitrile gradient. PTH-amino acids are detected 
by UV absorption monitoring at 270nm. By identification of 
PTH-amino acids derived in each successive cycle, the amino 
acid sequence is determined.
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4 TUMOUR ANTIGENS IDENTIFIED BY IMMUNOPRECIPITATION ASSAYS
4.1 Background information
A set of cellular polypeptides is immunoprecipitated 
(i.p.) by the monoclonal antibody TG7A from HSV-transformed RE 
cells (Bn5T cells) but not from normal control RE cells 
(Macnab et al_. , 1985a); (figure 4.1). TG7A monoclonal was 
raised against DNA-binding proteins from HSV-2 infected cells 
and in Western blotting studies, it recognizes cellular 
polypeptides induced on HSV infection which are of similar MW 
to those i.p. from transformed cells (Dr N.B. LaThangue, 
personal communication). The serum taken from rats bearing 
tumours induced by Bn5T cells (tumour bearing serum/TBS) has 
been shown to i.p. polypeptides from Bn5T cell lysate which 
comigrate exactly with those i.p. by TG7A and which give 
closely similar or identical peptide maps. Like TG7A, TBS 
does not i.p. the polypeptide set from normal control RE 
cells. The same results were also obtained with rat antisera 
to HSV-2 infected cells (Macnab et al ., 1985a). These 
findings suggest that certain cellular polypeptides induced by 
HSV-2 infection are related to polypeptides expressed at 
raised levels in HSV-2 transformed cells. On the basis of 
these and other observations the authors suggested that 
cellular polypeptides induced by HSV may be important in the 
initiation of transformation by the virus (Macnab et al., 
1985a). A more detailed account of this work is given in 
section 1 .2.7.
The results of further characterization studies on these 
polypeptides will be presented in this thesis together with 
the results of studies aimed at providing a probe to allow for
screening of cDNA libraries to identify the encoding gene(s).
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Figure 4.1; Electrophoretic analysis of RE and Bn5T cell 
polypeptides i.p. by TG7A. Autoradiograph of a 6-15% gradient 
polyacrylamide gel containing electrophoretically separated 
S-methionine labelled polypeptides. MW markers are shown in 
track 1. Tracks 2 and 3 show a total Bn5T cell and HSV-2 
infected (HG52 strain, 10 p.f.u./cell, harvested 8h. p.i.) RE 
cell polypeptide profiles respectively. Tracks 4 to 7 contain
i.p.s of RE and Bn5T cells with control ascites and TG7A 
monoclonal arranged as follows: track 4, RE i.p. control
ascites; track 5, RE i.p. TG7A; track 6, Bn5T i.p. control
ascites; track 7, Bn5T i.p. TG7A.
The M W ’s of polypeptides i.p. by TG7A are indicated to 
the right of track 7. There is a 97kDa polypeptide band 
referred to as "U90", and a 93kDa polypeptide band referred to
as "L90” . For an explanation of this nomenclature see section
4.2.3.
On this particular gel a 200kDa polypeptide is seen in 
the track corresponding to a TG7A i.p. of RE cell lysate 
(track 6). This band is not always seen in such i.p.s, and is 
likely to represent myosin which tends to be precipitated 
non-specifically (Dr D. Lane, personal communication).
< 200kDa
U90
*1-90
actin
40 k Da 
35kDa
In this chapter, a detailed analysis of polypeptides 
expressed by normal control RE cells and by transformed Bn5T 
cells will by described. Much use was made of the 
immunoprecipitation technique throughout these studies, and 
the two antibody preparations most often employed were the
monoclonal TG7A and the polyclonal TBS. TBS was often
utilised as an alternative to TG7A, owing to the limited 
supply of the monoclonal antibody.
4.2 Analysis of Bn5T polypeptides immunoprecipitated by TBS
4.2.1 Techniques used
TBS is serum taken from rats bearing tumours induced by 
Bn5T cells and contains antibodies that i.p. a group of Bn5T 
polypeptides which are not detectable in control RE cells. 
These polypeptides can be demonstrated by in vivo 
radiolabelling of Bn5T cells with ^S-methionine, i.p. with 
TBS, separation of i.p. polypeptides by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and 
autoradiography of the resulting gel 4.1. This method of 
polypeptide labelling and detection was used throughout these 
studies, except where stated otherwise.
4.2.2 Estimates of molecular weight
Estimates of the molecular weight (MW) of polypeptides 
were made by comparison of their mobility on SDS-PAGE, with MW 
standards run on the same gels. MW estimates for Bn5T 
polypeptides i.p. by TBS are shown in Table 4.1. Values for 
each polypeptide are highly consistent and in general agree 
well with previously assigned MWs. However some important 
differences exist in the 32 - 36kDa region, and these are
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Polypeptide Mean of ten Original MW New MW
number MW estimates assignment assignment
assignment
1 . 202.6 (SD=2.9) 200 200
2. 97.3 (SD=2.2) 90 97
3. 92.8 (SD=2.3) 90 93
4. 38.7 (SD=0.6) 40 40
5. 35.5 (SD=0.9) 32 35
6. 34.0 (SD=0.9) 32 34
Table 4.1; Molecular weight estimates in kDa for Bn5T 
polypeptides i.p. by TBS. Estimates were obtained from 
calibration curves constructed by plotting relative mobility 
on SDS-PAGE (6 - 15% acrylamide gradient gels) against Log>jQ 
MW for a number of BRL standard MW markers (myosin H chain - 
200kDa, phosphorylase b - 97.4kDa, bovine serum albumin - 
68kDa, ovalbumin - 43kDa, alphachymotrypsinogen - 25.7kDa). 
For every polypeptide ten estimates were made, each from a 
different gel. Mean values and standard deviations (SD) are 
given. Original MW assignments are taken from Macnab et a l ., 
(1985). New MW assignments are given, taking into account 
recent findings. On gels showing high resolution the 34kDa 
band is resolved into three components.
discussed in section 6.1.
4.2.3 Nomenclature
Each polypeptide is named according to: (1) Cell of
origin, (2) antibody used to i.p., and (3) apparent MW (as 
determined by migration rate on SDS-PAGE). This information 
is given in the order 1:2:3. Thus, the 40kDa polypeptide i.p. 
by TBS from Bn5T cell lysate is named Bn5T:TBS:40. A slight 
variation is that the 93kDa polypeptide i.p. by TBS from these 
cells is named Bn5T:TBS:L90. This is because the 93kDa 
polypeptide migrates faster than the 97kDa polypeptide and 
thus produces the lowermost (hence "L90") of the two bands in 
the 90kDa region of the gel. The 97kDa polypeptide is named 
Bn5T:TBS:U90 for similar reasons. For polypeptides which have 
not been i.p. and are seen in total cell polypeptide profiles 
the abbreviation PP is inserted into the notation. Thus the 
polypeptide giving the major 40kDa band seen in total Bn5T 
polypeptide profiles is denoted Bn5T:PP:40. Polypeptides of 
200, 97, 93, 40, 35 and 34kDa i.p. from Bn5T cell lysate by 
TBS will be referred to collectively as the Bn5T:TBS set.
4.3 Analysis of RE and Bn5T total polypeptide profiles
Polypeptides radiolabelled in vivo with ^S-methionine 
and separated by SDS-PAGE can be visualized by both 
autoradiography and Coomassie blue staining. A number of 
differences are seen between total polypeptide profiles of 
control RE (non-transformed) cells and Bn5T (transformed) 
cells (figure 4.2).
4.3.1 Autoradiography
Of the thirteen or more ^5S-methionine labelled
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Figure 4.2; Analysis of transformed cell (Bn5T) and normal 
control cell (RE) polypeptides by SDS-PAGE. Autoradiograph of 
a 6-15# gradient polyacrylamide gel containing electrophoret- 
ically separated - ^ S - m e t h i o n i n e  labelled polypeptides 
extracted from RE control cells (track 1) and transformed Bn5T 
cells (track 3). Polypeptide bands only present for one of 
these two cell types, are arrowed (tracks 1 and 3). Also 
compared are TBS i.p.s. of RE cell lysate (track 2) and Bn5T 
cell lysate (track 4). Polypeptides i.p. by TBS are indicated 
by solid arrows in track 4 and the designated MW values given 
on the right side of the gel.
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polypeptides seen to be present at higher levels in Bn5T cells 
than in RE cells (figures 4.2 and 4.3), three appear to be 
i.p. by TBS (200, 97 and 40kDa). Use of TBS in i.p. assays 
therefore allows attention to be focussed on a proportion of
these polypeptides which are not detectable in control RE
cells and which may be responsible for some features of the 
oncogenic phenotype.
On comparison of total Bn5T cell polypeptides labelled 
with ^S-methionine, with total control RE cell polypeptides 
labelled the same way, there are two prominent bands which are 
consistently observed for Bn5T cells and not observed for RE 
cells. These have apparent MWs of 84.8kDa (mean of seven 
estimates each from a different gel; standard deviation(SD)=
1.2) and 38.7kDa (observed to comigrate with the Bn5T:TBS:40
on more than ten different gels).
There are, in addition, at least four ^S-methionine 
labelled polypeptides which are present at lower levels in 
Bn5T cells than in RE cells (figures 4.2 and 4.3). These may 
also be important determinants of the normal/transformed 
phenotype, but have not been investigated in this study.
4.3.2 Coomassie blue staining
Total cell polypeptides, radiolabelled with 
•^S-methionine and separated by SDS-PAGE give some bands that 
are visible on autoradiography but not on Coomassie blue 
staining. Corresponding polypeptides may be too low in 
abundance to be detected by Coomassie blue staining and only 
detectable on autoradiography because of high methionine 
content or rapid turnover rate. Coomassie blue staining of 
polyacrylamide gels allows detection of 0.2ug polypeptide if
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Figure 4-3; Electrophoretic analysis of RE and Bn5T 
polypeptides using both Coomassie blue and autoradiographic 
detection techniques. Examination of Coomassie blue stained 
and autoradiographed tracks from a single 6-15% gradient 
polyacrylamide gel containing electrophoretically separated 
^S-methionine labelled polypeptides. Tracks 1 and 2 show 
Coomassie blue stained tracks containing total Bn5T and RE 
cell polypeptides respectively. Tracks 3 and 4 show the 
corresponding autoradiograph on which visible differences 
between the two polypeptide profiles are indicated by the 
outlined arrows. Solid arrows indicate 97kDa and 40kDa Bn5T 
polypeptides which comigrate with U90 and 40kDa Bn5T 
polypeptides in TBS i.p.s. (track 6). Track 5 shows a 
Coomassie blue stained track containing four standard TBS 
i .p ;s of Bn5T cell lysate. Track 6 shows the corresponding 
autoradiograph on which the i.p. polypeptides are arrowed. 
Comparison of tracks 5 and 6 shows that the U90 and L90 Bn5T 
polypeptides i.p. by TBS give faint bands on Coomassie blue 
staining. Non-specific bands labelled a, b and c represent 
serum components which bind to protein-A sepharose.
200kDa
97k Da
- <40kDa40kDa
present in a sharp band (Hames, 1981).
In Coomassie blue stained gels of total Bn5T cell 
polypeptide profiles, no bands are seen that comigrate with 
the 35S-methionine labelled polypeptides i.p. by TBS. This 
suggests that Bn5T:TBS polypeptides are present at low 
abundance in the cell.
4.3.3 Bands comigrating with Bn5T polypeptides 
immunoprecipitated by TBS
Bn5T total cell polypeptide profiles show three bands on 
autoradiography which comigrate with bands in Bn5T:TBS i.p.s. 
These have MWs of 40kDa, 97kDa and 200kDa (figures 4.2 and
4.3). The fact that these bands are seen in total Bn5T cell 
polypeptide profiles but are not seen in total RE cell 
polypeptide profiles, suggests that they may be the 
polypeptides recognized by TBS.
(a) 40kDa and 97kDa bands: The 40kDa band is easily visible
in - ^ S - m e t h i o n i n e  labelled total Bn5T cell protein profiles, 
but the 97kDa band is more difficult to see. These bands are 
not detected by Coomassie blue staining and are not seen in 
total RE cell polypeptide profiles.
(b) 200kDa band: Analysis of this band is more complex. It
can be seen from gels showing very fine resolution, that in 
•^S-methionine labelled total Bn5T cell polypeptide profiles 
there are two 200kDa bands very close together (figure 4.2). 
The lower band is much stronger than the upper band. In total 
RE cell polypeptide profiles there is only one 200kDa band and 
it is of similar intensity to the strong Bn5T 200kDa band.
In Bn5T:TBS i.p.s there are two 200kDa bands which
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comigrate with the two 200kDa bands in the total Bn5T cell 
polypeptide profile. However, in contrast to the total Bn5T 
cell polypeptide profile, it is the upper band in a Bn5T:TBS 
i.p. which is the strongest. This strong 200kDa band in 
Bn5T:TBS i.p.s comigrates with the weak 200kDa band which is 
present in total Bn5T cell, but not in total RE cell, 
polypeptide profiles. Thus/ the major 200kDa polypeptide band 
in TBS i.p.s corresponds to the polypeptide specific to the 
transformed cell.
4.4 Summary
(1) The apparent MWs of Bn5T:TBS polypeptides were 
rigorously determined and a system of nomenclature defined.
(2) A detailed analysis of total Bn5T and RE cell 
polypeptide profiles was carried out.
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5 POLYSOME IMMGNQSELECTIQN AND RNA STUDIES
The initial aim of this project was to use the polysome 
iramun©selection technique to obtain a specific cDNA probe to 
study Bn5T cell gene(s) encoding polypeptides recognized by
TBS and TG?A.
5.1 Polysome immunoselection
The author learned the details of polysome preparation 
and immunoselection techniques by reference to publications 
(Palmiter, 1974; Palacios et a l ., 1972; Gough and Adams, 
1978; Shapiro and Young, 1981; Benchimol et a l ., 1984) and 
by communications with. Dr M. Gren and Dr L. Crawford.
The polysome immunoselection technique has been used 
successfully for the selection of the low abundance mRNAs 
encoding p53 (Oren and Levine, 1983; Benchimol et a l . , 1984) 
and the precursor for ornithine transcarbamoylase (Kraus and 
Rosenberg, 1982). It was also used to select the message for 
the HSV-induced heat shock protein (HSP) of 57kDa recognized 
by the TI56 monoclonal (Patel et a l ., 1986). However, it was 
later learned that the same workers were unable to 
iiimunoselect polysomes from HSV-2 infected cells using the 
TG7A monoclonal (Dr N.B. LaThangue, personal communication).
5.1.1 Preparation of total cell polysomes
Polysom.es were prepared as described in section 3*4.4 and 
the quality of preparations was assessed by sedimentation 
profile analysis, as described in section 3*4*5 (Palacios et_ 
al.» 1972; Palmiter, 1974; Shapiro and. Young, 1981). BHK 
cells were used to practise polysome preparation and a total 
of seven polysome preparations were made before a satisfactory 
polysome sedimentation profile was obtained (fig 5*1)* An
Figure 5-1; Polysome profiles. Sedimentation profiles of 
polysomes following centrifugation through a 0.5M - 1 .5M 
sucrose gradient (see section 3.4.5). (A) BHK cell polysomes
(B) Bn5T cell polysomes.
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important factor contributing to the improvement in polysome 
preparations was the addition of cycloheximide (20ug/ml) to 
the PBS used to wash cell monolayers and harvest cells. This 
reduces the polysome "run-off" that occurs when cold PBS is 
applied (Dr C. Darnborough, personal communication; Dr C. 
Schneider, personal communication). Other alterations 
included: (a) changing the cell culture medium to EF5
containing cycloheximide (20ug/ml), 15 min. before harvesting,
(b) reducing the time taken to homogenize cells, pellet nuclei 
and add 1M MgCl2 , to less than 4 min. (delays at this stage 
are very detrimental to polysome preparations; Dr M. Oren, 
personal communication), (c) preparation of sucrose gradients 
using highly pure BRL sucrose, to obviate the need to 
autoclave sucrose solutions (some batches of autoclaved 
sucrose solution had been previously found to raise the 
background absorbance of UV at 260nm and consequently obscure 
the polysome peaks), and (d) technical improvements in the 
method of sucrose gradient sedimentation profile analysis.
With regard to the latter, experiments were carried out to 
optimize the resolving power of the pump, tubing and 
spectrophotometer system. The effects of alterations on 
resolution were assessed by pumping two 20ul boluses of RNA 
solution, separated by 200ul water, through the system while 
continuously monitoring the &260 us -^nS a Cecil CE500 control 
record module. Resolution of the two &260 Pea^s was increased 
by: (i) finding the optimum pump speed (a flow rate of 4ml
per min. gave the best resolution; figure 5.2), and (ii) 
reducing the length of tubing through which gradient fractions 
were pumped before reaching the spectrophotometer flow cell. A 
major length reduction was achieved by placing the gradient 
next to the flow cell inside the spectrophotometer and using a
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Figure 5.2; Optimizing conditions for recording polysome 
sedimentation profiles. Graphs A, B and C show the effect of 
different pump speeds on the resolution of A2£q Pea^ s 
corresponding to two 20ul boluses of an RNA solution, 
separated by 200ul distilled water (DW), which were pumped 
through a spectrophotometer flow cell. Graph D shows the 
effect of reducing the path length between sucrose gradient 
and flow cell from 40cm (as in A, B and C), down to 10cm.
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pump placed outside to "pull" fractions through the flow cell 
(figure 5.2).
5.1.2 Immunoselection of polysomes
The technique of Kraus and Rosenberg (1982) was used to 
immunoselect Bn5T polysomes (see section 5*4.6). Polysome 
immunoselection was attempted twice with TBS and once with 
TG7A.
The first approach used to purify antibody for 
immunoselection and remove RNases, was purification by 
protein-A sepharose CL4B chromatography. 1ml TBS was applied 
to a 1ml protein-A sepharose column in 4ml 0.1M sodium 
phosphate pH7.4, at a flow rate of 5ml/h for 18h. After 
washing with 5 column volumes of the phosphate buffer, 
antibody was eluted with 0.1M glycine-Cl pH2.5. Eluate 
fractions were immediately adjusted to neutral pH by the 
addition of 1M tris-Cl pH9.0 (75ul/ml eluate). Antibody 
containing fractions were identified by approximate 
determination of their protein concent rations by measuring 
absorbance directly. An A2Q0 reading of 1.0 was taken to 
indicate 1mg/ml of protein (Cantor and Schimmel, 1980). It 
was estimated that approximately 2.5mg antibody was purified 
from 1ml TBS. To reduce RNase activity further, human 
placental ribonuclease inhibitor (HPRI) was added to the 
purified antibody to a concentration 1U/ul. HPRI is a 50kDa 
protein which forms a 1:1 complex with bovine pancreatic RNase 
A and is a non-competitive inhibitor of the pancreatic enzyme 
with a of 3X10"10M (Blackburn et al ., 1977).
On the first occasion polysome immunoselection was tried, 
no immunoselected message could be in vitro translated (IVT). 
The problem was unlikely to be due to RNase degradation of
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polysomes as poly-A+ RNA prepared from breakthrough fraction 
polysomes translated well in vitro and polypeptides of up to 
200kDa were synthesised. The possible explanations considered 
were:
(a) No Bn5T polysomal epitopes recognized by TBS: The
epitope recognized by TBS might depend on the conformation 
adopted by the polypeptide chain of the native protein. 
Alternatively, it might result from post-translational' 
processing of the polypeptide.
(b) Inactivation of antibody during purification: The
antibody might have been denatured by exposure to low pH 
glycine buffer. The antibody should have been tested in an 
immunoprecipitation assay before use in immunoselection to 
examine this possibility.
(c) Antibody and/or immune complexes removed by excessive 
washing: If the antibody showed low affinity binding to
protein-A sepharose excessive washing could remove it. The 
use of TBS-protein-A sepharose immunoaffinity columns to 
purify Bn5T:TBS polypeptides had given very poor yields (Dr J. 
Macnab, personal communication), which would be consistent 
with low affinity binding. These columns, which were prepared 
by Dr J. Macnab and Mr A. Orr, were washed extensively before 
use of dimethyl pimelimidate to covalently bind the antibody 
to protein-A sepharose (Schneider et al ., 1982).
(d) RNase degradation of the immunoselected message: A very
low concentration of immunoselected message leading to RNase 
susceptibility and inefficient ethanol precipitation.
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On the second occasion that polysome immunoselection was 
attempted, both TBS and TG7A (ascites) were used for 
immunoselection. The following modifications were made to the 
protocol, taking into account the possible explanations listed 
above for the initial failure of polysome immunoselection.
Antibody was reacted with the protein-A sepharose before 
the addition of polysomes, so that the antibody could be 
washed without the need for elution and re-binding. Antibody 
bound to protein-A sepharose was washed with 20 bed volumes of 
buffer. Following this 10 bed volumes of buffer containing 
1U/ul HPRI were added, the column sealed and then incubated 
on a rotating mixer for 2h. Buffer was then run through the 
column, polysomes added and the column sealed again and then 
incubated as before. Columns were then unsealed and washed 
with only 4 column volumes of buffer A“ .
Duplicate columns were eluted with 4 column volumes of 
polysome elution buffer containing HPRI (1U/ul), either with 
or without 2ug of calf thymus tRNA. The tRNA was to act as 
carrier RNA to protect the small amount of immunoselected 
message from RNases, and to aid ethanol precipitation. Eluted 
fractions were collected in pre-cooled Eppendorf tubes 
containing appropriate volumes of ethanol and sodium acetate, 
then vortexed and ethanol precipitated at -70°C overnight. 
Breakthrough fraction polysomes were treated as before, that 
is, phenol extracted and then poly-A+ selected.
IVT of immunoselected mRNA preparations did not produce 
any detectable polypeptide bands that were not also seen for 
the minus RNA control. Thus polysome immunoselection by TBS 
or TG7A was unsuccessful, either with or without the use of 
carrier RNA. IVT of TBS breakthrough fraction mRNA produced 
ill-defined polypeptide bands above 90kDa, suggesting that
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RNases may have been a problem. In contrast however, IVT of 
TG7A breakthrough fraction mRNA gave a protein profile 
indistinguishable from IVT poly-A+ RNA prepared from total 
polysomes (figure 5.3). This indicated that for TG7A 
immunoselection at least, the RNase problem had been overcome.
Following this negative result, it was decided to test 
whether or not the epitopes recognized by TBS and TG7A, are 
expressed on nascent polypeptide chains during translation on 
the polysomes. An approach suggested by Dr C. Preston, was to 
test whether polypeptides synthesised by IVT of Bn5T RNA could 
be i.p. with these antibodies. This led to the interesting 
finding described below, that the Bn5T:TBS set of polypeptides 
could not be detected in the IVT products of Bn5T RNA or 
polysomes.
5.2 Experiments to detect Bn5T:TBS polypeptides synthesised 
in vitro
5.2.1 Analysis of total polypeptides produced by IVT
(a) Total cytoplasmic RNA: -^S-methionine labelled
polypeptides resulting from in vitro translation (IVT) of 
total Bn5T cell RNA with rabbit reticulocyte lysate, were 
analysed by SDS-PAGE. Three different preparations of Bn5T 
cell cytoplasmic RNA were prepared by the author for IVT. The 
polypeptide products of six separate IVT reactions, were 
analyzed by SDS-PAGE, some of them more than once. Altogether 
ten different gels were examined and results were entirely 
consistent. As illustrated in figure 5*4, many Bn5T 
polypeptides were successfully synthesised in vitro, but in
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Figure 5.3; Results of Bn5T polysome immunoselection with 
TG7A and TBS. Autoradiograph of a 6-15% gradient 
polyacrylamide gel containing electrophoretically separated 
^S-methionine labelled polypeptides. This shows the 
polypeptides IVT in rabbit reticulocyte lysate from poly-A+ 
RNA prepared from total Bn5T cell polysomes (tracks 1 and 7) 
and breakthrough polysomes after TG7A and TBS immunoselection 
(tracks 2 and 8 respectively). Tracks 3 and 4 contain IVT 
products of TG7A immunoselected RNA and tracks 9 and 10 
contain IVT products of TBS immunoselected RNA. RNA prepared 
from immunoselected polysomes was eluted from protein-A 
sepharose in the absence (tracks 3 and 9) or presence (tracks 
4 and 10) of calf thymus carrier tRNA. The products of minus 
RNA control IVT reactions are seen on tracks 5 and 11. Total 
Bn5T cell polypeptides are shown in track 6.
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Figure 5.4; Electrophoretic analysis of Bn5T polypeptides 
synthesised in vitro. Autoradiograph of a 6-15% gradient 
polyacrylamide gel containing electrophoretically separated 
- ^ S - m e t h i o n i n e  labelled polypeptides. Total Bn5T cell 
polypeptide profiles are seen in tracks 1 and 7 and track 2 
shows a standard TBS i.p. of Bn5T cell lysate. Total 
polypeptides resulting from IVT of Bn5T cell cytoplasmic RNA 
are seen in track 3 and a TBS i.p. of these polypeptides is 
seen in track 4. Track 5 shows a TBS i.p. of IVT polypeptides 
mixed with total cell polypeptides and track 6 shows the 
products of a minus RNA control IVT reaction.
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contrast to profiles of total Bn5T cell polypeptides, no 40kDa 
polypeptide band was seen.
(b) Poly-A+ RNA: A total of five different preparations of 
Bn5T cell poly-A+ RNA were prepared for IVT, three by Mr G. 
Patterson and two by the author. Poly-A+ RNA was selected 
from total Bn5T RNA prepared by the guanidinium/caesium 
chloride method (see section 3.4.1) by either oligo-dT 
cellulose column chromatography or the use of Hybond 
messenger-activated paper selection, using the protocol 
provided by the suppliers. The latter technique was used by Mr 
G. Patterson for two of his three poly-A+ RNA preparations. 
Poly-A+ Bn5T RNA prepared by the author using an oligo-dT 
cellulose column was used for the preparation of a cDNA 
library by Dr J. Macnab. The author analysed the resulting 
1st cDNA strand by alkaline denaturing gel electrophoresis 
(McDonnell et a l . , 1977). The majority of the cDNA was in the 
1k.b. to 2k.b. range (fig 5.5) indicating that the poly-A+
Bn5T RNA synthesised was of an acceptable quality.
IVT products of the five different preparations of 
poly-A+ Bn5T RNA were analysed separately by SDS-PAGE on a 
total of six different gels. In every case, exactly the same 
result was obtained as for preparations of cytoplasmic RNA.
No evidence of the 40kDa polypeptide band was seen on any of 
the polypeptide profiles.
(c) Total cell polysomes: Four different Bn5T cell polysome 
preparations were IVT and translation products analyzed by 
SDS-PAGE on ten different gels. The result was the same as 
for IVT of cytoplasmic RNA and poly-A+ , with one exception.
On one occasion, polysomes were IVT for time periods ranging
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Figure 5.5; Analysis of cDNAs by agarose gel electrophoresis.
Autoradiograph of a alkaline denaturing (1%) agarose gel 
containing the electrophoretically separated first cDNA 
strands, synthesised from Bn5T RNA (track 2) and HSV-2 
infected RE cell RNA (track 3). End-labelled lambda Hind III 
restriction fragments are seen in track 1 and their sizes in 
k.b. are indicated on the left side of the gel. The identity 
of band labelled "a" was not determined.
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from 2.5 min. to the standard period of 60 min. On SDS-PAGE 
analysis of volumes of IVT polypeptides corresponding to 7X104 
c.p.m., it was found that a 40kDa band which is clearly 
visible at 2.5 min., becomes progressively less prominent with 
increasing times of incubation, such that at 60 min. it was 
not visible above background (data not shown). Shortage of 
time prevented repetition of this experiment.
(d) Poly-A+ RNA prepared from total cell polysomes: Poly-A+ 
RNA prepared from Bn5T polysomes, was IVT on two different 
occasions as part of the polysome immunoselection procedure. 
The IVT polypeptide products were analyzed by SDS-PAGE on a 
total of three gels. On one of these gels only, a weak 40kDa 
polypeptide band was seen (figure 5.5).
(e) Conclusions: A detectable 40kDa Bn5T polypeptide was
produced by IVT, in some special circumstances, which 
comigrated with the Bn5T:TBS:40. However, the band produced 
on autoradiography was always weaker than that of the total 
cellular polypeptide profile. It is important to note that 
the 40kDa band of polypeptide profiles of Bn5T cell lysate, 
gives a very similar V8 protease peptide map to Bn5T:TBS:40 
and Bn5T:TG7A:40 (see section 6.2.2). This implies that the 
Bn5T:TBS:40 is only synthesised to a limited extent, (at 
most), by IVT. Two possible explanations why the 40kDa 
polypeptide produced by IVT of polysomes was only detectable 
after short incubation periods are that: (i) the mRNA
encoding the 40kDa polypeptide is unstable in reticulocyte 
lysate, and (ii) initiation of translation in reticulocyte 
lysate is inefficient and the 40kDa polypeptide synthesised in_ 
vitro results mainly from polysome "run-off". It is important
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to note however, that the 40kDa polypeptide produced by IVT 
may not be related to the Bn5T:TBS:40 polypeptide. The only 
available evidence of identity is comigration on SDS-PAGE.
No conclusions can be reached from the analysis of IVT 
polypeptides about the in vitro synthesis of 97kDa and 200kDa 
members of the Bn5T:TBS set. The bands in total cell 
polypeptide profiles, thought to correspond to these i.p. 
polypeptides, are very faint and only visible on gels showing 
particularly good resolution. The bands seen on SDS-PAGE 
analysis of IVT polypeptides were never as well resolved as 
the bands seen for cell lysates.
5.2.2 Immunoprecipitation assays on polypeptides produced by 
IVT
(a) Total cytoplasmic RNA: IVT cytoplasmic RNA was i.p. by
TBS on three different occasions by the author. It was also 
i.p. once with TBS and once with TG7A by Mr A. Orr. On 
SDS-PAGE analysis of TBS i.p.s, no polypeptide bands were 
seen, on any occasion, in the vicinity of polypeptide bands of 
the Bn5T:TBS set (figure 5.4). One positive control used in 
this experiment was a TBS i.p. of the following mixture: 
Radiolabelled Bn5T cell lysate added to reticulocyte lysate 
which had been IVT in the absence of RNA. The amount of 
radiolabelled cell lysate required for a single standard i.p. 
(4X10^ c.p.m.) was used for this positive control i.p., and 
the volume:volume ratio of Bn5T cell lysate to reticulocyte 
lysate, never exceeded 1:20. In every case the positive 
control i.p. gave exactly the same result as a standard 
Bn5T:TBS i.p., indicating that no reticulocyte lysate 
component was interfering significantly with the i.p.
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reaction. Ideally, another positive control should have been 
included, using an antibody directed against a normal cellular 
polypeptide to i.p. IVT Bn5T polypeptides and in repeat 
experiments this would need to be tested. The total 
polypeptide profile of IVT products of Bn5T RNA was a further 
positive control used in this experiment, and this showed that 
polypeptides over a MW range from 200kDa to less than 30kDa
were being synthesised. The faint and poorly defined bands of
high MW polypeptides indicate that they did not translate 
well. However, results were entirely satisfactory for 
polypeptides with MWs below 110kDa.
For the TG7A i.p. of in vitro translated Bn5T
polypeptides very weak bands were seen comigrating with
200kDa, L90 and 40kDa Bn5T:TBS polypeptides. The significance 
of this is doubtful however, as there was a high background in 
this i.p. and many bands of greater prominence were visible 
(data not shown). Unfortunately, the limited supply of TG7A 
monoclonal made it impossible to repeat this experiment.
(b) Total cell polysomes: Polysomes from three different 
preparations were IVT and i.p. with TBS by the author. Mr G. 
Patterson also made a polysome preparation and assayed by i.p. 
with TBS. The i.p.s were separately analyzed by SDS-PAGE on 
five different gels. No evidence was seen on any of these 
gels of bands comigrating with those of the Bn5T:TBS set. In 
addition, two different preparations of polysomes were IVT and 
i.p. with TG7A, but no bands were seen on SDS-PAGE analysis of 
these i.p.s.
(c) Conclusions: Two possible reasons for the absence of
detectable Bn5T:TBS polypeptides after IVT of Bn5T RNA and
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polysomes are: (i) the levels of Bn5T:TBS polypeptides 
produced by IVT are too low for detection, and (ii) the 
polypeptides are not post-translationally processed in the IVT 
system, to forms recognizable by TBS or TG7A. Experiments 
were therefore carried out to investigate the possible 
post-translational processing of Bn5T:TBS polypeptides.
5.3 Experiments to detect post-translational processing
5.3.1 Analysis of polypeptides produced by IVT in the 
presence of canine pancreatic microsomal membranes
Microsomal membranes are used to study two main types of 
post-translational or co-translational processing. One is the 
removal of signal peptides (Dorner and Kemper, 1978) and the 
other is glycosylation of pre-secretory or membrane proteins 
(Rothman and Lodish, 1977). As a positive control human 
placental lactogen mRNA, which encodes a polypeptide with a 
signal peptide, was IVT in the presence or absence of 
microsomal membranes. As was expected, a polypeptide of 
approximately 30kDa was IVT without the microsomal membranes 
and on addition of the membranes a lower MW polypeptide band 
(approximately 20kDa) appeared. Thus, the microsomal 
membranes were working effectively.
Two different preparations of polysomes were IVT in the 
presence of canine pancreatic microsomal membranes on three 
different occasions, twice by the author and once by Mr G. 
Patterson. No evidence of a 40kDa polypeptide band was seen 
in the total polypeptide profile of polysomes IVT in the 
presence or absence of microsomal membranes. Nor was it 
possible to i.p. polypeptides migrating at a similar rate to
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Figure 5.5; Analysis of transformed cell (Bn5T) polypeptides 
by SDS-PAGE. Autoradiograph of a 6-15% gradient 
polyacrylamide gel containing electrophoretically separated 
^S-methionine labelled (tracks 1 and 3), and 
^P-orthophosphate labelled polypeptides (tracks 2 and 4) . 
Total cell polypeptides are seen in tracks 1 and 2, and TBS 
i.p. polypeptides in tracks 3 and 4. Polypeptides i.p. by TBS 
are indicated by solid arrows in track 3 and the designated MW 
values given on the right side of the gel.
Bn5T:TBS bands, despite three attempts using TBS and one 
attempt using TG7A (data not shown).
5-3-2 Metabolic labelling with -^P-orthophosphate
Lysate from Bn5T cells radiolabelled in vivo with 
■^P-ort hop ho sp hate was i.p. with TBS and then subjected to 
SDS-PAGE. Autoradiography showed a ^2P-lahelled band 
comigrating with the ^5S-labelled Bn5T:TBS:200 and :40 of a 
standard BnST:TBS i.p. run in an adjacent track (figure 
5-5). No ^P-labelled bands were seen in the 90 - 100kDa 
region, a finding confirmed by Dr D.O. Toft (personal 
communication) , nor were any seen in the 30-36kDa region.
This suggests that the Bn5T:TBS:200 and :40 are phospho- 
proteins, unlike the Bn5T:TBS:U90, L90, :35 and :34.
5-3-3 Metabolic labelling with -%-mannose
It was not possible to demonstrate any glycosylated 
Bn5T:TBS i.p. polypeptides by radiolabelling with ^H-mannose 
(data not shown). Treatment of Bn5T cells with tunicamycin 
resulted in the loss of the low MW component of the 34kDa band 
(see Table 4.1) indicating that it may be a glycoprotein, but 
no other changes were seen (data not shown).
5-4 Conclusions
The only direct evidence found here of post-translational 
processing of major Bn5T:TBS polypeptides, is for the 
phosphorylation of 40kDa and 200kDa polypeptides. No direct 
evidence was found of post-translational modifications common 
to all polypeptides of the Bn5T:TBS set, which might account 
for our inability to i.p. any one of these polypeptides from 
the products of IVT Bn5T RNA.
128.
It is possible that Bn5T:TBS polypeptides require post- 
translational changes to occur such as complex formation with 
other cellular components, in order to be i.p. by TBS and 
TG7A. If this is true then TBS and TG7A are unlikely to 
recognize epitopes expressed by polysomes on which Bn5T:TBS 
polypeptides are synthesised. Another possible explanation 
for our inability to i.p. Bn5T:TBS polypeptides translated in 
vitro, is that the reticulocyte lysate system is unsuitable 
for the efficient IVT of mRNAs encoding Bn5T:TBS polypeptides. 
Whatever the correct explanation, our inability to detect IVT 
Bn5T:TBS polypeptides suggests that it would also be 
impossible to IVT mRNA immunoselected by TBS or TG7A. This 
presents a serious problem, as in order to demonstrate that a 
specific mRNA has been purified by the polysome 
immunoselection technique, it is important to be able to 
analyze that mRNA by IVT and SDS-PAGE. Thus, our inability to 
IVT polypeptides recognized by TBS or TG7A, suggests that 
polysome immunoselection is a technique ill-suited for the 
Bn5T:TBS system. Its use was therefore discontinued.
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6 COMPARING TUMOUR ANTIGENS RECOGNISED BY TBS AND TG7A
The TG7A monoclonal antibody was previously found to 
recognize polypeptides of 90kDa, 40kDa and 32kDa in Bn5T cells 
(Macnab et a l . , 1985a). Bn5T polypeptides i.p. by TG7A and 
TBS, were analysed and compared by one-dimensional peptide 
mapping using Staphylococcus V8 protease at a single enzyme 
concentration. The 90kDa polypeptide band (U90 and L90 
combined) gave indistinguishable results on peptide mapping, 
whether from Bn5T:TG7A or Bn5T:TBS i.p.s. The 40kDa 
polypeptides were found to be similar but not identical and 
the same was found for 32kDa polypeptides. Results are 
presented in this chapter of a further and detailed 
investigation into the relationship between Bn5T polypeptides 
recognized by TBS and TG7A.
6.1 Analysis of immunoprecipitates by SDS-PAGE
In all cases where Bn5T:TBS:U90, L90 and 40kDa 
polypeptides could be i.p. by TBS from a cell lysate, these 
polypeptides were always i.p. in addition by the TG7A 
monoclonal. These polypeptides were never found to be i.p. by 
only one of these two antibody preparations.
(a) Comigrating polypeptides: Analysis by SDS-PAGE shows
that for each polypeptide i.p. by TBS from Bn5T lysate, there 
is a comigrating polypeptide i.p. by TG7A (Figure 6.1). Thus, 
in each case there are polypeptides of 200, 97, 93, 40, 35, 
and 34kDa.
(b) Different precipitation ratios: The intensity of bands
seen on autoradiography indicates that the precipitation ratio 
for TBS and TG7A polypeptides is quite different (figure
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Figure 6.1; Comparison of Bn5T:TBS and Bn5T:TG7A polypeptides 
by SDS-PAGE. Autoradiograph of a 6-15% gradient polyacryl­
amide gel containing electrophoretically separated 
^^S-methionine labelled polypeptides i.p. from Bn5T cell 
lysate by TG7A (tracks 2, 4, 6, 8 and 10) and TBS (tracks 3,
5, 7 and 9). Bands of interest are indicated by solid arrows 
for the TBS i.p. (track 9) and outlined arrows for the TG7A 
i.p. (track 10). The designated MW or notation for each of 
these bands is given on the right side of the gel. MW markers 
are'shown in track 1.
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6.2). For TBS the U90 is the major band, usually followed by 
the L90, 200kDa, 40kDa, 34kDa and 35kDa in order of intensity. 
The TBS 35kDa is often too faint to see. For TG7A in contrast, 
the strongest bands are of 40 and 35kDa, followed by the U90 
and L90. The TG7A 200 and 34kDa bands are often too faint to 
see.
(c) Polypeptides of 34kDa and 35kDa: In Bn5T:TBS i.p.s the
major band below 40kDa is of slightly lower apparent MW than
that of TG7A i.p.s (figure 6.1). For TBS i.p.s the 34kDa
polypeptide gives a major band, while for TG7A it is a 35kDa
polypeptide which gives a major band.
6.2 One-dimensional peptide mapping analysis
Comparisons were made by one-dimensional peptide mapping 
analysis using the Cleveland digest technique (Cleveland et_ 
al. , 1977), between comigrating polypeptides i.p. by TBS and 
TG7A.
6.2.1 Comigrating polypeptides of 90 ~ 100kPa
(a) Bn5T U90 polypeptide: No differences were detected
between Bn5T U90 polypeptides i.p. by TBS and TG7A with either 
V8 protease or chymotrypsin, over a range of enzyme 
concentrations. In digests of the TBS and TG7A polypeptides 
with 1/25ug V8 protease, all of the fifteen resulting peptide 
bands comigrated exactly (figure 6.3), as did all of the eight 
bands produced by 1/25ug chymotrypsin (figure 6.4).
(b) Bn5T L90 polypeptide: Similarly, no differences were
found when comparing L90 polypeptides in this way. On
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Figure 6.2; Densitometric analysis of TBS and TG7A i.p.s of 
Bn5T cell lysate, analyzed by SDS-PAGE and autoradiography.
The intensities of major bands seen on autoradiography 
(200kDa, U90, L90, 40kDa, 35kDa and 34kDa) are expressed 
graphically. Batches of TBS prepared in different animals 
(batches A to E) were used to i.p. the same preparation of 
Bn5T cell lysate, in two replicate experiments.
Accordingly, graphs A1 and A2 represent profiles of Bn5T 
polypeptides i.p. by TBS batch A, in experiments 1 and 2.
The same rule applies for graphs B1 and B2, C1 and C2, D1 and 
D2 and E1 and E2. Graph F shows the band intensities in a 
typical Bn5T:TG7A i.p.
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Figure 6.3; V8 protease peptide maps of the Bn5T:TBS:U90 and 
Bn5T:TG7A:U90 compared. Cleveland digest analysis of the U90 
polypeptide as i.p. from Bn5T cell lysate by TG7A (tracks 1-3) 
and TBS (tracks 4-6). Tracks 1 and 4 contained 1/25ug, tracks 
2 and 5 contained 1/5ug and tracks 3 and 6 contained 1ug of 
S.aureus V8 protease. MW markers are shown in track 7.
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Figure 6.4; Chymotrypsin peptide maps of Bn5T:TG7A:U90, 
Bn5T:TBS:U90 and L90. Cleveland digest analysis using 
chymotrypsin of U90 and L90 polypeptides i.p. from Bn5T cell 
lysate. The U90 polypeptide i.p. by TG7A (tracks 4 and 5) is 
compared with the U90 (tracks 6 and 7) and L90 (tracks 8 and 
9) polypeptides i.p. by TBS. Tracks 4, 6 and 8 contained 
1/25ug and tracks 5, 7 and 9 contained 1ug of chymotrypsin. 
Comigrating bands in digests of TBS U90 and TBS L90 are 
indicated by the arrows in tracks 7 and 9 respectively. 
Undigested TG7A U90, TBS U90 and TBS L90 are seen in tracks 1, 
2 and 3 respectively. MW markers are seen in track 10.
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digestion with 1/25ug V8 protease seventeen out of seventeen 
resulting peptides comigrated exactly (figure 6.5).
These results indicate that the 97kDa and 93kDa tumour 
antigens recognized by tumour bearing serum are also 
recognized by the TG7A monoclonal.
6.2.2 Comigrating polypeptides of 40kDa
(a) Bn5T:TBS:40 compared with Bn5T:TG7A:40: V8 protease
peptide maps of Bn5T 40kDa polypeptides i.p. by TBS and TG7A 
are similar but not identical (figure 6.6). To examine the 
subtle differences between V8 protease peptide maps of these 
two 40kDa polypeptides, a detailed comparison has been carried 
out. No peptides are seen in digests of one polypeptide that 
do not correspond with a comigrating peptide in digests of the 
other. On well exposed autoradiographs, digests of both 40kDa 
polypeptides show seven comigrating peptides with the MWs 
shown in table 6.1. The exact comigration of these seven 
peptides strongly suggests that TBS and TG7A 40kDa 
polypeptides are closely related. However, the peptide maps 
differ in the relative intensity of the peptide bands on 
autoradiography. The three strongest bands in a Bn5T:TBS:40 
digest with 1/25ug V8 protease, are numbers 5, 7 and 2 (table
6.2). In contrast, for the Bn5T:TG7A:40 digested with 1/25ug 
enzyme they are 4, 6 and 3. These findings suggest that a 
difference exists between the molar ratios of peptide 
fragments of the 40kDa polypeptides recognized by TBS and 
TG7A. Two possible explanations are: (a) two or more of the
same 40kDa polypeptides, not resolved by SDS-PAGE, are i.p. by 
both TBS and TG7A. The two different antibodies i.p. these
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Figure 6.5; V8 protease peptide maps of the Bn5T:TBS:L90 and 
Bn5T:TG7A:L90 compared. Cleveland digest analysis of the L90 
polypeptide as i.p. from Bn5T cell lysate by TBS (tracks 4-6) 
and TG7A (tracks 7-9). Tracks 4 and 7 contained 1/25ug, 
tracks 5 and 8 contained 1/5ug and tracks 6 and 9 contained 
1ug of S.aureus V8 protease. Tracks 1 and 2 correspond to 
undigested L90 polypeptides i.p. by TBS and TG7A respectively. 
MW markers are shown in tracks 3 and 10.
CM
Figure 6.6; V8 protease peptide maps of Bn5T:TBS:40, 
Bn5T:TG7A:40 and Bn5T:PP:40 compared. Cleveland digest 
analysis of the 40kDa polypeptides i.p. from Bn5T cell lysate 
by TBS (tracks 1 and 2) and TG7A (tracks 5 and 7) compared 
with the comigrating polypeptide seen in total Bn5T 
polypeptide profiles (tracks 3 and 4). Tracks 1, 3 and 5 
contained 1/25ug, tracks 2, 4 and 7 contained 1ug of S.aureus 
V8 protease. Peptide bands are numbered in track 1 and MW 
markers are shown in track 8.
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Table 6.1; MW estimates of peptides produced on digestion of 
Bn5T:TBS:40 and Bn5T:TG7A:40 with V8 protease: Calibration
curves were plotted for each gel using BRL MW standards 
(ovalbumin - 43kDa, alpha-chymotrypsinogen - 25.7kDa, 
beta-lactoglobulin - 18.4kDa, lysozyme - 14.3kDa). For every 
band, five independent MW estimates were made, each from a 
different gel. Mean values and SDs are given. Band no.1 
probably represents undigested polypeptide as the MW estimate 
is approximately 40kDa.
A. Digests with 1/25ug enzyme
T B S :40 - Gel 1 : 7 > 5 > 2 > 1
• • • 2 : 5 > 7 > 2 > 6 > 4 > 3
• • • 3 : 5 > 7 > 2 > 6 > 4 > 1
TG7A:40 - Gel 1 : 4 > 3 > 6 > 5
• • • 2 : 4 > 6 > 3 > 5 > 7
• • • 3 : 4 > 6 > 3 > 7 > 5 > 2
PP:40 - Gel 3 : 2 > 6 > 5 > 4 > 1 > 3
B. Digests with 1ug enzyme
T B S :40 - Gel 1 : 7 > 5... 2 : 7 > 6 > 5 > 4
3 : 7 > 6 > 5
TG7A:40 - Gel 1 : 7 > 6 > 4 > 5... 2 : 7 > 6 > 4
3 : 7 > 6 > 5 > 4
P P : 40 - Gel 3 : 7 > 6 > 5
Table 6.2; Analysis of V8 protease peptide maps of 
Bn5T:TBS:40, Bn5T:TG7A:40 and Bn5T:PP:40 polypeptides:
Protease digests using two different enzyme concentrations 
were analyzed on three different gels. Band numbers (defined 
in table 6.1) are placed in order of band intensity, as 
measured by densitometer.
polypeptides in different molar ratios. Thus, proteolysis of 
40kDa polypeptides i.p. by TBS, gives peptide fragments in 
different molar ratios to those resulting from proteolysis of 
40kDa polypeptides i.p. by TG7A. (b) A different protein :
enzyme ratio for Bn5T:TG7A:40 and Bn5T:TBS:40 digestions 
produces the differences in peptide map pattern. The stronger 
signal obtained from peptide bands in Bn5T:TG7A:40 digests 
compared with the Bn5T:TBS:40, suggests that the TG7A i.p. 
polypeptide is more abundant. Further supporting evidence is 
seen in table 6.2, which shows that peptide maps of different 
40kDa polypeptides become more alike when digestion is closer 
to completion, as with the higher enzyme concent ration.
Despite the differences in peptide band intensity, the 
above evidence suggests that TBS and TG7A recognize very 
similar, if not identical 40kDa polypeptides. For reasons not 
determined peptide mapping of these 40kDa polypeptides with 
chymotrypsin gave peptide maps with poor resolution which were 
very difficult to interpret.
(b) Bn5T:PP:40: Peptide mapping of the Bn5T:PP:40 with V8
protease gives seven peptide bands which comigrate with those 
produced on digestion of both Bn5T:TBS:40 and Bn5T:TG7A:40 
(figure 6.6). On visual inspection the pattern of bands in 
Bn5T:PP:40 peptide maps appears very similar to the pattern 
for Bn5T:TG7A:40 . However, densitometric analysis of these 
peptide maps indicates that the pattern for digests of 
Bn5T:PP:40, shares features with both Bn5T:TBS:40 and 
Bn5T:TG7A:40 (data not shown).
6.2.3 Polypeptides of 200. 33 and 34kDa
Peptide mapping comparisons were not possible for the
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200, 35 and 34kDa polypeptides i.p. by TBS and TG7A. For 
successful peptide mapping, i.p. polypeptides separated on the 
first gel must produce strong bands on autoradiography 
otherwise the signal will be too weak for detection after 
proteolytic digestion and separation of peptides on the second 
gel (section 3.7.2). The 200 and 34kDa polypeptide bands in 
Bn5T:TG7A i.p.s and the 35kDa polypeptide band in Bn5T:TBS 
i.p.s were always too weak to allow successful peptide 
mapping.
6.3 Conclusions
TBS and TG7A recognize comigrating polypeptides of 200, 
97, 93, 40, 35 and 34kDa in Bn5T cells but not in RE cells 
prepared from late gestation embryos. Those comigrating 
polypeptides for which comparison by peptide mapping was 
possible (97, 93 and 40kDa), show very similar digest 
patterns. This evidence suggests that TBS and TG7A identify 
the same set of transformed cell polypeptides.
7 RELATIONSHIPS BETWEEN TUMOUR ANTIGENS RECOGNIZED BY TBS
Evidence is presented in chapter 6, which indicates that 
TBS and TG7A recognize members of the same set of transformed 
cell polypeptides. Evidence will now be presented which sheds 
light on the inter-relationships of these polypeptides 
belonging to this set.
7 -1 Co-expression or non-expression
Every cell type examined appears to express either all or 
none of the polypeptides recognized by TBS and TG7A with MWs 
of 200, 97, 93, 40, 35 and 34kDa.
7.1.1 Different cell types
TBS and TG7A i.p. polypeptides of the above MWs from a 
range of immortalized cells. These include the established 
cell lines Rat-1, Rat-2 and Hood, the transformed cell lines
/  T k s  C e r f t - to r k :  O v jc o a I  gk 4 - / f W - 0
Bn5, LA24 and LA90 (data not shown) and the tumour cell line 
Bn5T. LA90 cells are RSV transformed mouse 3T3 cells and so 
expression of the polypeptides is not specific for rat cells.
No polypeptides of similar MW were i.p. by TBS or TG7A from 
the human HeLa cell line. These polypeptides were not i.p. by 
TG7A from lysates of ten different preparations of rat embryo 
fibroblasts (Macnab et a l .,1985a). Similar results were 
obtained with TBS. These results were obtained using cells 
prepared from embryos of approximately 16 to 20 days old. 
However, when embryos of approximately 12 days are tested, it 
is possible to i.p. polypeptides with TBS which co-migrate 
exactly with Bn5T:TBS polypeptides (data not shown). This has 
also been observed for two different cultures by Dr J.Macnab.
To further investigate the pre-natal expression of these 
polypeptides, the embryonal carcinoma cell line PC1315 and
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four embryonal carcinoma cell lines differentiated in vitro 
were i.p. with TBS. These cell lines were found to be the 
only immortalized rodent cells so far encountered which do not 
express the Bn5T:TBS polypeptide set. Owing to lack of time 
the author was unable to repeat this experiment.
7-1.2 Different culture conditions
No culture conditions were identified which consistently 
influenced the level of expression of any of the Bn5T:TBS 
polypeptides or induced the expression of any comigrating 
polypeptides in RE cells.
(a) Degree of confluence: No RE cell polypeptides were i.p.
by TBS from either subconfluent or highly confluent cultures 
prepared from late gestation rat embryos. The same Bn5T cell 
polypeptides were i.p. by TBS from both sub- confluent and 
highly confluent cultures. In one experiment the intensity of 
the U90 was found to be greater for confluent Bn5T cell 
cultures, while the intensity of the 34kDa polypeptide was 
greater in subconfluent cultures. However, this experiment 
could not be repeated (Dr J.Macnab, personal communication).
(b) Serum concentration: RE cell cultures prepared from late
gestation embryos were incubated in medium containing 
different concentrations of serum. Cells were radiolabelled 
for 18h with ^5S-methionine in Eagle's minus methionine 
culture medium containing 0%, 2.% and 10% foetal calf serum
(FCS). Neither high nor low serum concentration induced 
detectable levels of any polypeptides comigrating with 
Bn5T:TBS polypeptides (data not shown).
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7-1.3 IVT polypeptides
A further characteristic shared by all Bn5T polypeptides 
recognized by TBS and TG7A is that none of them can be i.p. 
from the IVT products of Bn5T mRNA (section 5.2.2).
7.1.4 Co-expression: conclusions
The fact that Bn5T:TBS polypeptides are either expressed 
as a complete set or not expressed at all, indicates a common 
origin and/or regulation by the same factor(s). It also 
suggests that they may have related functions.
7.2 Co-precipitation
As stated above, every cell type examined will express 
either all or none of the polypeptides recognized by TBS and 
TG7A with MWs of 200, 97, 93, 40, 35 and 34kDa. In addition, 
analysis of cells expressing these polypeptides shows that 
polypeptides of 97, 93, 40 and 35kDa are co-precipitated in 
all i.p. assays with TG7A and polypeptides of 200, 97, 93, 40 
and 34kDa are co-precipitated in all i.p. assays with TBS.
7-2.1 Explanations for co-precipitation of Bn5T:TBS 
polypeptides
Co-precipitation of Bn5T polypeptides by the TG7A 
monoclonal antibody suggests that they are antigenically 
related and/or linked in a multi-subunit complex. TG7A 
detects Bn5T polypeptides of approximately 90kDa, 40kDa and 
35kDa on Western blotting analysis, which indicates that these 
polypeptides are antigenically related (Dr N.B. La Thangue, 
personal communication). TBS detects U90 and L90 Bn5T 
polypeptides on Western blots (Dr D.O. Toft, personal 
communication). Thus, TBS must recognize an epitope on both
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the U90 and the L90 polypeptide. Western blotting studies 
leave unresolved the question of whether 200, 40 and 34kDa 
polypeptides have epitopes recognized by TBS. The alternative 
being, that they are i.p. due to complex formation with U90 
and L90 polypeptides. The circumstantial evidence that 
follows suggests that 200, 40 and 34kDa polypeptides do have 
epitopes recognized by TBS:
(a) In Bn5T:TBS i.p.s with some batches of TBS, the L90 
polypeptide gives a very weak band and yet 200, 40 and 34kDa 
polypeptides are easily visible (figure 6.2). This indicates 
that complexing to the L90 polypeptide is unlikely to account 
for the i.p. of the 200, 40 and 34kDa polypeptides.
(b) Analysis of Bn5T:TG7A i.p.s shows that U90 and L90 bands 
are easily visible, but that 200kDa and 34kDa bands are not 
(figure 6.2). In contrast, for most Bn5T:TBS i.p.s the 200kDa 
and 34kDa bands are easily visible, as well as the U90 and L90 
bands. This suggests that 200 and 34kDa polypeptides are not 
complexed to U90 or L90 polypeptides and that the i.p. of 
200kDa and 34kDa polypeptides by TBS is due to recognition of 
epitopes on these molecules.
(c) There was considerable variation in the specificity of 
sera from different tumour bearing rats as indicated by the 
variation in precipitation ratios shown in table 7.1. The 
widest range of precipitation ratios is between 34kDa and U90 
polypeptides. This suggests that i.p. of the 34kDa 
polypeptide by TBS does not depend on complex formation with 
the U90 polypeptide.
(d) When developing a large scale i.p. technique (section
9.1.2) a single carefully quantitated study was carried out to 
test the effect of increasing the antigen concentration on the 
strength of the immunopurified polypeptide bands. It was
138.
Bands
compared
Ratio for 
TBS i.p.s 
minimum - maximum
Ratio for 
TG7A i.p.
200.-U90 0.32, 0.34, 0.37, 0.50, 0.54 0.00, 0.00
0.00, 0.00, 0.27, 0.44, 0.75 0.87, 1.10
0.46, 0.78, 0.82, 1.11, 1.30 6.06, 8.50
0.57, 0.67, 0.69, 0.95, 2.03 0.00, 0.00
L90:U90
40.-U90
34:U90
Table 7.1; Quantitative analysis of precipitation ratios of 
Bn5T polypeptides i.p. by TBS and TG7A: 5 batches of TBS each
from a different tumour bearing rat were used to i.p. the same 
sample of Bn5T cell lysate and precipitates analysed on 
SDS-PAGE in replicate experiments. Bn5T:TG7A i.p.s were also 
analysed. Densitometer measurements of autoradiograph band 
intensity allow quantitative comparison of precipitation 
ratios. Ratios of band intensity measurements give a measure 
of precipitation ratio for polypeptides corresponding to the 
bands compared.
found that increasing the antigen concentration had a marked 
effect on the intensity of the 97kDa Bn5T polypeptide band. 
More dramatic than this however was the increase in intensity 
of the 40kDa band. Densitometric analysis showed that a 10X 
increase in antigen concent rat ion gave a 1 .5X increase in U90 
polypeptide binding and a 3.8X increase in 40kDa binding.
Thus, the U90:40 precipitation ratio does not appear to be 
constant with increasing antigen concentration, indicating 
that the 40kDa polypeptide does not need to be complexed to 
the U90 in order to be recognized by TBS antibodies. This 
implies that the 40kDa polypeptide has an epitope recognized 
by TBS antibodies.
7.2.2 Coprecipitation: conclusions
There is direct evidence that TG7A recognizes epitopes on 
U90, L90, 40 and 35kDa polypeptides and that TBS recognizes 
epitopes on U90 and L90 Bn5T polypeptides. In addition there 
is evidence which suggests that TBS also recognizes epitopes 
on 200, 40 and 34kDa polypeptides. Thus, shared epitopes seem 
a more likely explanation for co-precipitation, than the 
existence of Bn5T:TBS polypeptide complexes.
7-3 Peptide mapping studies
To investigate the possibility that shared domains 
account for the antigenic relatedness of Bn5T polypeptides 
i.p. by TBS and TG7A, one-dimensional peptide mapping analysis 
was performed. Both staphylococcal V8 protease and 
chymotrypsin were used in these studies and each was used at a 
range of concentrations giving partial proteolysis.
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7.3.1 Analysis of Bn5T polypeptides i.p. by TBS
(a) U90, L90 and 200kDa polypeptides: With both enzymes and
in particular with V8 protease, there were similarities 
between U90 and L90 polypeptides. V8 protease peptide maps 
were carried out on these polypeptides using three different 
concentrations of enzyme. Peptide maps of U90 and L90 
polypeptides with 1ug V8 protease per track show major 
comigrating bands of 13.3kDa and 14.1kDa (mean of 3 
independent MW estimates for each peptide band); (figure 
7.1). V8 protease digestion of the 200kDa polypeptide gave a 
peptide map showing similarities with those of U90 and L90 
polypeptides (figure 7.1). All show comigrating 13.3kDa and 
14.1kDa peptides (observed in 3 independent experiments) which 
suggests that they share a similar domain. Comigrating 
14.5kDa peptides are also seen in digests of the U90 and 
200kDa polypeptides. Digestion of the U90 and L90 bands with 
1 ug chymotrypsin yielded comigrating bands of 13-5, and 15kDa 
(figure 6.4).
Thus, there is evidence from peptide mapping studies for 
shared regions of homology between the U90, L90 and 200kDa 
Bn5T polypeptides i.p. by TBS. Further evidence of a close 
relationship between U90, L90 and 200kDa polypeptides comes 
from a comparison of the precipitation ratios in Bn5T:TBS and 
Bn5T:TG7A i.p.s. These three polypeptides are all recognized 
more strongly by TBS than TG7A (figures 6.1 and 6.2). TBS 
recognizes the 200, 97 (U90 polypeptide), 93 (L90 polypeptide) 
and 34kDa more strongly than TG7A. Conversely, TG7A 
recognizes the 40 and 35kDa more strongly than TBS. This 
suggests that within the total set of polypeptides recognized 
by the two antibody preparations there are two subsets of
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Figure 7.1; V8 protease peptide maps of the Bn5T:TBS:200kDa,
U90 and L90 compared. Cleveland digest analysis of the 200kDa 
(tracks 1-3), U90 (tracks 4-6) and L90 (tracks 7-9) 
polypeptides as i.p. from Bn5T cell lysate by TBS. Tracks 1,
4 and 7 contained 1/25ug, tracks 2, 5 and 8 contained 1/5ug 
and tracks 3, 6 and 9 contained 1ug of S.aureus V8 protease.
MW markers are shown in track 10.
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polypeptides which are more closely related: one subset
containing 200kDa, U90, L90 and 34kDa polypeptides and the 
other subset containing 40kDa and 35kDa polypeptides.
(b) 40kDa and 34kDa polypeptides: No similarities are seen
between peptide maps of 34 and 40kDa Bn5T polypeptides i.p. by 
TBS. Neither polypeptide gives a peptide map resembling that 
of the L90 or U90 polypeptide. A comparison of V8 protease 
peptide maps for 40kDa and U90 polypeptides is seen in figure 
7.2, and a further detailed peptide mapping analysis of these 
two polypeptides with 1 , 5 ,  10 and 25ug V8 protease per track 
showed no similarity with any enzyme concentration (data not 
shown). In addition, chymotrypsin digests of these 
polypeptides showed no obvious similarity (figure 7.3).
The 40kDa polypeptide gives V8 protease and chymotrypsin 
peptide maps which show similarities to those of the 200kDa 
polypeptide. Using 1ug V8 protease, two out of five bands in 
40kDa polypeptide digests, appear to comigrate with two out of 
eight bands in 200kDa polypeptide digests (figure 7.2). These 
two comigrating bands are different from the comigrating bands 
shared by 200kDa, U90 and L90 polypeptides and have MWs of 
approximately 14.3kDa and 14.7kDa (estimated from a single 
gel). No obvious similarity was seen between peptide maps of
34kDa and 200kDa polypeptides (figure 7-3).
7.3.2 Analysis of Bn5T polypeptides i.p. by TG7A
(a) U90 and L90 polypeptides: The U90 and L90 polypeptides
i.p. by TG7A from Bn5T cells give indistinguishable peptide 
maps to those of the comigrating polypeptides i.p. by TBS
(section 6.2.1), and the relationship between peptide maps of
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Figure 7.2; V8 protease peptide maps of Bn5T:TBS:200, U90 and 
40kDa polypeptides compared. Cleveland digest analysis of 
polypeptides i.p. by TBS from Bn5T cell lysate using 1ug of 
S.aureus V8 protease. Peptide maps of the 200kDa polypeptide 
(track 1), U90 polypeptide (track 2) and 40kDa polypeptide 
(track 3) are shown. Bands which appear to comigrate are 
indicated by arrows in tracks 1 and 3.
x
1 2 3
Figure 7-3; Chymotrypsin peptide maps of Bn5T:TBS 
polypeptides compared with Bn5T:AC88:90. Cleveland digest 
analysis using 1ug chymotrypsin of polypeptides i.p. from Bn5T 
cell lysate by TBS and AC88. The TBS i.p. 200kDa (track 1), 
U90 (track 2), L90 (track 3), 40kDa (track 5) and 34kDa (track 
6) are compared with the AC88 i.p. 90kDa polypeptide (track 
4). Arrows in tracks 1-4 indicate bands which appear to 
comigrate.
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U90 and L90 polypeptides recognized by TG7A is therefore 
exactly the same as for corresponding polypeptides recognized 
by TBS (section 7.3.1).
(b) 40kDa and 35kDa polypeptides: Peptide map patterns of 35
and 40kDa polypeptides with 1/25ug V8 protease appear similar 
(figure 7*4), but careful inspection shows that many bands do 
not comigrate exactly. Thus, out of eleven bands seen for the 
35kDa polypeptide and nine bands for the 40kDa polypeptide 
only two comigrate. No similarity was seen between 35 and 
40kDa polypeptides on peptide mapping using either 10ug V8 
protease or 10ug chymotrypsin (data not shown). In summary 
then, peptide maps of the 35kDa and 40kDa Bn5T cell 
polypeptides i.p. by TG7A show little true similarity to 
either to eachother or to other Bn5T polypeptides i.p. by 
TG7A.
7.3.3 Peptide mapping studies: conclusions
Peptide maps of Bn5T:TBS:U90, L90 and 200kDa polypeptides 
share a number of comigrating peptide bands and this suggests 
a region of similarity in these three polypeptides. Some 
slight similarity was also seen between peptide maps of 
Bn5T:TBS:40kDa and 200kDa polypeptides.
7.4 Kinetic studies
When the author investigated the effect of radiolabelling 
Bn5T cells for 4h instead of the usual 18h, it was noted that 
in a TBS i.p. the 40kDa band was very weak relative to the U90 
band. This finding was further investigated.
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Figure 7.4; V8 protease peptide maps of the Bn5T:TG7A:40 and 
35kDa compared. Cleveland digest analysis of the 35kDa 
(tracks 1-3) and 40kDa (tracks 4-6) polypeptides as i.p. from 
Bn5T cell lysate by TG7A. Tracks 1 and 4 contained 1/25ug, 
tracks 2 and 5 contained 1/5ug and tracks 3 and 6 contained 
1ug of S.aureus V8 protease. MW markers are shown in track 7.
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7-4.1 Pulse labelling experiments
Bn5T cells were labelled with ^S-methionine as described 
in section 3.6.2. Cells were incubated with radiolabel for 
increasing periods of time and after harvesting, volumes of 
lysate corresponding to 4X10^ c.p.m. were i.p. with TBS and 
i.p.s then analysed by SDS-PAGE. With incubation periods 
increasing from 1 h to 45h, the intensity of the U90 band 
remains relatively constant, while the intensities of the 
40kDa and 34kDa bands increase steadily.
Another interesting observation was the coordinate 
fluctuation in L90 and 200kDa band intensity. These results 
are shown by the autoradiograph in figure 7.5 and the 
densitometer scan results in figure 7.6. The pulse labelling 
experiment was carried out twice with the same results each 
time.
In figure 7.6 the intensities of a number of bands are 
expressed as a proportion of U90 band intensity and the reason 
for this is as follows: minor artefactual variations in band
intensity should be expected with i.p. assays, as it is 
technically very difficult to remove the supernate with a 
pipette after each washing step, without removing small 
amounts of the protein-A sepharose bound immune complexes 
which form the pellet. Pellets at the end of the washing 
stages are therefore frequently of slightly different size. 
Apart from minor fluctuations, the U90 band intensity appears 
relatively constant throughout the pulse labelling experiment, 
and therefore by expressing the intensity of other bands as a 
proportion of the U90 band intensity, artefactual fluctuations 
can be ignored, allowing underlying trends to be seen more 
easily.
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Figure 7.5; Pulse labelling experiment. Autoradiograph of a 
6-15# gradient polyacrylamide gel containing electrophoret- 
ically separated ^ S - m e t h i o n i n e  labelled polypeptides 
extracted from Bn5T cells, radiolabelled for different time 
periods before harvesting for i.p. assay with TBS. Cells were 
pulse radiolabelled for the following times: track 3, 1h.;
track 4, 2h.; track 5, 4h.; track 6, 7 h . ; track 7, 9.25h.; 
track 8, 20h.; track 9, 31h.; track 10, 45h. Track 12 shows 
a standard TBS i.p. of Bn5T cells radiolabelled 18h. and 
tracks 1, 2, 11, 13 and 14 show total Bn5T cell polypeptide 
profiles.
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Figure 7-6; Pulse labelling experiment. Graphs show changes 
in the intensity of autoradiograph bands seen in figure 7.5. 
U90 band intensity changes with time, are displayed in A. In 
B changes in ratio of 40:U90 band intensities are shown, and 
in C changes in 200:U90 and L90:U90 ratios are shown.
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'7.4-2 Pulse—chase experiments
In order to explore possible precursor-product 
relationships within the set, pulse-chase experiments were 
carried out as described In section 3.6.3. Cell monolayers 
were radlolaoelled for 1 h, then washed and Incubated In EF5 
for Increasing periods prior to harvesting for assay by I.p. 
with T B S .
The 090 band Is relatively constant In Intensity over the 
first five h after the chase. However, the 40kDa polypeptide 
band Increases steadily In Intensity over this period (figures 
$ •( and 7.8) , The 200k0a and L90 bands show coordinate 
fluctuation In intensity, but show no general Increase or 
decrease. Densitometer readings for 200kDa, L90 and 40k.Da 
polypeptide bands are expressed In figure 7.8 as a proportion 
of 0901 readings, for the reason explained In the above 
section. The iOkOa polypeptide gives a weaker band In 
pulse-chase experiments than In standard i.p.s because as 
pulse labelling experiments show, radiolabel accumulates 
gradually In this band, over a period of 20' h or more. 
Radiolabel also accumulates gradually in the 34kDa polypeptide 
In pulse labelling experiments but this band Is not visible at 
all In the pulse-chase experiment. In contrast to the 4QkDa 
polypeptide therefore, Insufficient radiolabelled 34kBa 
polypeptide seems to be produced In the 1 h pulse-chase 
experiment, to produce a visible band on autoradiography.
The pulse-chase experiment was repeated with very similar 
results including a constant U90, a steadily increasing 40kDa 
and coordinately fluctuating L90 and 200kDa band intensities. 
However, it was noted that the pattern of L90 and 200kDa 
coordinate fluctuation was different on the second occasion 
that this experiment was carried out, which suggests that the
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Figure 7.7; Pulse-chase labelling experiment. Autoradiograph 
of a 6-15# gradient polyacrylamide gel containing 
electrophoretically separated - ^ S - m e t h i o n i n e  labelled 
polypeptides extracted from Bn5T cells, pulse radiolabelled 
for 1h. and chased with non-radioactive culture medium for 
different time periods before harvesting for i.p. assay with 
TBS. The chase time periods were as follows: track 3, Oh.;
track 4, 0.5h.; track 5, 1h.; track 6, 2.5h.; track 7,
5.5h.; track 8, 7.75h.; track 9, 18.5h.; track 10, 29.5h.; 
track 11, 43.5h. Track 13 shows a standard TBS i.p. of Bn5T 
cells radiolabelled 18h. and tracks 1, 2, 12 and 14 show total 
Bn5T cell polypeptide profiles.
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Figure 7-8; Pulse-chase labelling experiment. Graphs show 
changes in the intensity of autoradiograph bands seen in 
figure 7.7. U90 band intensity changes with time, are
displayed in A. In B changes in ratio of 40:U90 band 
intensities are shown, and in C changes in 200:U90 and L90:U90 
ratios are shown.
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fluctuation is due to an artefact rather than to temporal 
variation in polypeptide synthesis.
With a shorter pulse of 10 min. and 2X the concentration 
of radiolabel (to increase the incorporation of radiolabel), 
the same results were obtained (data not shown). 
Similar results were obtained for TG7A i.p.s of the same cell 
lysates although the increase in intensity of the 40kDa band 
was less marked. A possible explanation for this is as 
follows: there may be a larger number of polypeptide species
in the TG7A 40kDa band than in the corresponding TBS band 
which is consistent with the observations that the 
Bn5T:TG7A:40 band is stronger than the Bn5T:TBS:40 and also 
that it gives a slightly different peptide map (see section 
6.2.2). If a 40kDa polypeptide species recognized by TG7A 
alone gave a signal of constant strength at all times 
following pulse-chase, then another 40kDa polypeptide species 
recognized by TG7A (and also TBS) giving a signal of 
increasing intensity following pulse-chase, would not produce 
such an obvious rise in autoradiograph band intensity as it 
would if it were the only polypeptide in the 40kDa band.
7.4.3 Kinetic studies: conclusions
No precursor-product relationship between Bn5T:TBS:U90 
and L90 polypeptides is evident from the kinetic studies 
described. In the pulse-chase experiment, the delayed 
appearance of radiolabel in the 40kDa band following chase, 
suggests that a post-translational change must occur before 
the polypeptide can be recognized and i.p. by TBS. As no 
bands show any decrease in intensity concomitant with the 
increase in intensity of the 40kDa band after pulse-chase, no 
putative precursor polypeptide can be identified from this
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experiment. When the pulse-chase experiment was repeated, the 
timing of coordinate fluctuation in L90 and 200kDa polypeptide 
band intensities differed from the original experiment. This, 
together with the irregular nature of the fluctuations 
indicates that these changes are not related to the time 
elapsed since the chase. It seems more likely therefore that 
the levels of these two polypeptides are influenced by minor 
differences in one or more of the following: (a) culture
conditions, (b) cell lysate preparation and storage procedure, 
and (c) i.p. procedure.
7.5 Conclusions
(1) "All or nothing" expression of Bn5T:TBS polypeptides 
suggests that the polypeptides have a common origin and/or are 
regulated by the same factor(s).
(2) Evidence presented suggests that Bn5T:TBS 
polypeptides all have epitopes recognized by TBS.
(3) Immunological and peptide mapping studies suggest 
that Bn5T:TBS:200, U90 and L90 polypeptides are closely 
related.
(4) Kinetic studies suggest that Bn5T:TBS:40 and 34kDa 
polypeptides are synthesised from precursors by post- 
translational modification.
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® ^ M O U R  ANTIGENS COMPARED WITH STRESS- AND VIRUS-INDUCED 
POLYPEPTIDES
The TG7A monoclonal antibody recognizes a 90kDa 
polypeptide induced in BHK21 cells by heat-shock and HSV-2 
infection (Latchman et al ., 1987). This monoclonal has also 
been shown to recognize a polypeptide of approximately 90kDa, 
present in Bn5T cells but not in control RE cells (Macnab et 
al_. , 1985a) . It was therefore of great interest to analyze 
the relationship between polypeptides recognized by TG7A in 
cells either infected or transformed by HSV-2, and the 90kDa 
heat-shock protein.
8.1 The 90kDa heat-shock protein
8.1.1 Identification of the 90kDa heat-shock protein, HSP9Q
The AC88 monoclonal antibody recognizes the 90kDa 
heat-shock protein, HSP90, in a range of avian and mammalian 
tissues (Riehl et al ., 1985; Sanchez et al., 1985; Catelli 
et a l ., 1985). The AC88 monoclonal was used in this study to 
investigate alterations in the expression of HSP90 and related 
polypeptides, in HSV infected and transformed cells.
SDS-PAGE analysis of polypeptides i.p. by AC88 shows that 
the 90kDa polypeptide recognized in RE cells comigrates 
exactly with that recognized in Bn5T cells and gives a V8 
protease peptide map which is either very similar or identical 
(data not shown). With 1 ug of V8 protease per track, seven 
comigrating peptides are seen for digests of both RE and 
Bn5T:AC88:90 polypeptides. This indicates that the 
constitutive HSP90 is very similar whether it is present in 
normal control RE cells, or transformed Bn5T cells. On gels 
showing high resolution the 90kDa band i.p. by AC88 appears as
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a doublet suggesting heterogeneity of the HSP90 (figure 8.1).
The identity of the 90kDa rat polypeptide i.p. by AC88
was verified by comparison of its peptide map with that of
rabbit reticulocyte HSP90 kindly supplied by Dr Tim Hunt
(Department of Biochemistry, Cambridge). This had been
prepared by a similar method to that described by Welch and
Feramisco (1982) involving gel filtration on Sepharose CL-6B
and anion exchange chromatography on a Pharmacia Mono Q
column, using fast protein liquid chromatography (FPLC)
(Walker et a l . , 1985). On receipt of the protein it was
subjected to SDS-PAGE, located by Coomassie blue staining of
the gel and the band excised for peptide mapping. The protein
had not been radiolabelled in vivo and so could not be peptide
mapped and autoradiographed in the usual way. Two approaches
were used to overcome this problem. One approach was to
detect peptides on the peptide mapping gel by staining with
Coomassie blue followed by silver stain. The other approach
1 2 Swas to radiolabel the protein in vitro with prior to the
initial electrophoresis step, allowing subsequent detection of 
peptide fragments by autoradiography (figure 8.2). The 
chloramine-T ^ I - l a b e l l i n g  method which radiolabels tyrosine
residues was used here.
Peptides separated by SDS-PAGE do not necessarily give 
identical patterns when detected in different ways. For 
example, a methionine-rich peptide that incorporates 
^S-methionine very efficiently in vivo may produce a strong 
signal on autoradiography, even if too little is present for 
detection of the peptide by silver staining. However, if very 
similar peptide map patterns are revealed for two different 
protein preparations using different detection techniques,
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Figure 8.1; Analysis by SDS-PAGE of Bn5T polypeptides i.p. by 
TBS and AC88. Autoradiograph of a 6-15% gradient 
polyacrylamide gel containing electrophoretically separated 
- ^ S - m e t h i o n i n e  labelled polypeptides extracted from Bn5T 
cells, i.p. by control serum (track 1), TBS (track 2) and AC88 
(track 3). The bands of interest in the 90kDa region are 
indicated by arrows.
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Figure 8.2; V8 protease peptide maps of Bn5T:TBS:L90 and 
HSP90 compared. Cleveland digest analysis of the L90 
polypeptide i.p. by TBS from Bn5T cell lysate (tracks 2-4) 
compared with the 90kDa polypeptide i.p. by AC88 from Bn5T 
cell lysate (tracks 5-7) and in vitro radiolabelled rabbit 
HSP90 (tracks 8 and 9). Tracks 2, 5 and 8 contained 1/25ug, 
tracks 5 and 6 contained 1/5ug and tracks 4, 7 and 9 contained 
1ug of S.aureus V8 protease. MW markers are shown in tracks 1 
and 10.
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this does constitute evidence of similarity. HSP90 contains 
2.7$ methionine and 2.9$ tyrosine (Welch and Feramisco, 1982) 
and a peptide of 20kDa would be expected to contain 
approximately 180 amino acid residues. Therefore, it is 
likely that such a peptide would contain at least one 
methionine and one tyrosine residue. It is also likely that 
if present in sufficient quantity the peptide would produce a 
band on SDS-PAGE, detectable by all three approaches used in 
this study.
The major band in V8 protease digests of the Bn5T:AC88:90
(and RE:AC88:90) polypeptide, using both 1/25ug and 1ug
enzyme, corresponds to a peptide of 2 1 .OkDa (mean of three MW
estimates from two different gels). The two other peptides
giving strong bands include a 17.6kDa peptide with 1/25ug
enzyme and a 19.3kDa peptide with 1ug enzyme (figure 8.2).
12 8^I-labelled rabbit reticulocyte HSP90 gives a very similar 
pattern for the strongest bands (figure 8.2). The major band 
using both 1/25ug and 1ug V8 protease, corresponds to a 
peptide of 22.6kDa (single estimate). The two other peptides 
giving strong bands include a 19.OkDa peptide with 1/25ug 
enzyme and a 20.OkDa peptide with 1 ug enzyme. Silver staining 
gave a very similar result, the major band of 21.1kDa being 
present at both enzyme concentrations and the two next 
strongest bands being 18.OkDa with 1/25ug enzyme and 19.OkDa 
with 1ug enzyme (data not shown).
Heat-shock proteins are highly conserved in evolution 
(Schlesinger et a l ., 1982). Rabbit reticulocyte and rat 
fibroblast HSP90 would therefore be expected to give closely 
similar peptide maps. The close similarity detected here 
between RE and Bn5T HSP90 and rabbit reticulocyte HSP90 
prepared by Dr Hunt’s group, provides evidence that the
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polypeptide i.p. by AC88, is the HSP90 or a closely related 
species.
8.1.2 Comparison of HSP90 and tumour antigens
Immunofluorescence studies on a wide range of cells have 
shown that TG7A recognizes antigens that are induced 
dramatically on heat-shock treatment (Dr N.B. La Thangue, 
personal communication). It was therefore of interest to test 
whether the 90-100kDa tumour cell polypeptides recognized by 
TG7A are related to the HSP90. It has not been possible to 
detect any differences between the 90-100kDa polypeptides i.p. 
by TBS and TG7A (see section 6.2.1). Owing to a shortage of 
the TG7A monoclonal, TBS was used instead for comparison with 
the HSP90.
The Bn5T:TBS:L90 appears to co-migrate with the HSP90 on 
some 9-10$ polyacrylamide gels. On 7.5$ gels however, the 
HSP90 usually migrates slightly behind the Bn5T:TBS:L90 
(figure 8.1). Two-dimensional gel electrophoresis studies 
have shown comigration of 90-100kDa Bn5T polypeptides i.p. by 
TBS and AC88 (personal communication, Dr Macnab). This 
indicates that they have similar isoelectric points as well as 
similar MWs. One-dimensional peptide mapping with V8 protease 
was used to compare the HSP90 with Bn5T:TBS:L90 and U90 
(figure 8.3). There are obvious differences in peptide bands 
of over 15kDa, but comparison of peptide bands in the 11kDa to 
15kDa region suggests a possible relationship between HSP90 
and the Bn5T:TBS:U90 and L90 polypeptides.
In contrast to AC88, TBS fails to recognize and i.p. any 
Bn5T phosphoproteins in the 90kDa region, a finding confirmed 
by Dr D.Toft. This indicates that the HSP90 is phosphorylated 
in Bn5T cells, but that the 90-100kDa polypeptides recognized
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Figure 8.3; W8 protease peptide maps of HSV-2 transformed and 
infected cell polypeptides in the 90kDa-100kDa MW range.
Cleveland digest analysis using 1ug S.aureus V8 protease, of 
polypeptides with apparent MWs close to 90kDa (as determined 
by SDS-PAGE). The U90 Bn5T polypeptide i.p. by TBS (track 1) 
is compared with the 90kDa RE polypeptide i.p. by AC88 (track 
3) which represents the HSP90. The arrows in tracks 1 and 3 
indicate bands which appear to comigrate. The 90kDa 
polypeptide i.p. from HSV-2 infected RE cells by TG7A (track 
2) is compared with the two 90kDa polypeptides i.p. from these 
infected cells by AC88: lower band (track 4), upper band
(track 5). The arrows in tracks 2 and 4 indicate bands which 
appear to comigrate. The 90kDa polypeptide i.p. by AC88 from 
HSV-1 infected RE cells is in track 6 and MW markers are shown 
to the right of the gel.
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by TBS are not.
These results indicate that while TBS and TG7A do not 
recognize the HSP90 in Bn5T cells, the Bn5T polypeptides they 
do recognize of 90-100kDa may be related to the HSP90.
HSV infected cell polypeptides recognized by TG7A and 
AC88
8.2.1 HSV infected cell polypeptides of 90kDa
(a) In BHK cells: Western blotting studies have shown that
the TG7A monoclonal reacts with a 90kDa cellular polypeptide 
which accumulates during lytic infection of BHK cells with 
HSV-2, but not HSV-1, and also during heat-shock (La Thangue 
and Latchman, 1988). To demonstrate the virus-induced 
polypeptide, confluent BHK 21 cells were infected with HSV-2 
strain 333 (m.o.i. 10). The level of the TG7A-recognized 
90kDa polypeptide increased between 2h and 16h p.i., as 
demonstrated by western blotting (La Thangue and Latchman, 
1988).
(b) In RE cells: TG7A and AC88 i.p.s of HSV-2 infected RE
cell lysates, were kindly supplied by Mr A. Orr. The AC88 
monoclonal i.p.s two polypeptides of approximately 90kDa from 
the lysate of RE cells infected with HSV-2 strain HG52 (m.o.i. 
10), harvested I6h p.i. These polypeptides which will be 
described here as REHSV-2:AC88:U90 (upper band) and 
REHSV-2:AC88:L90 (lower band), migrated very close together 
and gave very similar peptide maps (figure 8.3)» suggesting 
that they represent closely related polypeptides. In 
addition, these peptide maps show some similarity to the
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RE:AC88:90 (HSP90) digest (figure 8.3). One possible 
explanation for this peptide map similarity is that on HSV-2 
infection of RE cells, HSP90-related 90kDa polypeptides are 
synthesised. This might result from altered processing of 
HSP90 or its mRNA, following HSV-2 infection.
The 90kDa polypeptide i.p. by AC88 from HSV-1 infected RE 
cells, gives a peptide map which appears indistinguishable 
from that of the RE:AC88:90 (figure 8.3). This suggests that 
HSV-1 does not induce the same HSP90-related polypeptides as 
those induced by HSV-2.
The TG7A monoclonal also i.p.s a polypeptide of 
approximately 90kDa from the lysate of RE cells infected with 
HSV-2 strain HG52 (m.o.i. 10), harvested 16h p.i. TG7A i.p.s 
a comigrating polypeptide of approximately 90kDa from 
tsK-infected but not HSV-1-infected RE cells, which is 
consistent with the findings of LaThangue and Latchman (1988). 
The HSV-2 induced polypeptide recognized by TG7A, which will 
be described here as REHSV-2:TG7A:90, comigrates with the 
HSP90. REHSV-2:TG7A:90 was peptide mapped with V8 protease to 
investigate its relationship with the HSP90 and the 90-100kDa 
Bn5T polypeptides i.p. by TG7A and TBS (figure 8.3). The 
peptide map of REHSV-2:TG7A:90, with 1ug V8 protease per track 
is unlike that of either Bn5T U90 or L90. It is also unlike 
that of the RE:AC88:90. These results suggest that the 90kDa 
polypeptide i.p. by TG7A from HSV-2 infected cells, does not 
appear to be closely related to the 90-100kDa species i.p. by 
the same antibody from lysates of HSV-2 transformed cells 
(Bn5T cells).
The peptide map pattern for REHSV-2:TG7A:90 is very 
similar to that of the REHSV-2:AC88:L90 and U90. There are 
five peptides of 27kDa to 34kDa MW in the REHSV—2 iTG7A:90
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digest, which comigrate with peptides in the REHSV-2:AC88:L90 
digest (figure 8.3). This strong similarity between the 
distinctive peptide map patterns of REHSV-2:AC88:L90 and 
REHSV-2:TG7A:90, suggests that on HSV-2 infection of RE cells 
a 90kDa polypeptide is induced, which is recognized by both 
AC88 and TG7A monoclonals.
8.2.2 HSV infected cell polypeptides of 40kDa
(a) In BHK cells: Western blotting studies have shown that
TG7A recognizes a 35-40kDa polypeptide induced on HSV-1
infection (LaThangue and Latchman, 1988). To demonstrate 
this, confluent BHK 21 cells were infected with HSV-1 strain 
HFEM (m.o.i. 10), and this polypeptide has been found to 
accumulate to high levels between 6h and 10h p.i. (Dr N. La 
Thangue, personal communication).
(b) In RE cells: SDS-PAGE analysis of TG7A i.p.s of lysates
prepared from RE cells infected with HSV-1 strain 17 syn+ 
(m.o.i. 10) harvested 8h p.i., gave a strong 38kDa polypeptide 
band. Peptide mapping of this 38kDa band with V8 protease
gave a pattern unlike that of either Bn5T:TG7A:35 or 40 (data
not shown). TG7A i.p.s of lysates prepared from RE cells 
infected with HSV-2 strain HG52 (m.o.i. 10) harvested 8h p.i., 
gave a 40kDa polypeptide band which comigrated exactly with 
the Bn5T:TG7A:40. However, on V8 protease peptide mapping the 
REHSV-2:TG7A:40 gave a pattern unlike the Bn5T:TG7A:40 (figure
8.4).
These results indicate that the TG7A recognized 38kDa and 
40kDa polypeptides induced on HSV infection of RE cells differ 
from the TG7A recognized 40kDa polypeptide present in
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Figure 8.4; A comparison of the S.aureus V8 protease peptide 
map of the Bn5T cell 40kDa polypeptide i.p. by TG7A, with that 
of the comigrating HSV-2 infected RE cell polypeptide i.p. by
TG7A. Cleveland digests of the 40kDa polypeptides i.p. from 
Bn5T cell lysate by TG7A (tracks 3 and 4) are compared with 
digests of the 40kDa HSV-2 infected cell polypeptide i.p. by 
TG7A (tracks 5 and 6). Tracks 3 and 5 contained 1/25ug and 
tracks 4 and 6 contained 1ug of V8 protease. Tracks 1 and 2 
correspond to undigested 40kDa polypeptides i.p. by TG7A, from 
Bn5T cells and HSV-2 infected cells respectively. MW markers 
are shown in track 7.
;'v
transformed RE cells.
8.3 Conclusions
(1) The HSP90 and Bn5T:TBS polypeptides of 93kDa and 97kDa 
are different polypeptides. However, they have similar MW and 
pi values and also give similar V8 protease peptide maps.
(2) HSV-induced RE cell polypeptides seen in TG7A i.p.s give 
different V8 protease peptide maps from comigrating Bn5T:TG7A 
polypeptides.
(3) A 90kDa polypeptide induced on HSV-2 infection of RE 
cells is seen in both TG7A and AC88 i.p.s.
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9 AMINO ACID SEQUENCE ANALYSIS
Two approaches were taken by the author to obtain 
sequence data for Bn5T:TBS polypeptides for the purposes of: 
(i) identification and (ii) the preparation of DNA and 
antibody probes. The first of these approaches was to use the 
technique of polysome immunoselection, but as described in 
chapter 5, this was not successful. The second approach taken 
was to purify the Bn5T:TBS:U90 polypeptide for amino acid 
sequence analysis, as from Coomassie blue staining 
experiments, this appears to be the most abundant Bn5T:TBS 
polypeptide. A purification protocol was developed for 
preparing large amounts of Bn5T:TBS:U90 and as a result, amino 
acid sequence data was obtained.
9-1 Polypeptide purification for sequence analysis
9.1.1 The standard Bn5T:TBS i.p.
A standard Bn5T:TBS i.p. carried out on 100ul undiluted 
lysate does not produce an U90 band on SDS-PAGE that is 
visible after Coomassie blue staining of the gel. To produce 
a visible U90 band it is necessary to run at least four such 
i.p.s in a single track (figure 4.3).
In general 0.2ug of a protein running in a tight band is 
just sufficient to be visible on Coomassie blue staining of 
polyacrylamide gels, but this does vary to some extent as 
Coomassie blue is an anionic dye which binds most strongly to 
more basic proteins (Hames, 1981). From two-dimensional gel 
electrophoresis studies of Dr J. Macnab and Mr A. Orr 
Bn5T:T B S :U90 is known to have an isoelectric point of 5.0-5.3 
while the majority of proteins have isoelectric points in the 
5-7 range (Walker and Gaastra, 1983), and so it is not a
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highly acidic polypeptide. Therefore the above quantitation 
guide is probably fairly accurate. Thus, if four standard 
i.p.s contain about 0.2ug of the 97kDa polypeptide (roughly 2 
picomoles), then 1 standard i.p. contains about 0.5 picomoles 
of polypeptide. For sequencing on the Applied Biosystems 470A 
gas phase sequencer, 20-50 picomoles are usually required so 
that over forty standard i.p.s were needed to provide 
sufficient material for sequencing. Carrying out so many 
identical standard i.p.s was extremely tedious and it was 
therefore decided to scale up the procedure.
9-1-2 The large-scale immunoprecipitation
A large-scale i.p. protocol was devised by the author, 
and sequence data was obtained on the Bn5T:TBS:U90 polypeptide 
so prepared.
In a standard i.p. (see section 5.6.7) a volume of Bn5T 
cell lysate corresponding to 4X10 c.p.m. is made up to 100ul 
with RIPA buffer, then incubated with 5ul TBS for 1 h at 4°C. 
Immune complexes are precipitated by addition of a suspension 
of protein-A sepharose and incubated for 1 h on a rotating 
mixer. Immune complexes are washed by cycles of 
centrifugation, removal of supernate and resuspension of 
pellet in fresh buffer. Addition of electrophoresis sample 
buffer (e.s.b) to the final pellet is followed by heating to 
100°C for 5 min. releasing bound polypeptides into the 
supernate. This supernate was then collected and analysed by 
SDS-PAGE.
The following alterations were made for the scaled up
procedure (see section 5.8*1):
(a) The volume of lysate used was increased to 10ml and the 
volume of TBS increased to 1ml. Thus, the scale of the
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reaction was approximately 200X that of a standard i.p.
(b) Protein-A sepharose was maintained in suspension during 
incubation periods by gentle mixing in a 50ml conical flask 
with a small magnetic stirring bar. For the increased volumes 
used this was found to be more effective than incubating on a 
rotating mixer.
(c) Protein-A sepharose and bound complexes were washed by 
transfer to a column, over which 5ml of first RIPA buffer, 
then tris saline were run. This was simpler for the scaled-up 
volumes used than the washing cycles of a standard i.p.. It 
also required much less washing buffer and gave cleaner 
results than standard i.p.s, as judged by autoradiography 
after SDS-PAGE analysis.
(d) Initially, polypeptides were eluted from the protein-A 
sepharose column using electrophoresis sample buffer (e.s.b.). 
The e.s.b was run into the column until the bromophenol blue 
dye front reached the bottom. The column was then sealed in a 
polythene bag and heated to 100°C in a boiling water bath for 
5 min. The column was then unsealed and polypeptides eluted 
by application of further e.s.b to the column. This proved an 
efficient method of eluting polypeptides. However, e.s.b. 
contains 2% SDS and the content of SDS was further increased 
on concentration of the eluted fractions (see section 5.8.1). 
The resulting high concentration of SDS was thought to cause 
distortion of polypeptide bands on subsequent SDS-PAGE (Dr J. 
Walker, personal communication). Alternative elution buffers 
tested include: 0.1M glycine-HCl pH2.5; 1M acetic acid;
20mM diethylamine pH10.8, 10#(v/v) glycerol and 5M KSCN. 5M 
KSCN gave the best results and was as efficient as e.s.b. in 
eluting polypeptides from the column.
The author was kindly helped by Dr J. Macnab and Mr D.
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McNab in optimizing the following aspects of this procedure:
(e) Lysate was made 10X more concentrated to maximize antigen 
concentration in the reaction. In a preliminary study, this 
modification was shown to increase the intensity of U90 and 
40kDa bands by 1 .5X and 3.8X respectively, as measured by 
densitometer.
(f) Antibody was incubated with protein-A sepharose before 
the addition of cell lysate to minimize the binding of large 
numbers of antibody molecules to each antigen molecule, thus 
improving the efficiency of the reaction (Dr H. Marsden, 
personal communication).
(g) Incubations were at carried out at room temperature 
instead of 4°C, which gave slightly improved yields of i.p. 
polypeptides.
(h) Eluted polypeptides in 3M KSCN were desalted on a 
Pharmacia PD-10 column (sephadex G-25 M), eluted in 10mM 
ammonium bicarbonate, freeze-dried and then dissolved in 
electrophoresis sample buffer. Removal of KSCN appears to 
improve the stability of the polypeptide on storage.
SDS-PAGE analysis of large-scale i.p.s shows that the 
97kDa polypeptide comigrates exactly with the Bn5T:TBS:U90 
polypeptide of a standard i.p. (figure 9.1). Peptide mapping 
of the 97kDa band from two independent scaled-up i.p.s gave an 
identical pattern to the Bn5T:TBS:U90 from standard i.p.s 
(figure 9.1), and is therefore assumed to represent the same 
polypeptide. On analysis of large-scale i.p.s there is 
sometimes a faint band visible on autoradiographs which 
comigrates with the Bn5T: TBS:L90. The reason that the 
intensity of this band differs between standard Bn5T:TBS i.p.s 
and large-scale i.p.s is not known, but it may relate to the
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Figure 9-1; Comparison of the 97kDa polypeptides in standard 
and large-scale Bn5T:TBS i.p.s, by SDS-PAGE and Cleveland 
digest analysis. A. Autoradiographs of a gel before (1-4) and 
after (5-8) excision of 97kDa polypeptide bands for the 
Cleveland digest analysis seen in B. The 97kDa or U90 
polypeptide in standard i.p.s (tracks 1 and 3) is seen to 
comigrate with the strong 97kDa polypeptide band in large 
scale i.p.s (tracks 2 and 4). The absence of 97kDa bands in 
tracks 5-8 indicates that these bands were accurately excised 
for peptide mapping. B. Comparison by Cleveland digest 
analysis of 97kDa Bn5T polypeptides i.p. by TBS in standard 
(tracks 1 and 2) and large-scale i.p.s (tracks 3 and 4).
Tracks 1 and 3 contained 1/25ug and tracks 2 and 4 contained 
1ug of S.aureus V8 protease. MW markers are shown in track 5-
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different washing procedures used. In autoradiographs of 
large-scale i.p.s analysed by SDS-PAGE, the signal:background 
ratio of 97kDa and 40kDa polypeptides is greater than for 
standard i.p.s. This suggests that washing of protein-A 
sepharose-bound immune complexes is more thorough in the 
large-scale i.p. procedure than in the standard i.p. 
procedure. Hence, polypeptides bound with lower affinity 
would be more likely to be removed in the large-scale i.p than 
in the standard i.p. This may explain why on SDS-PAGE 
analysis of large-scale i.p.s, the L90 (93kDa) polypeptide is 
either weak or absent.
Figure 9.2 shows a Coomassie blue stained track 
containing a large-scale Bn5T:TBS i.p., together with the 
autoradiograph of the same track. The strong 97kDa band seen 
on autoradiography, can be seen to correspond to a strong 
Coomassie blue stained band.
9-1.3 Transfer of polypeptides onto Immobilon membrane
Polypeptides were separated out by SDS-PAGE on a 7% 
acrylamide gel and transferred electrophoretically onto an 
Immobilon membrane as described in section 3.8.2. Polypeptide 
bands of interest were excised from this membrane, and the 
accuracy of this excision is demonstrated by the 
autoradiograph in figure 9.3).
Optimum transfer conditions were determined using MW 
markers separated by SDS-PAGE on a 7% acrylamide gel. A 
current of 0.3mA/cm^ for 2h gave best results as it 
transferred all detectable phosphorylase b (97.4kDa) and 
ovalbumin (43kDa) from gel to membrane. Only a small 
proportion of the ovalbumin passed through the membrane to be 
deposited on a second Immobilon membrane placed on the anode
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Figure 9-2; Analysis of a large-scale Bn5T:TBS i.p. by 
SDS-PAGE. ^S-methionine labelled polypeptides from a 
Bn5T:TBS large scale were subjected to SDS-PAGE on a 7.5$ 
polyacrylamide gel and the gel was then Coomassie blue stained 
(track 1) and autoradiographed (track 2). MW markers are 
shown to the right of track 2.
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Figure 9-3; Testing the accuracy of band excision for 
sequence analysis: A single large-scale i.p. of Bn5T cell
lysate using TBS was subjected to SDS-PAGE, then 
electrophoretically transferred onto Immobilon PVDF transfer 
membrane. An autoradiograph of the Immobilon transfer 
membrane was used to locate the 97kDa band for excision. The 
Immobilon membrane was re-autoradiographed to demonstrate that 
the 97kDa band had been accurately excised for sequence 
analysis.
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side of the first (data not shown).
9-2 Amino acid sequence analysis
Sequence analysis was performed by Mr F. Northrop and Dr 
I. Fearnley. Peptides were prepared by Dr J. Macnab and the 
author, under the direction of Dr J. Walker (Laboratory of 
Molecular Biology, Cambridge). The techniques used are 
described in section 3.8.
9-2.1 Sequence analysis of intact Bn5T:TBS;U90
Comparison of the Coomassie blue stained U90 band with a 
known amount of phosphorylase b MW marker, indicated that a 
minimum of 25ug (approximately 250 picomoles) of U90 
polypeptide is precipitated in a single large-scale i.p., an 
amount which should be sufficient for sequence analysis of 
most proteins. It was surprising then, that when Bn5T:TBS:U90 
resulting from a single large-scale i.p. prepared by the 
author, was sequenced by Mr F. Northrop, very low levels of 
PTH-amino acid derivatives were obtained in the first two 
sequencer cycles. The levels suggested that only 1-2 
picomoles of polypeptide had been sequenced, which is less 
than 1/100th the quantity of polypeptide that was estimated 
from Coomassie blue staining. In addition the PTH-amino acids 
obtained on sequencing were derived from more than one 
polypeptide. This result was interpreted to mean that the 
major polypeptide present in the U90 band has a blocking group 
at the N-terminus which prevents sequencing and that minor 
unblocked polypeptide components of the band account for the 
small amount of sequenceable polypeptide detected. Examples 
of blocking groups include cyclized glutamine, acetylated 
glycine and N-formyl methionine (Fearnley, I., 1987? Ph.D.
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thesis, University of Cambridge).
9.2.2 Sequence analysis of peptide fragments of the 
Bn5T:TBS:U90
Preparation of peptide fragments of a polypeptide allows 
sequence data to be obtained even if the polypeptide 
N-terminus is blocked. This approach also has the advantage 
that a lot more sequence data can be obtained for the 
polypeptide as a whole, as amino acid sequencing does not 
usually allow sequencing of more than 20 to 30 residues in 
from the N-terminus. This is because the recovery of all 
PTH-amino acids decreases as the Edman degradation proceeds, 
due to chromatography and sequencer artifacts which increase 
the system noise level and the accumulation of protein/peptide 
breakdown products which are also sequenced (Fearnley, I., 
Ph.D. thesis). Large amounts of Bn5T:TBS:U90 and 40 were 
prepared by Dr J. Macnab and Mr D. McNab, using the large- 
scale i.p. procedure and peptides were prepared from these 
polypeptides at the LMB, Cambridge, by Dr J. Macnab and the 
author.
Separate preparations of the U90 polypeptide were cleaved 
by treatment with trypsin or by treatment with cyanogen 
bromide. Peptides were separated by HPLC on a 0% - 80# 
acetonitrile gradient and then sequenced separately on an 
Applied Biosystems sequencer by Mr F. Northrop and Dr I. 
Fearnley. Sequence data obtained on these peptides, is shown 
in table 9.1. The evaluation of sequencing data by computer 
analysis is discussed in the next chapter.
9-3 Summary
(a) A protocol was developed for the large-scale preparation
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Table 9.1; Sequence analysis of peptide fragments of the 
97kDa polypeptide: Peptides A11-22 were derived by tryptic
digestion and peptides 010-40 by cyanogen bromide cleavage.
The sequences obtained were analysed using EMBL databases for 
protein and DNA sequences (section 10.4.1).
* indicates no sequence data obtained on the peptide.
  indicates no homology detected to sequence data on the
EMBL database.
Peptides C14, 036 and 037 have been compared by Dr Macnab 
with sequence data for HSP90 and GRP94 in the literature, but 
no homology has been detected.
One letter amino acid code: A = alanine, C = cyseine, D = 
aspartic acid, E = glutamic acid, F = phenylalanine, G = 
glycine, H = histidine, I = isoleucine, K = lysine, L = 
leucine, M = methionine, N = asparagine, P = proline, Q = 
glutamine, R = arginine, S = serine, T = threonine, V = 
valine, W = tryptophan, X = not determined, Y = tyrosine
Peptide Sequence Source
A11 IVGGY
12 IVG
14 APILSXSSXK + SAYPGQITSN
15 TIVPPSY
16 *
17 *
18 *
19 SSGTSYPXVLK
20 *
21 XVGGYT
22 IVGGYTXGANTVPK
C10 XVXK
11 KEGI
12 *
15 *
14 APFPE
16 *
17 XQPHNV
18 *
19 *
20 XPXILEKL
21 *
22 *
25 XPXIGXKTXVQXYK
29 *
56 PIQAFLLY
57 XXVKQELAYFYPELFXQF
40 *
Trypsin
Trypsin
Trypsin
Trypsin
Trypsin
Trypsin
bovine a l p h a ^ -  
casein
bovine a l pha^-  
casein
bovine beta-casein
bovine alphag^- 
casein
of the 97kDa polypeptide recognized by TBS.
(b) Sequence data was obtained on the 97kDa polypeptide 
prepared by this protocol.
10 DISCUSSION
The results will be discussed under four main headings. 
Firstly, data on general features of Bn5T:TBS polypeptides 
will be examined and a model presented to explain the 
inter-relationships of these polypeptides. After this, the 
terms "tumour antigen" and "oncofoetal antigen" will be 
discussed in relation to Bn5T:TBS polypeptides. Next studies 
indicating the existence of an HSP90-related protein family 
will be reviewed and finally, the preliminary sequence data on 
the Bn5T:TBS:U90 will be discussed.
10.1 PROPERTIES OF Bn5T:TBS POLYPEPTIDES
10.1.1 The cell type specificity of polypeptides 
immunoprecipitated by TBS and TG7A
Bn5T cells express a group of polypeptides which are 
detected in i.p. assays using serum from rats bearing tumours 
induced by injected Bn5T cells and also using the TG7A 
monoclonal antibody. They are not detected by i.p. assay in 
control RE cells prepared from embryos of 16-20 days 
gestation. However, comigrating polypeptides are detected in 
RE cultures prepared from younger embryos of approximately 12 
days gestation. Hence, Bn5T:TBS polypeptides appear to show 
oncofoetal expression.
In all established and transformed rat and mouse cell 
lines tested, with the exception of mouse embryonal carcinoma 
(EC) derived cell lines, polypeptides can be i.p. with TBS 
which comigrate with Bn5T:TBS polypeptides. It is interesting 
that TBS did not recognize the characteristic set of 
polypeptides in any of four differentiated EC-derived cell 
lines. One of these, EB28/10n has myoblast-like culture
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morphology and produces tumours containing muscle-like cells, 
cartilage and bone (Morgan et a l ., 1983). EB28/10n therefore
has a mesodermal origin, as does the RE fibroblast-derived 
Bn5T cell line. Perhaps then, the polypeptide set recognized 
by TBS is expressed specifically by immortalized fibroblastic 
cells, rather than being characteristic of immortalized 
mesoderm derived cells in general. It may be relevant that, 
unlike all other rodent cells tested, EC-derived cell lines 
are always trypsinized in the presence of 1 % (v/v) chick serum 
to protect against trypsin toxicity (Dr M. Hooper, personal 
communication). Hence, it is possible that the expression of 
Bn5T:TBS polypeptides is a consequence of trypsin toxicity. 
However, the fact that Bn5T:TBS polypeptides are not detected 
in control RE cells suggests otherwise, because RE cells like 
Bn5T cells, are trypsinized without the addition of chick 
serum.
10.1.2 The implications of Bn5T:TBS polypeptide co-expression
When members of the Bn5T:TBS polypeptide set have been 
detected for a particular cell type, they have always been 
found to be co-expressed in an "all or nothing" manner, 
regardless of culture conditions. Possible explanations for 
this include: (a) that Bn5T:TBS polypeptides have a common
origin (all members of the set being encoded by a single 
primary transcript, with differential post-transcriptional or 
post-translational processing accounting for the different 
polypeptides produced), and (b) that expression of all 
Bn5T:TBS polypeptides may be regulated by common control 
mechanisms at transcriptional or post-transcriptional levels.
Whether co-expression is due either to a common origin or 
common control mechanism, it may still indicate a shared
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purpose for Bn5T:TBS polypeptides. Interestingly, these 
polypeptides share epitopes recognized by TG7A and TBS, which 
may represent related domains important for a common function. 
Latchman et a l ., (1987) have found that TG7A recognizes an 
epitope which is highly conserved, indicating that it 
represents part of a functionally important domain. The only 
clue to the function of this domain so far, is that TG7A 
recognizes a protein in E. coli which has protease activity 
(Latchman et a l ., 1987).
10.1.3 Developing a model to explain Bn5T:TBS polypeptide 
inter-relationships
Kinetic studies were carried out to examine the 
inter-relationships between Bn5T:TBS polypeptides. Very 
similar experiments to those reported in this thesis were 
performed in a different system by Khosravi et a l ., (1985). 
These authors studied a human melanoma-associated oncofoetal 
antigen of 87kDa by pulse labelling and pulse-chase 
experiments and identified an 83kDa precursor polypeptide in 
this way. The 83kDa precursor was shown to be converted over 
a 4h period to the 87kDa polypeptide and tunicamycin treatment 
showed that the processing involved glycosylation (Khosravi et_ 
al., 1985).
The results of pulse-chase labelling experiments 
described in section 7.4.2, suggest that the Bn5T:TBS:40 
polypeptide is also synthesised from a precursor polypeptide, 
as the corresponding autoradiographic band shows a gradual 
increase in intensity at increasing time periods following 
chase. However, results from metabolic labelling studies with 
tritiated mannose and treatment of cells with tunicamycin 
indicate that the Bn5T:TBS:40 is unlikely to be a
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glycoprotein. Bn5T:TBS:40 may be a processing/breakdown 
product of a precursor polypeptide, which may or may not be 
recognized by TBS. In the pulse-chase labelling experiment, 
no Bn5T:TBS polypeptide bands show a fall in intensity on 
autoradiography, concomitant with the rise in intensity of the 
Bn5T:TBS:40 band. However, if the quantity of precursor 
greatly exceeds the quantity of breakdown product formed 
during the pulse-chase experiment, a decrease in precursor 
band intensity would not necessarily be detectable. Peptide 
mapping studies showed no similarity between the Bn5T:TBS:40 
and other members of the Bn5T:TBS set, except for a slight 
similarity with the 200kDa polypeptide. Another link between 
200kDa and 40kDa polypeptides is that they are the only 
phosphorylated members of the Bn5T:TBS set. If the 40kDa were 
a breakdown product of the 200kDa, then given the fact that it 
is only 20$ of the size of the 200kDa, a close similarity 
between peptide maps would in fact be surprising. The slight 
peptide map similarity between Bn5T:TBS:200 and 40kDa may 
therefore reflect a precursor-product relationship.
In pulse-chase experiments the Bn5T:TBS:34 band is too 
faint to be visible, but in pulse labelling experiments it is 
visible and like the Bn5T:TBS:40 shows a gradual rise in 
intensity with increasing labelling periods. This suggests 
that the 34kDa polypeptide may also be a breakdown/processing 
product of some precursor polypeptide, but peptide mapping 
studies did not demonstrate any obvious similarity to any 
other Bn5T:TBS polypeptides. However, owing to the small size 
of the 34kDa polypeptide relative to other members of the 
Bn5T:TBS set, the possibility still remains that the 34kDa 
polypeptide is derived from another Bn5T:TBS polypeptide.
Very similar patterns of variation in L90 and 200kDa band
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intensity were seen for both pulse labelling and pulse-chase 
labelling experiments, suggesting some relationship between 
these two polypeptides. Perhaps both are bound by antibody 
with low affinity, so that they are more sensitive than other 
Bn5T:TBS polypeptides to the minor inevitable differences that 
occur in the handling of replicate tubes in an i.p. assay.
The fact that U90, L90 and 200kDa polypeptides are i.p. 
strongly as a group by TBS and weakly as a group by TG7A, 
together with the fact that they give similar peptide maps, 
suggests that they form a closely related subgroup of the 
Bn5T:TBS set. Precursor-product relationships between these 
three polypeptides were not evident from pulse-chase 
experiments and no evidence for post-translational processing 
of these polypeptides has been found apart from 
phosphorylation of the 200kDa polypeptide. U90, L90 and 
200kDa polypeptides may therefore be the products of related 
genes, or may be the products of a single gene like the 
calcitonin gene, for which there are a number of alternative 
modes of post-transcriptional modification. The calcitonin 
gene generates distinct mRNAs by differential splicing, which 
encode either the hormone calcitonin, or a novel neuropeptide 
(Amara et a l ., 1984).
One model which explains the assembled data on Bn5T:TBS 
polypeptide inter-relationships is as follows: (a) the
200kDa, U90 and L90 polypeptides are encoded by the same gene 
or similar genes, (b) the 40kDa polypeptide is a breakdown/ 
processing product of the 200kDa polypeptide, and (c) the 
34kDa polypeptide is a breakdown/ processing product (perhaps 
also a product of the 200kDa polypeptide).
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10-1-4 Explaining why IVT Bn5T polypeptides are not 
recognized by TBS and TG7A
An unusual feature of the Bn5T:TBS polypeptides is that 
it has not been possible to demonstrate their synthesis in 
vitro by i.p. assay using TBS and TG7A. This finding was 
thoroughly investigated because it suggested that Bn5T:TBS 
polypeptides might require post-translational processing to be 
recognized by TBS and TG7A, a possibility which would make the 
immunoselection of Bn5T polysomes unlikely to work with these 
antibodies.
On IVT of total cytoplasmic Bn5T RNA for the standard 
period of 1 h, no 40kDa polypeptide could be detected by i.p. 
with TBS. This is not surprising in the light of results from 
pulse-labelling studies (section 7 .4.1) which showed that the 
40kDa band in TBS i.p.s of Bn5T cell lysate is much weaker if 
cells are radiolabelled 1 h than for the usual 18 h incubation 
period. However, the kinetic studies do not explain the fact 
that 200kDa, U90 and L90 are not detected in the IVT products 
of Bn5T RNA.
A 40kDa band has been seen in profiles of the total 
polypeptide products of IVT Bn5T polysomes (only if IVT for a 
shorter time period than usual) and of IVT poly A+ RNA (on one 
out of three occasions); (section 5.2). The IVT 40kDa bands 
do not necessarily represent the same 40kDa polypeptide seen 
in total protein profiles of Bn5T cell lysate, even though 
both comigrate exactly with the Bn5T:TBS:40. Unfortunately, 
peptide mapping comparisons were not possible because the IVT 
40kDa bands did not give a strong enough signal on
autoradiography.
The following are possible explanations why no IVT Bn5T
polypeptides were i.p. by TBS:
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(a) The mRNAs encoding Bn5T:TBS polypeptides are unstable:
Unstable mRNA may be degraded during RNA preparation, or may 
have a short half-life in the cytoplasm-like environment of 
reticulocyte lysate. On examination of polypeptides resulting 
from IVT of total cytoplasmic Bn5T RNA, clearly defined bands 
are visible in the 30kDa to 100kDa range, indicating that at 
least some mRNAs which encode polypeptides within this MW 
range had been prepared intact. Thus, it would not have been 
unreasonable to expect to be able to i.p. Bn5T:TBS:U90, L90,
40 and 34 polypeptides. When this was found not to be 
possible, total cell polysomes were substituted for total 
cytoplasmic RNA. The quality of the mRNA in the polysome 
preparations was better than in cytoplasmic RNA preparations, 
Judging by the efficient translation of high MW polypeptides 
from the former. However, no members of the Bn5T:TBS set were 
i.p. by either TBS or TG7A from the products of IVT polysomes. 
These results suggest that if mRNA degradation does account 
for our inability to detect IVT Bn5T:TBS polypeptides, then it 
is due to the unstable nature of the corresponding transcripts 
rather than to being a reflection of the overall quality of 
RNA or polysome preparations.
Short mRNA half-life in reticulocyte lysate, does not 
seem to provide a very satisfactory explanation for the 
inability to i.p. IVT Bn5T polypeptides with TBS. Firstly, 
the half-life would need to be extremely short. An mRNA 
half-life of 1 h is relatively short (Theodorakis and 
Morimoto, 1987), yet to account for our inability to detect 
any polypeptide after IVT for 1 h, the mRNA would need to have 
a half-life of a few minutes or seconds. Secondly, one would 
also have to argue that the polypeptides translated within the 
short life of the mRNA are so unstable that within 1 h of
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synthesis they are undetectable.
(b) The mRNAs encoding Bn5T:TBS polypeptides are either not 
IVT efficiently, or not IVT at all: Observations on profiles
of total IVT polypeptides suggest that this explanation 
accounts, at least partly, for the fact that no members of the 
Bn5T:TBS set could be i.p. with TBS. In the special 
circumstances when a 40kDa polypeptide could be IVT, it still 
only gave a faint band compared with that seen for Bn5T cell 
lysates. It must be remembered that although peptide mapping 
studies have shown that the 40kDa polypeptide seen in Bn5T 
cell lysate profiles is closely related to the Bn5T:TBS:40, 
the only evidence that it is also closely related to the IVT 
40kDa polypeptide is that the two bands comigrate on SDS-PAGE. 
Thus, despite the fact that a 40kDa Bn5T polypeptide has been 
IVT, there is still no strong evidence that any Bn5T:TBS 
polypeptides can be IVT from Bn5T cell RNA or polysomes.
(c) The IVT products of Bn5T RNA and polysomes require post- 
translational processing in order to be recognized by TBS: A
problem with this explanation is that the inclusion of 
microsomal membranes in IVT reactions (which allows for 
post-translational processing including removal of signal 
peptides and glycosylation), did not result in the IVT of Bn5T 
polypeptides recognized by TBS. Further, the only evidence 
found of post-translational processing, for members of the 
Bn5T:TBS set, was the phosphorylation of 200kDa and 40kDa 
polypeptides and possible glycosylation of the 34kDa 
polypeptide. No evidence was detected for a type of 
processing common to all members of the Bn5T:TBS set. Perhaps 
then, the recognition of Bn5T:TBS polypeptides by TBS depends
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on some unanticipated type of processing, or depends on the 
formation of complexes which are not formed in vitro.
In conclusion, we can only speculate as to why it was not 
possible to i.p. Bn5T:TBS polypeptides from the products of 
IVT RNA and polysomes. From the above discussion the two 
following explanations seem to be the most likely: (a) Bn5T:
TBS polypeptides may be encoded by mRNAs which are extremely 
fragile and/or translated extremely inefficiently in the 
reticulocyte lysate system, and (b) polypeptides i.p. by TBS 
and TG7A may require some unusual kind of post-translational 
processing before they can be recognized by TBS and TG7A.
10.2 Tumour antigens and oncofoetal antigens
Before defining Bn5T:TBS polypeptides as either "tumour 
antigens" or "oncofoetal antigens" and examining their 
relationship with other members of these groups, the 
definitions of these terms will first be considered in detail.
10.2.1 Evaluation of definitions for tumour antigens and 
oncofoetal antigens
Tumour antigens have been defined as immunological 
determinants present in tumour tissue, which elicit an 
antibody response in a tumour bearing animal (Maltzman et al ., 
1981), while oncofoetal antigens have been defined as 
antigenic substances expressed exclusively as phase-specific 
autoantigens in the developing embryo or foetal tissues, of 
metazoans and their tumours (Coggin, 1986a).
Tumour-specificity is an important feature in both of the 
above definitions and the fact that there are no problem-free 
criteria for deciding whether an antigen is tumour—specific,
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gives rise to problems with both definitions. The two 
criteria used in the cited definitions are; the ability to 
induce an antibody response in a tumour bearing animal, and 
the exclusive expression in embryo/foetal tissues and tumours. 
These criteria will now be discussed:
(a) Induction of an antibody response in a tumour bearing 
animal: Induction of an immune response in a syngeneic tumour
bearing animal suggests that the antigen is not expressed by 
normal adult tissues, but failure to induce antibodies does 
not necessarily suggest the opposite. The antigen may: (i)
have low intrinsic immunogenicity, resemble a self component 
to which the host is tolerant, or not be expressed in a 
cellular location accessible to the immune system, (ii) 
induce antibodies of a subtype not detected in the assay 
system used (e.g. IgM would not be detected in i.p. assays), 
or (iii) induce a cell mediated immune response instead of an 
antibody response (Roitt, 1984). Therefore, the detection of 
an antibody response is a useful, though not infallible 
indicator that an antigen is tumour-specific.
(b) Exclusive expression in embryo/foetal tissues and 
tumours: It is not possible to state with certainty that an 
embryo/foetal antigen is not expressed in any non-neoplastic 
adult tissue, given the diversity of adult tissues and the 
very wide range of non-neoplastic disease. Hence, the 
classification of an antigen as an oncofoetal antigen can only 
be provisional.
A further problem with the cited definition of oncofoetal 
antigens: "antigenic substances expressed exclusively as
172.
phase-specific autoantigens in the developing embryo or foetal 
tissues, of metazoans and their tumours” (Coggin, 1986a), is 
the use of the term "autoantigen". This is presumably 
intended to mean an antigen that induces autoantibodies, but 
in the context of an embryo or foetus, the meaning of this 
term is less clear. An embryo/foetus would not be expected to 
produce antibodies against antigens which are normally 
expressed in pre-natal development and it would be incorrect 
to describe maternal antibodies produced against embryonic/ 
foetal antigens as autoantibodies. The most important problem 
in the application of this definition is the difficult or 
impossible task of finding out whether an antigen is expressed 
exclusively in embryonic and neoplastic tissues.
In contrast, the cited definition for tumour antigens: 
"immunological determinants present in tumour tissue, which 
elicit an antibody response in a tumour bearing animal" 
(Maltzman et a l ., 1981), is a useful working definition, 
although it is not problem-free.
10.2.2 Classification of Bn5T:TBS polypeptides
(a) Can Bn5T:TBS polypeptides be defined as tumour antigens?
Polypeptides of the Bn5T tumour cell line i.p. by TBS 
(the Bn5T:TBS set), are not detectable in control RE cells.
The presence of antibodies to these polypeptides in TBS 
indicates that they are recognized by the tumour bearing 
animal as being immunologically foreign and distinct from 
normal self antigens. On this basis, it seems correct to call 
Bn5T:TBS polypeptides, tumour antigens.
(b) Can Bn5T:TBS polypeptides be defined as oncofoetal
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antigens?
Bn5T:TBS polypeptides are not expressed by primary and 
secondary cultures of late gestation RE cells, but we do not 
know whether this also applies to all normal adult tissues and 
adult tissues with non-neoplastic disease. It is therefore 
not possible to decide whether Bn5T:TBS polypeptides can be 
defined as oncofoetal antigens. However, Bn5T:TBS 
polypeptides do appear to show oncofoetal expression, as 
polypeptides comigrating with these tumour cell polypeptides 
were detected in RE cells prepared from embryos of 
approximately 12 days, but not in cells prepared from embryos 
of 16-20 days gestation.
10.2.3 Comparison of Bn5T:TBS polypeptides with other 
polypeptides which show oncofoetal expression
A number of tumour-associated antigens show oncofoetal 
expression as discussed in section 1.3. Examples are p53, the 
OFAs of 44kDa and 200kDa described by Payne and Coggin (1985) 
and the SDEAs of 35kDa and 40kDa described by Gerhards and 
Mehnert (1986). These antigens share a number of features 
with Bn5T:TBS polypeptides which include:
(a) Expression in transformed/tumour cells independent of the 
oncogenic agent: The p53 tumour antigen is expressed in cells
transformed by a range of viruses including SV40 and in cells 
transformed by chemical carcinogens (DeLeo et a1 ., 1979; 
Linzer and Levine, 1979; Rotter et al., 1981). It is also 
detected in a variety of human tumour cell lines (Crawford et 
al., 1981). Similarly the 44kDa and 200kDa OFAs (Payne and 
Coggin, 1985) are detected in cell lines derived from SV40- 
and methy1cho1anthrene — induced mouse fibrosarcomas, as well as
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from a range of human tumours, including ovarian, colonic and 
rectal carcinomas. In the same way, the 35kDa and 40kDa SDEAs 
(Gerhards and Mehnert, 1986) are detected in SV40 and 
polyomavirus transformed cells and cell lines derived from a 
variety of human tumours including HeLa and rhabdomyosarcoma 
cell lines.
(b) Phase specific expression in embryonic/foetal life: The
expression of p53 occurs in primary cell cultures prepared 
from 12-14 day mouse embryos, but not 16 day embryos (Mora et^  
a l ., 1980). Similarly the 44kDa and 200kDa OFAs are present 
in cell cultures of 12-13 day mouse embryos, but not 19-21 
days (Payne and Coggin, 1985). The 35kDa and 40kDa SDEAs-are 
expressed in primary cell cultures of 16 day BALB/c mouse 
embryos, but not 12, 14 or 18 day embryos (Gerhards and 
Mehnert, 1986).
The p53 tumour antigen has been shown to be the product 
of an immortalizing oncogene (Jenkins et a l ., 1984; Eliyahu 
et al ., 1984; Parada et a l ., 1984) and it will be interesting 
to find out whether these other oncofoetally expressed tumour 
antigens are also encoded by oncogenes. The expression of 
these polypeptide antigens in transformed and tumour cells 
independent of the oncogenic agent, suggests that their 
induction is a common secondary event and not the primary 
oncogenic event.
It has been suggested that gene products important in 
prenatal development might confer a survival advantage in the 
tumour environment (Gerhards and Mehnert, 1986). If this is 
correct the reactivation of embryonic genes may be a common 
event in tumour progression or evolution rather than being a
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direct consequence of the primary oncogenic event. However, 
embryonic antigens are expressed by tissue culture cells 
transformed in vitro, which indicates that the possibility 
that they aid tumour cell survival can not be the only reason 
for their reactivation in neoplasia.
10.3 HSP90-related proteins provide a possible link between 
lytic infection by HSV-2 and oncogenic transformation
TG7A monoclonal was raised in mice to DNA-binding 
proteins in HSV-2 infected cells and it recognizes an HSV-2 
induced 90kDa polypeptide and an HSV-1 induced 40kDa 
polypeptide in lytically infected cells. It has been shown to 
recognize heat-shock induced cell surface antigens by 
immunofluorescence studies (Dr LaThangue, personal 
communication) and also recognizes polypeptides of 97kDa,
93kDa and 40kDa in HSV-2 transformed cells.
10.3.1 Stress induction of TBS- and TG7A-recognized 
polypeptides
It was very difficult to induce a heat-shock response in 
RE cells. However, incubation of RE cells for 1.5-5 h at 
44°C, followed by 0.5 h at 37°C prior to labelling for 18 h 
with -^^S-methionine, induced the appearance of HSP bands in 
total cell polypeptide profiles (Dr Macnab, personal 
communication). On two occasions a 90kDa polypeptide induced 
in these conditions was i.p. by TBS and TG7A and gave a faint 
band on autoradiography. TBS and TG7A do not recognize a 
90kDa polypeptide in control RE cells. A 90kDa polypeptide 
i.p. by TBS and TG7A was also induced in RE cells both by 
incubation in medium lacking glucose for 18-24 h and by 
incubation in medium containing the calcium ionophore A 23187
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(Dr Macnab, personal communication). This is thought to be 
the GRP94. In the same conditions a TBS- and TG7A-recognized 
polypeptide of 70kDa was induced, which may represent the 
GRP78. Taken together these results suggest that the 
heat-shock induced HSP90, the GRP94 and the GRP78, all express 
epitopes recognized by TBS and TG7A.
10.3.2 Peptide map comparisons of TG7A- and AC88-recognized 
polypeptides
As described in section 8.1.1, the AC88 monoclonal i.p.s 
the constitutively expressed HSP90 from control RE cells. On 
close examination of RE:AC88 i.p.s on SDS-PAGE, two bands of 
approximately 90kDa are seen, of which the upper band is the 
strongest. This suggests that there is more than one form of 
constitutively expressed HSP90. Two polypeptide bands of 
approximately 90kDa are also seen in AC88 i.p.s of HSV-2 
infected RE cells. These bands do not migrate as close 
together as for RE:AC88 i.p.s, so that it was possible to 
excise the two bands separately for peptide mapping analysis.
Peptide mapping studies with V8 protease, show that the 
constitutive HSP90 gives a peptide map which bears some 
similarity to peptide maps of the polypeptides i.p. by AC88 
from HSV-2 infected cells. The two REHSV-2:AC88:90 
polypeptide bands give peptide maps which are very similar to 
eachother and which in addition share some similarity with the 
constitutive HSP90. The REHSV-2:AC88:90 polypeptides are 
therefore likely to represent HSV-induced HSP90s.
TG7A and TBS do not i.p. the constitutive HSP90 from RE 
cells, but do i.p. a comigrating polypeptide from HSV-2 
infected RE cells. On peptide mapping analysis the 
REHSV-2:TG7A:90 polypeptide gave a very similar pattern to the
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REHSV-2:AC88:90 polypeptides. TG7A and TBS also i.p. 93kDa 
and 97kDa polypeptides from transformed Bn5T cells, both of 
which give peptide maps showing some similarity to the 
constitutive HSP90.
10-3-3 HSV type-specific induction of the HSP90-related 
polypeptide
Immunoprecipitation experiments carried out by Mr Orr, Dr 
Macnab and the author, have shown that a 90kDa polypeptide 
i.p. by TBS and TG7A is induced by infection with HSV-2, but 
not by HSV-1. Immunoblotting studies by Latchman et a l ., 
(1987) agree with these results, and show that TG7A recognizes 
a 90kDa polypeptide induced by HSV-2, but not HSV-1. In 
addition, we have demonstrated the induction of a 
TG7A-recognized 90kDa polypeptide on tsK infection. This 
agrees with results of Notarianni and Preston (1982) who 
demonstrated HSP90 induction by tsK. It is interesting that 
tsK is an HSV-1 mutant, yet the TG7A-recognized 90kDa 
polypeptide is induced by wt HSV-2, but not wt HSV-1.
Russell et a l ., (1987) have analyzed the induction of 
HSP90 by tsK and have concluded that the induction is due to 
the abnormal Vmw175 polypeptide encoded by the mutant. Our 
studies indicate that HSV-2 also induces a form of HSP90, 
which suggests that like the Vmw175 encoded by tsK, HSV-2 
Vmw175 differs from HSV-1 Vmw175 in such a way as to induce 
the HSP90-related protein. The involvement of Vmw175 in the 
expression of the virus-induced HSP90 may result from:
(1) trans-activation by Vmw175 of a gene encoding 
HSP90-related polypeptide; and (2) complex formation between 
Vmw175 (particularly abnormal forms of the protein) and the 
HSP90-related polypeptide. This might increase the level of
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the HSP90-related polypeptide by a stabilizing effect.
Thus, HSV type-specific induction of HSP90-related 
polypeptide may be due to differences in the DNA binding 
specificity or protein binding activity of the Vmw175 
polypeptides encoded by HSV-1 and HSV-2.
10.3.4 Classification of HSP9Q-related proteins
Our findings suggest the existence of a range of 
HSP90-related proteins and supporting evidence for this, comes 
from several other sources. Hickey et a l . (1986) have 
identified two non-cross hybridizing mRNAs which encode 89kDa 
heat-shock induced proteins. In addition, Ullrich et a l . 
(1986) appear to have shown that the TSTA of a mouse sarcoma 
induced by methylcholanthrene is an HSP90-related protein.
This group has also shown that the TSTA belongs to a highly 
polymorphic family of TSTAs, which vary between individual 
tumours induced by the same or different carcinogens (DuBois 
et a l ., 1982, 1984; DeLeo et a l ., 1977). From these studies 
the potential number of HSP90-related proteins would seem to 
be almost limitless.
We have shown that AC88 recognizes constitutive and 
HSV-induced forms of the HSP90, while TG7A and TBS recognize 
HSV-induced and transformation-induced forms of the HSP90. In 
addition, TG7A and TBS appear to recognize the heat-shock 
induced HSP90. From this data there seem to be at least three 
groups of HSP90-related polypeptide which are: (i) constit­
utively expressed HSP90, e.g. RE:AC88:90, (ii) stress-induced 
HSP90, e.g. REHSV-2:AC88:90 and REHSV-2: TG7A:90 and 
RE-heat-shocked:TG7A:90, and (iii) transformation-related 
HSP90, e.g. Bn5T:TG7A:U90 and Bn5T:TG7A:L90. It is not yet 
known whether different HSP90 forms are induced by the
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different stresses of HSV-2 infection, tsK infection and 
heat-shock, but it will be interesting to compare the peptide 
maps of these polypeptides.
Recognition of the HSV-2 induced HSP90 by TBS suggests 
that this protein, or an antigenically related form, is 
expressed by tumour cells and induces antibodies in the tumour 
bearing animal. In addition, Macnab et a l ., (1985a) showed 
that rat antisera raised against HSV-2 infected cells, contain 
antibodies which i.p. the transformation-related HSP90 from 
Bn5T cells. This suggests that HSP90-related proteins, which 
show altered expression in HSV-2 infected and transformed 
cells, are antigenically closely related and perhaps share 
domains with important functions in oncogenesis.
10.4 Sequence data
Sequence data discussed here was obtained for peptide 
fragments of 97kDa Bn5T polypeptide, prepared by the author 
and Dr J. Macnab (section 9).
10.4.1 Evaluation of amino acid sequence data
Sequence data on peptide fragments the 97kDa Bn5T cell 
polypeptide was analyzed by computer-assisted comparisons with 
sequence data on other polypeptides. This analysis was 
carried out by Dr J. Walker, Mr M. Brunswick and Dr J. Macnab 
with the help of Dr P. Taylor. Of the peptides obtained by 
trypsin digestion, sequence data was obtained on seven (see 
table 9.1) and of these, six showed homology to trypsin and 
one showed no homology to stored sequence data on EMBL 
databases.
Of peptides obtained by cyanogen bromide cleavage, 
sequence data was obtained on eight (table 9*1) and of these
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three showed homology to bovine alphag1-casein (C11, C14 and 
C37), one showed homology to bovine beta-casein (C36), one was 
not evaluated (C25) and three showed no homology to stored 
sequence data on EMBL databases (C10, C17 and C20). Three 
peptides (C14, C36 and C37) were compared with all available 
data on the HSP90 and GRP94, but no homology was detected (Dr 
Macnab, personal communication). The conclusion regarding the 
peptides yielded by trypsin digestion, was that the enzyme had 
yielded peptides by autodigestion and that these peptides had 
been sequenced.
Bovine alpha^-casein has a relative MW of 23.6kDa 
(reviewed by Ribadeau Dumas et a l ., 1975) and contains 199 
amino acid residues (figure 10.1). Our three peptides that 
show sequence homology to this protein, correspond to the 
following residues: residues 26-30 (peptide C14); residues
124-127 (peptide C11); and residues 138-150 (peptide 37). As 
bovine alpha^-casein is approximately 1/4 the MW of the 
polypeptide prepared for sequencing, which has a MW of 97kDa 
as determined by SDS-PAGE, it is possible that bovine casein 
represents one domain on this 97kDa molecule. As the three 
sequenced peptides correspond to widely spaced regions of the 
primary sequence of bovine alpha^-casein protein, it seems 
likely that a major portion of bovine alphag>|-casein would be 
contained within the 97kDa molecule.
Explaining why a bovine protein has been detected in the 
transformed rat cell line, Bn5T, would not appear to present a 
problem. It is quite possible that a bovine protein could 
have entered the system, as the rat cells were cultured in a 
medium containing foetal calf serum. The bovine protein must 
adhere to or be incorporated by the rat cells, as these were 
washed 3X with PBS before preparation of the cell lysate for
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Figure 10.1; Amino acid sequence of bovine alphas>| -casein 
variant B (Mercier et al., 1971). Enclosed amino acid 
residues are those corresponding to substitutions which 
differentiate the known genetic variants. Sequences showing 
homology to peptides C11, C14 and C37 (table 9.1) are 
highlighted.
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large-scale i.p. If the 97kDa polypeptide that we have 
sequenced does represent bovine casein bound to another 
molecule (giving it the apparent MW of 97kDa) then this 
binding would have to be strong, probably covalent binding, as 
otherwise the molecules would have been separated by 
electrophoresis under the reducing conditions used. As 
described in section 1.4 of the Introduction there is an HSP 
called ubiquitin which binds covalently to other proteins, 
targeting them for proteolysis. It is possible that 
radiolabelled rat ubiquitin or a similar rat HSP might bind to 
bovine casein taken up by the transformed rat cell, targeting 
this foreign protein for proteolytic degradation. Such an 
explanation may also account for recognition of the 97kDa, 
polypeptide by TG7A, a monoclonal known to react with HSPs in 
eukaryotic and bacterial cells. Bovine beta-casein has a 
relative MW of 24.0kDa and comprises 209 amino acids (reviewed 
by Ribadeau Dumas et a l ., 1975). Why this protein might also 
be present in the 97kDa band is not clear, but it is possible 
that beta-casein is processed in the rat cell in the same way 
as alpha^-casein, giving a molecule of similar MW.
10.4.2 The reliability of the sequence data
The sequence data would be unreliable if either: (a) the
wrong polypeptide was prepared for sequencing, or (b) the 
sequence data corresponded to a major contaminant. These two 
possibilities will now be considered.
(a) Could the wrong polypeptide have been prepared for 
sequencing? The 97kDa polypeptide prepared for sequence 
analysis was carefully compared with the 97kDa polypeptide in 
standard TBS i.p.s of Bn5T cell lysate to establish that it
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represented the same polypeptide. Apart from the comigration 
on SDS-PAGE of the 97kDa polypeptide bands in large scale and 
standard i.p.s, as detected both by Coomassie blue staining 
and autoradiography, the 97kDa polypeptides were 
indistinguishable on peptide mapping. Peptide mapping with V8 
protease shows that for four independent large-scale 
preparations of the 97kDa polypeptide each prepared on a 
different day and each mapped with two different enzyme 
concentrations, the peptide map pattern obtained was 
indistinguishable from that of the 97kDa polypeptide seen in 
standard i.p. Further, as the large scale preparation 
technique is essentially a scaled-up version of the standard 
i.p. reaction, it would be unlikely to bring down a different 
97kDa polypeptide if the same antibody and antigen are used.
(b) Could the sequence data correspond to a contaminant 
polypeptide? One possible explanation for the sequencing 
result is that a contaminant 97kDa polypeptide was sequenced 
rather than the Bn5T:TBS:U90 which is the polypeptide of 
interest. As bovine proteins are not synthesised in rat 
cells, they would not incorporate ^S-methionine j_n the same 
way as rat polypeptides during translation. It is possible 
then that a 97kDa bovine protein could be present in Bn5T:TBS 
i.p.s prepared by either or both of the techniques used 
(standard and large-scale i.p.s), without giving any evidence 
of its presence on autoradiography.
From peptide mapping studies, the 97kDa polypeptide of 
interest is clearly present in large-scale TBS i.p.s of Bn5T 
cell lysate. It is possible however that this radiolabelled 
97kDa polypeptide has an undetected companion polypeptide 
^hieh accounts for the sequence data. The unseen companion
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polypeptide must co-migrate exactly with the polypeptide of 
interest and co-purify on i.p. It must also be present in at 
least comparable quantity, as four of the eight cyanogen 
bromide peptide fragments of the polypeptide prepared showed 
homology to bovine casein. The sequence data may correspond 
to a contaminant 97kDa polypeptide band which by unfortunate 
coincidence, overlaps the band of interest. The putative 
contaminant polypeptide would presumably be abundant enough to 
give a significant Coomassie blue stained band (as this is a 
criterion used to judge whether one has sufficient material 
for sequencing) and the only significant Coomassie blue 
stained band in the 80kDa to 150kDa range can be seen from 
figure 9.2, to be a 97kDa band which exactly overlaps the 
97kDa band on autoradiography.
From 2-D gel electrophoresis studies by Dr J. Macnab and 
Mr A. Orr, in which separated radiolabelled polypeptides were 
detected by autoradiography, we know that the Bn5T:TBS:U90 
band is composed of a number of polypeptides which incorporate 
^S-methionine. This result suggests caution in the 
interpretation of our sequence data. However, it can also be 
argued that as RE:TBS i.p.s subjected to SDS-PAGE, do not show 
any 97kDa band on autoradiography, all radiolabelled 
polypeptide components of the Bn5T:TBS:U90 band must be 
transformation-specific and therefore of interest.
10.4.4 Sequence data: conclusions
While it seems very unlikely that the polypeptide of 
interest was not present in the polypeptide sample subjected 
for sequence analysis, it is possible that the bovine casein 
sequence data corresponds to a contaminant polypeptide. 
However, if the correct explanation for the sequencing result
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is that the Bn5T:TBS:U90 contains a bovine alpha -,-casein
3 i
domain, this may help to explain why it was not possible to 
demonstrate Bn5T:TBS polypeptides after IVT of Bn5T cell RNA 
and polysomes and also why it was not possible to immunoselect 
Bn5T polysomes with TBS and TG7A.
Whether or not the sequence data corresponds to the 
Bn5T:TBS:U90 polypeptide, the sequence data still poses two 
interesting questions: (a) why is a culture medium protein of
bovine origin, present in abundance, in immunoselected 
fractions of a rat cell lysate, and (b) why does bovine casein 
present in our preparations, migrate under reducing conditions 
on SDS-PAGE, as a protein with an apparent MW of approximately 
4X its known MW?
One possible explanation is that the Bn5T:TBS:U90 
polypeptide is synthesised in Bn5T cells by the covalent 
attachment of rat cell polypeptides (which would incorporate 
radiolabel) to bovine alphag>]-casein which has been taken up 
from the culture medium. Ubiquitin is an example of a 
polypeptide which attaches in this way to certain polypeptides 
to mark them for proteolysis (section 1.4.3). Furthermore, 
ubiquitin is a heat shock protein and therefore a candidate 
target antigen for the monoclonal antibody, TG7A.
10.5 Conclusions and future prospects
The oncofoetal expression of members of the Bn5T:TBS 
polypeptide set suggests that they have a role in cell growth 
and differentiation and the invariable co-expression of these 
polypeptides suggests that they may have related functions.
Evidence is presented which indicates that HSV-2 
infection induces a 90kDa stress protein which is related 
to, but distinct from the HSP90. Antibody and peptide mapping
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studies presented here also indicate that the 97kDa Bn5T 
polypeptide recognized by TG7A (and TBS) is related to the 
constitutive HSP90. However, initial amino acid sequencing 
studies indicate that the 97kDa Bn5T:TBS polypeptide has a 
casein domain. The explanation for this paradoxical finding 
remains to be determined.
The sequencing results suggest that the 97kDa polypeptide 
consists of a bovine casein moiety derived from a culture 
medium protein, and a rat moiety which is covalently attached. 
The rat component may be a polypeptide such as ubiquitin, 
which is a heat-shock protein known to attach covalently to 
abnormal proteins. If this is the correct interpretation of 
the data then it poses many new questions such as: (i) why do
immortalized and transformed rat cells differ from control 
primary rat embryo cell cultures with respect to the 
production of the 97kDa Bn5T:TBS polypeptide, (ii) are the 
other members of the Bn5T:TBS set derived from foreign 
proteins, and (iii) are some other "tumour antigens" in fact 
derived in the same way from foreign proteins taken up from 
the culture medium by transformed cells in culture?
Further studies will be necessary to establish the nature 
of the 97kDa Bn5T:TBS polypeptide with more certainty. These 
include the analysis of Bn5T cell polypeptides from cells 
grown in culture media that do not contain bovine components. 
In addition, the purity of the Bn5T:TBS:U90 polypeptide used 
for sequence analysis will need to be thoroughly assessed 
before repeated sequence analysis is carried out. In 
particular, the presence of non-radiolabelled contaminant 
polypeptides in the 97kDa band will need to be excluded.
186.
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